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xxi 
In contrast to the widespread interest in metabolism 
of tumour cells, the effect of tumour growth on the 
metabolism of non-involved organs of the host has 
received little attention, although the importance of 
this is elucidating systemic effects of tumours is 
great. 
This thesis therefore first set out to study the 
hepatic contents of the key regulatory intermediates 
acetyl CoA, CoA and citrate in liver of mice bearing 
either TLX-S lymphoma, Sarcoma 180 or [1 C3H 
transplantable mammary tumour. Thes2 sbldies showed 
that the hepatic contents of acetyl CoP_ aEd the free 
coenzyme were significantly decreflscd in liver of 
these animals, with concomitant i:1Cl:eas-:;s in the 
citrate content. The direction of chaTlge j n th2 
hepatic contents of acetyl CoA and citt'C~tc were 
opposite to that found in starved tumoll:t:"-.free ard~n2ls, 
and it was suggested that the incr,,~as~ ':"n the hepatic 
contcnt of citrate would favour glu('.oDeogenp.sis cy 
inhibition of phosphofructokinase. 
The changes in the hepatic content ;)f the'S., 
metabolites occurred irrespective of tIle cV!.ldition of 
the animal. Thus mice bearing TLX-S l;nnph'Jma 
presented with anorexia, cachexia and hypoth,~rIT'ta, 
There was also evidence that this t~mov~ invaaed .. J 1.\rer. 
In contrast, both the mammary twnou~ and Sarcoma 180 
remained locally malignant, and the ani.n-lal::; 3"1tC7 v.:,j no 
apparent ill effects of their tumour. 
xxii 
Study of the daily changes of these metabolites 
showed that these occurred at an early stage of tumour 
growth in mice bearing TLX-5 lymphoma. Early changes 
in spleen and thynlUS weights were also found. Later 
in a study adjacent to the main line of enquiry it 
was shO'iVil that in mice bearing Sarcoma 180, the onset 
of thymic atrophy could be correlate.d with the 
begi.nning of loss of body weight. 
The administrati.on of pantothenat.e to mice 
bearing Sarcoma 180 failed to revert the tumour-
induced fall in the hepatic contents of free coenz~ue 
A, but under tllese conditions a marked fall in body 
weight and sple.F:n ';'leight occurred without altering 
the rate of tur.!0U!..' growth. These data suggested 
some defe:.t in the metabolism of pantothenate in mice 
bearing t~is t'-,:;·,uour. 
Further inv2stigni:lons shO'ived that !:he hepatic 
contents of lac t8.ce, pyn:~yate. m'3.1ate, eX -oxoglutarate 
and oxaloacetat r ! were 01. tered iu tumour-·bearing mice. 
Calculati.on of tn.:; cytosolic NAD+ / NADH ratios in 
these li veT'S, shC"·':f.!d that th~ cy topLlsm was in a mor,::. 
reduced state. than IJomt.?'.l, and it ';'laS suggested that 
this might favour' g.lJlC-V!1t':ogenesis. Decreases in the 
hepatic conren-cs Of hTP: ADP and M-f? ;'yere also found, 
but the ratios ATP / ADF and /,T? /AMP did not change 
significantly in mice beaTing .3arcoma 180, although 
the latter rat~o fell 3ig~ificantly in mice bearing 
the lymphoma. 
I twas s ~:.re s.3C'd 11o':.;'f"er, that determination of 
the whole cell content of some of these metabolites 
xxiii 
requires careful interpretation due to the well-
recognised problem of cornpartmentation. 
An increase in the lactate content of blood as 
a possible reason for the increase in the hepatic 
content of citrate in mice bearing either TLX-S 
lymphoma or Sarcoma 180 was examined. In the former 
model blood lactate was not significantly altered, 
but in the latter 9 this showed significant decreases. 
In both models, blood glucose values were significantly 
decreased. 
Although it was previously suggested that the 
increase in the hepatic content of citrat.e in these 
livers would favour gluconeogenesis, by citrate-
inhibition of phosphofructokinase~ the ccc.tivity of 
the latter, as well as that of frt.J.c 1:.ose-diphosphatase 
in liver of mice bearing TLX-S lymphoma ,,"as nGt changed 
significantly. The conditions of the J~~'·iSE£ assay 
of these enzymes did not however nec238f~~ly reflect 
the conditions in vivo. It was a1s.:.., f\.;~nJ. that the 
hepatic contents of glucose-G-phcsphat:.e 9.nd frllct:ose-
6-pnosphate were significantly dec) ea<:'l~d .I.E • 1 • \T,lc.e .:'ea~lng 
TLX-S lymphoma. A decrease in the ('.0nt~!-,'C 'Ji £::~uctose" 
6-phosphate would also suggest a decl-ense i:l t1:J.~ 
activity of phosphofructokinase. 
The possibility that the increas€.d CO:lt..:mt. cf 
citrate in tumour bearing mice involved SOntf; ,5'L~:;i:u'rbance 
of lipid metabolism due to inhibi t.iOit (If A'.~lJ-c i. CCC;.L.e 
lyase was next examined. These studies showed chat 
the activity of this enzyme was significffilt].y decreased 
in liver of mice bearing either TLX-S lymphc,:uEi or 
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Sarcoma 180. The question then arose as to whether 
the tumour·~induced changes in the hepatic contents of 
acetyl GoA and citrate could be altered by starvation 
of tumour-bearing mice. Under these conditions 
however, the hepatic contents of acetyl GoA did not 
increase, nor did a significant decrease in citrate 
occur, and in fact in starved mice bearing Sarcoma 180, 
the hepatic contents of citrate showed further increases. 
The aCetyl GoA/GoASH ratios in liver of fed mice 
bearing Sa.!:('..oma 180 were not significantly altered 
when compared to normal fed mice. Starvation of mice 
bearing this tUllour increased the ratio acetyl GoA/ 
CoASH i.n 0 . .sinrLlar manner to that found in starved 
tumour-fret..,: rd.ce. In contrast in fed mice bearing 
TLX-S lyrrlphoma, this ratio was increased significantly, 
but '\'Jhen these animals were starved, changes in the 
ratio did not oc~ur. However there was no evidence 
of k.etonuria in mice bearing either TLX~S lymphoma or 
Sarcor.i.2 ~ :)0. 
The ~.Ilcrease in the hepatic content of citrate 
tn fed or fe.sted tumour-bearing mice was considered to 
be of suf:EicienL magnitude to a(~tivate acetyl GoA 
carboxylaDe, ar.d stimulate fatty acid synthesis. It 
w~s also p0iuted out that the failure to reduce the 
hepat.1_c c0ntsnts of citrate by starvation of tumour-
bearing !llice could indicate that the regulation of 
[&tty acid synthesis in liver of these animals was 
out of control. 
Further investigations showed that in mice bearing 
TLX-S lymphoma, there was a two-fold increase in weight 
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of epididymal adipose tissue, whereas in mice bearing 
the sarcoma, decreases were found. The hepatic 
content of triglycerides in the latter model also 
showed significant decreases. When both of these 
models were starved, the weight of the epididymal fat 
pads of mice bearing Sarcoma 180 decreased further. 
There were no significant changes however in the weight 
of the epididymal adipose tissues in starved mice bearing 
the lymphoma. These data suggested that the two 
tumours had different effects of fat. mobilisation in 
their host, and this was discussed in terms of 
disturbances of hormonal activity in these animals. 
The ear~ier observation that changes in the hepatic 
contents of ("cetyl CoA, CoASH and c.~trr-l_te occurred 
shortly fo ,_ LO':v'ing tumO~1.r implant suggested that 
produc ts of turr,:)'.l:C might be in\Tolved in the 
aetiology cf th·.?se ,::.hA.::.ges. This was supported by 
the observation U:at C'-l.:i'ClLive resection of a small 
localised m8ITnnc:tCy tUillC,ur could :~e<.T~;rt these changes 
to nO'!:'mal, Fl~rtQ<o..c, Khen the resEction was unsuccess-
ful th9 t1..'I1l011T -irh~l1Ced (:.hanges ~n tht:> contents of tllP.se 
metabolites also r2cur~pd. 
I . (">.!,..'1 c· d' n suppurr or c~pse Lln lngs, it was also shown 
that change,::; i.n the hepatic contents uf these 
meta.bolites could 8.1so be irLd·,.~c..~d ii.1 normal mice 
following the in!.r3},.'::>ritoneal injection of a cell-free 
preparation of TLX<j lyftpc.l.oma .:::.el1s, or in some 
ins tances rwn-viablt.: t12...~o~r cells. 
Finally ~ ultrclstTuc1.:ural changes in liver of 
mice bearing Sarcomc, \';21:'e studied to examine whether 
xxvi 
there was evidence of injury to mitochondria. These 
studies showed that mitochondria in these livers were 
swollen with loss of cristae. Other changes were 
also observed. It was also shown that these effects 
on mitochondria could also be induced in normal mice 
following the intraperitoneal injection of a cell-free 
preparation of TLX-S lymphoma cells. 
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FOREWORD 
'Tumour-host L2lations exist, they are part of 
the natural history of cancer and the host, and 
until an understanding of them is achieved only 
a partial knowledge of cancer will be attained'. 
Begg (1958) 
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I N T ROD U C T ION 
General 
It has long been recognised that the growth of 
malignant tumours in man, and experimental animals 
may cause marked alterations in the physiological 
state of their host, that cannot be attributed to 
mechanical interference with vital organs, or as a 
result of the secretion of hormones by the tumour 
cells. These systemic effects of a tumour are 
generally referred to as cachexia, a symptom complex 
that has been estimated to be the m03t frequent cause 
of death in cancer patients (Warre!l, 1.~32) .. 
According to Theologides (197~), C8.r.cer cachexia, 
in patients is characterised by ano1':'~=xia, loss of body 
weight with depletion of fat and ot~'1er cC:'.lpone1J.ts, 
water and electrolyte abnormalities, ar..o irJ(,rcCised 
energy expenditure. Metabolic abnor.nc:.ll.i:.ies such as 
hypoalburninaemia (Mider, Alling and t:::crtJn~ 19)0; 
Winzler, 1953), hypoglycaemia (Marks, Steinke, POdolsky 
and Egdahl, 1974), and disturbances of li~.)id ~nc!;e.boli3m 
(Barclay, Skipski, Terebus-Kekish, Green(": ~ J\.[l.t1.frn'lli. and 
Stock, 1970) have also been reported. 
Clinical observations have shm"D ~:hat .Qi.)fi'.P l?~.ti.ents 
may present with cachexia at an early 3tag(~ c,f tU:::lour 
growth. However, others may only ber,olne cd(;.l-u'o·ctic 
at the terminal stage of their illness. 
In man and experimental animals it. lS \\ff:l1~ 
rf>.co.:rnised that different neoDlasms mav Drociuce very 
- - I...,..J ~ ~ 1...; .l. _ 
different systemic effects on their host. ThliS SOille 
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features of the cachexia syndrome may predominate 
over others. This is a complicating factor, not only 
"in attempts to define the mechanisms involved, but 
also in defining which particular systemic effect may 
be of prime importance. 
In spite of much investigation, the pathogenesis 
of cancer cachexia remains obscure. The problem of 
elucidating even one of the many systemic effects of 
a tumour on its host is reflected in a voluminous 
literature. Several authorities have discussed the 
problem in patients (Costa, 1963; De Wys, 1970; 
Theologidc.::s 1972; Bondy, 1976) and excellent re.views 
have been written on the systemic effects of tumour 
growth :Ln GlHfllJ. animals (Haven and Bloor, 1956; Begg, 
1958; Costa, 1963; Shapot, 1972). The immunological 
parameters of tlimour-host relations have also been 
document.ed (Horton, 1973). 
Vlii:hollt assuming too close a relationship between 
the syste:nic effects of transplant.able and induced 
tumours in srmll animals, and. those found in cancer 
patients, many similarities exist. 
In tUElour~-bearing animals these include anorexi.a, 
loss of body weight with depletion of fat and nitrogen 
(Mider, Shcrrr.an and Morton, 1949; Haven, Bloor and 
Randall, 194.9) , extensive muscle wasting (Sherman, 
MOl-ton and Mider, 1950), and increased energy expenditure 
(Hider, 1951; Pratt and Putney, 1958). Disturbances 
of lipid and carbohydrate metabolism have also been 
reported. 
The described effects of alterations in lipid 
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metabolism include loss of body fat (Boyd, Connell 
and HcEwans 1952), hyperlipaemia (Begg and Lotz, 1956; 
Haven and Bloor, 1956) and alterations in the pattern 
of circulat.ing lipoproteins (Creinin and Narayan, 1971; 
Cox and Gokcen, 1975). Although little is known of 
the mechanisms involved in these changes, it is likely 
that some can be attributed to anorexia (Costa, Lyles 
and Ullrich, 1976). It is known however that some 
tumour systems will induce loss of body fat in their 
host witnntl"::' inducing anorexia (Costa and Holland, 
1962). Also as discussed later it has recently been 
proposed tlu:it the disturbances of lipid metabolism and 
decreased fooi intake in some tumour-bearing mice may 
be mediClted by the release of a humoral factor from 
the tumour cells (Liebelt, Liebelt and Johnston, 1971). 
Disturban(2.':~s of carbohydrate metabolism in tumour-
bec:.r:Lrlg animals has been recognised for many Y2ars, 
8.Yld h3ve heen discussed by Costa (1963), and more 
cece~tlv by Shapot (1972). These effects of a tumour 
include lU8s of liver glycogen (HcFadzean and Jeung, 
1956; CA.:r:ey, Pretlow, Ezdinli and Holland, 1966), and 
hypoglycae:aia (Nallick, Banerj ee, and Shrivastava, 1968; 
Shapot and Blinov, 1974). 
It SEem~ likely that depletion of the glycogen 
reserve8 :eay ir..volve stimulation by glucagon (Shapot, 
1972), ~1..Lt the hypoglycaemia observed in some tumour-
lH~aT.ir..g animals is more difficult to explain. An 
excessive consumption of glucose by the tumour cells, 
'?[lich is utilised not only for the synthesis of amino 
acids (Campbell and Halliday, 1957) but also of pentose 
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of nucleic acids (Shapot, 1972), may be involved. 
However it is known that some tumour systems do not 
induce hypoglycaemia in the host, and this may 
involve an increase in gluconeogenesis in the host 
(Gutman, Thilo and Biran, 1969; Shapot and Blinov, 
1974) to maintain the normal level of blood glucose. 
Several studies have shown that growth of tumours 
in experimental animals may cause structural changes 
in organs distal to the tumour mass, and hypertrophy 
of spleen, liver and adrenals, and atrophy of the 
th~nus have been well-documented (Haven and Bloor, 1956; 
Begg, 1958; Medigreceaunu, 1970; l11cclogides and 
Pegelow, 1970). These changes al'f..~ fnUild in the absence 
of metastases in these organs, and :-lone s.rt' specific 
to the presence of a tumour. Se\,e:r:al factors appear 
to be involved. They include a:: ~liscu£;:ed in a later 
section of this thesis $ not only tl1t: ir.::n.I'HlOL)gi" a1 
response of the host, :)ut also metabolic e.iaptut::.or: to 
the presence of a tumour. 
In summary therefore, the syst8mic. ~f tE:-:.ts of a 
growing tumour in small animals CI.ay de?erl>:~ 'upon dle 
tumour system used. Also associated paLhologic~l 
states such as hormonal imbalance, and a1. te-:'2.:.:1f)J.12 in 
the nutritional status of the host [T.ay be Ervclved. 
There is also the possibility that somA of these effscts 
on the host are due to the release of prodl'::::-~ LTOhl t.he 
tumour cells. 
The following sections now discuss in inCl.·e detail 
some of the systemic effects of tumou:rs Lhal.- ,--~re 
pertinent to the studies to be presented in this thesis. 
SOME SYSTEMIC EFFECTS OF Till10URS 
ON THEIR HOST 
Loss of Body Weight 
Progressive weight loss is a frequent finding in 
cancer patients and tumour-bearing animals (Theologides, 
1972). Although in some patients this can be 
attributed to anorexia, malabsorption, and increased 
energy expenditure, there is considerable evidence 
both from clinical observation in patients, and 
studies on experimental animals that other factors are 
involved (Theologides, 1972; Bondy, 1°76). It is 
well-recognised for example that \-i.2ighc. loss may be 
the first manifestation of malignant dLsease, and also 
weight loss may occur in patients wi~l) advanced cancer, 
and in whom the caloric intake is more ~-han 8.d.eqllate. 
In such situations it has been p-rop'Jsed that tmdc 
factors released from the tumour cells may be :!'!17IJJxe.d 
(Donovan, 1954; Begg, 1958; Gellhorn, 1,970), bLJ.i:: as 
discussed later, the release of toxi~ facLors £r.om 
tumour cells in vivo has been clifficu:t to prO\T2. 
Attempts to induce weight gain ill t.umou:t.:~hE:.d.r:ing 
rats by force-feeding ha'fiebeen extensive·i..y i.r:vestigated 
(Begg and Dickenson, 1951; Stewart 3.n~l Begg, 1953; 
Mider, 1953; Sugimura, Birnbaum, Hil1i t~~ and G:ceenst.f.dr:, 
1959) but only a temporary improvement- Wa..3 af..:hieved. 
In these animals such treatment can be (;'(,TIsidel :::0 
unphysiological, and stress may influence th~ resuy.t.s. 
Intravenous feeding has also been studiedi.:r1 ;::1:..1,10\ll"-
bearing an.imals, but according to one report (Carneron 
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and Pavlat, 1976) the additional nutrition evoked a 
greater rate of tumour growth. However in recent 
studies on the effect of intravenous hyperalimentation 
in tumour-bearing rats it has been shmvn that although 
the absolute weight of the tumour increased, the ratio 
of tumour weight to body weight did not alter 
significantly (Ota, Copeland, Strobel, Daly, Gum, 
Guinn and Dudrick, 1977). 
Dudrick and his group have also shown that 
intravenous hyperali.mentation may induce weight gain 
in some cancer patients (Copeland, MacFadyen and 
Dudrick, 197L~). 
The earlier studies leading t.o t,~1.e COi.1.ccpt that 
tumours act as nitrogen 'traps' and G!::ilisi~ nitrogen 
from the tissues of the host when to.8 tntake of dietary 
nitrogen is reduced have been revlc;wed L,\T l~ider (1953) 
and Costa (1963). It has also beel.J rec..2ntl_y I_dstulatec; 
that tumours may 'trap' glucose and posc.:ib1y V·it8'I"~ns 
as well (Shapot, 1972). Although there is SOiT18 
evidence of an increased uptake of gJ.1.2COSQ '::Jy tumnUi:'S 
in viyo (Norman and Smith, 19SG; CarnO:')l2]t. and Hal1ic1ay~ 
1957) as well as amino acids (Yamamota, Ai.ka.~']ill 
Matsutaka, and I shiwaka , 1974), the upt6.\e of cu1 
essential nutrient such as a vitam5.n ] ea(iLlg to iLs 
depletion in the host has not been documented. 
Rivlin (1973) has investigated t:1e me i· Ci"'u,)"!, i3f!', (.'f 
riboflavin in tumour-bearing animal s. -t-~e "has stlg::estcd 
that tumours may affect the metabolism of vitCJn.~D~, 
and in studies to be presented later :t i.3 ~l-H:W'l. ~hat 
treatment of mice bearing Sarcoma 180 with pantothenate 
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induces a marked loss of body weight. There was also 
a reversal of the hypertrophy of spleen in these 
animals. These studies are presented in Chapter 2. 
As discussed therein, Ghadially and Wiseman (1956), 
have reported that supplementation of the diet of rats 
bearing RD3 sarcoma with methionine induces the tissues 
of the host to waste, and at the same time increases 
the rate of tumour growth. In our own studies 
however, tumour growth was not affected by treatment 
of the animals with the vitamin. 
MORPHOLOGICAL CHANGES IN ORGANS ____ "-.<::>11< __ 
OF THE HOST 
Al t11\)Up:h earlier l,\'orkers have rc:ported on the 
hypertrophy of .',pleen 1 1 iver ar,d ad:Lenals and atrophy 
of thymus iIi. turaour-bea:r.ing animals, j n ~cecent years 
attention h&~. been limited. 
These 8 tud19.3 have b~en !.·~~.rL'2'''ied by Haven and 
Bloor (195S·), <1.nd b~,,; Begg (1958) W~lO has also discussed 
the aS8oci.:::.ted llj :..i.:opa1.:!lo1oglcal C~all[;e.8 in these orgalls. 
Liver 
Analys:"s ,)f livers ~.Jf turnour-h\;~::n.ing animals has 
shown that lhe l,vater c0ntent (?-1cI:wr-.:n and Haven, 1941) 
as well as th:J.t: of r~;.t:t·(}8en (Shcr::lan, Morton and Mider, 
1950) is incre~sod. l;"e J:e8.S0il for these changes is 
unclear, bu',:, malr.ut:citi~n is not responsible since in 
starved an:im.s.J.s l:v:~[ Ht':L~ht decreases (Harrison, 1953). 
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According to Wiseman and Ghadially (l958)s the 
enlarged liver of the tumour-bearing host may reflect 
an increase in metabolic activity~ This would be 
consistent with a previous report of increased mitotic 
activity in liver of tumour-bearing animals (Malmgren, 
1956), as well as a more recent finding of increased 
synthesis of DNA (Rev-Kury, Kury and Friedell, 1966). 
Increases in both of these parameters may reflect 
increases in the activity of several enzymes involved 
in the synthesis of macromolecules (He·.::-zfeld and 
Greengard, 1972). 
Al thr)ugh (,xplanations for tl .... e 2nl argement of 
liver of t~le t.Uflloll-r-bearing host TSlU8io r)peculative~ 
it is of ir.te-rest that Toporek (].9/3) has show"U that 
there is !:l dec.rease in synthesis of serum proteins in 
liver of "Sumou:.:'~hearin[; rats, concomi t.ant. with an 
increased s)lrltht-~sis of liver proteins. Ii.:: was al so 
shown in these stud:Les t:hat both of these changes may 
involve a humorc.l faclor from l::.(;:! Lli.rnOUr cells. 
Hypertrophy of splFf~n in t.um0ur-bea:d.ng animals 
is a frequent. findL1.'iS (JteVlart and Begg, 1953; 
Medigrecenat,nu, 1070), aEd one of t.:ie most striking 
morphological chan8es seen. 
Rapid eniaJ:'gelw::r,t:. 0f spleen has been reported to 
occur follO\'1in; i:'-1'fl()U~ j mplant (Siegler and Koprowska, 
1962), and this has also been observed in the present 
studies on trilllour-bea.d .. ng mice. It has also been 
found in normal anit'als foll'Jwing the injection of 
is 
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extracts of various tumours - the so-called 
'toxohormone' - (Nakahara and Fukuoka, 1958; 
Kampschmidt; Adams and McCoy, 1959). 
As described later, the present author and 
colleagues (McAllister, Soukop and Calman, 1977), 
have shown that the enlarged spleen of mice bearing 
small localised mammary tumours is reverted to normal 
following a c~rative resection. Also as described 
later, t~li~ inj ection of cell-free ascitic fluid from 
mice bearing TLX-5 lymphoma, into normal mice also 
induces hype'rtrophy of spleen (as well as thymic 
atrophy) • 
These observations support the view that hyper-
trophy of spLeen. in tumour-bearing animals is due to 
the imnunological response (Konda, Nakao and Smith, 
1973; Konda 8:nc. Smith, 1973). They also suggest 
t.hat productE:, of tumour cells may be involved in this 
effects and these are being investigated at present. 
Thymus 
Although atrophy of the thymus of tumour-bearing 
animal s has ceen recognised for many years (Larionmv, 
1932; FltkL:c(j~a. and Nakahara, 1952; Simu, Toma, Nestor 
and Rosculet, 1968; Ert1, 1973), very little is known 
cf the mAchanisms involved. 
Ertl (1973) considers that thymic atrophy is 
related to hypertrophy of the adrena1s but the latter 
is a much less frequent finding (Nakahara and Fukuoka, 
1958) and thymic atrophy is diminished, but not 
abolished in adrenalectomised tumour-bearing rats 
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(Simu, Toma, Nestor and Rosculet, 1968). 
Studies on mice bearing MT890 ascitic tumour 
have shmvn that the beginning of thymic atrophy in 
these animals corresponded with enlargement of spleen, 
and histopathological changes in liver (Siegler and 
Koprowska, 1962). Later Ertl (1973) showed that the 
commencement of thymic atrophy in rats bearing Walker 
256 carcinoma could be related to the beginning of 
loss of body 'Yleight and progressive cachexia. 
These findings suggest a close physiological 
relationship between thymic atrophy and some of the 
systemic effects of a tumour, and later it is shown 
that the cci.bove relationship between thymic atrophy and 
loss of body v7eight is also found in mice bearing 
SarcomEt 180 (Chapter 8). 
Adrenals 
The histological and histochemical changes that 
OCCUl" i.n the adrenal of some tumour-bearing animals 
have been extensively studie.d (Haven and Bloor, 1956; 
Er t 1 , 19"/ 3 ) • 
According to some reports, hyperfunction of the 
adrenals with hypersecretion of glucocorticoids can 
be detcc'ced durilJ.g the early stages of tumour growth. 
In the lotter stages, these changes lead to exhaustive 
insufficiency, with depletion of the glucocorticoid 
reserves (Allot and Skelton, 1960; Ertl, 1973). 
Not all authors are in agreement with these findings. 
For example, increased hypophyseo-adrenal function, 
and increase in the plasma 
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corticosterone levels have also been described in the 
advanced stages of tumour growth in rats (Nakata, 
Suematsu, Nakata, Hatsumoto and Sakamoto, 1964). 
The importance however of glucocorticoids in the 
enhancement of gluconeogenesis is \vell recognised 
(for reviews see Weber, 1968 and Exton, 1972). Such 
mechanisms include the induction of several amino-
transferases in liver (Barnabel and Spreni, 1962; 
Estrada and Cordoba, 1963; Beat'), Ka1:Lmi and Feigelson, 
1972) and increased activity of several of these 
enzymes have also been reported in liver of tumour~ 
bearing 81J.:LlTlD.1.3 (Nakata, Suematsu~ Nakat.a, Hatsumoto 
and Sakofn0to; 1')64; Greengarcl, B2.~(CC c:md Friedell, 
1967) . 
Acco-rclil1g t.o Shapot (1972), l:he hypersecretion of 
glucocortic.oids \11ay be involved in t".he enhancement of 
gluconeogene:::~_s in tumuur-bearing animals. 
ULTP .. lI.ST:<.UCTURAL CHANGSS iN LIVER 
OF TUHOUR-BEARING Ara~LALS 
Several workers have described Ch<::tllg2S in the 
hepatocellular ultra.3tructures t.hat fre1uently accompany 
the grmvth ::>f localised 8ubcutaneo'C.s L1eoplasm:~ in small 
animals (Ghadially and Par:ry, J. 965; Parry a.nd Gha.dially, 
1966, 1967 s 1969 ~ ~<lla,.i.de1::ar, Dardachte J Garg, Tuchweber 
and Kovacs, 1972; Bhai18n~ Frisdell and Jacobs, 1975)~ 
but some of the findings differ according to the species 
of animal 'Used, tile LYfJc of tumour, and the condition 
of Lhe animal at the time of the observations 
11 
(Khandekar, Dardachte, Garg, Tuchweber and Kovacs, 1972). 
Parry and Ghadially (1966) studied rats bearing 
,subcutaneous carcinogen-induced tumours when the 
animals were in the agonal phase, and showed that 
these changes included marked swelling of mitochondria 
indicative of an uncoupling of oxidative phosphorylation. 
However, according to Baldwin, George and Cunningham 
(1975), mitochondria from livers of ~ats bearing 
Walker 256 carcinoma at a stage ,vhen the animals 
remained healthy showed no differen~2s in the rate of 
loss of respiratory control, although when the animals 
were near deatl"l r liver mitochondria coulr::l not catalyse 
ATP formation. 
These £1:ldings on the biochemical evidence alone, 
were consid'2red to indicate that ul tra~structural 
changes :Ln mi toc:lOndria '.'1ere due to the ciegenerati ve 
process of dying, and not tu the tunour per see 
However J or.~ier work9rs have reported that the 
growth of a Lrail.~jplantable ma!lnnary t'l"lH10nr in rats also 
induced ultra~structural changes in mitochondria in 
liver of the a;.)pm.:ently beal thy hos t (Kl1}~ndekar, 
Dardachte, G.:frg, Tuchwebi;;r and Kovacs: 1972). These 
latter workers proposee that hepatic fine structural 
changes in t'hese. liver::~ w~re due to 3. dir:ect toxic 
effec t of the: tumou;:, ~ a viai' also [JI.:!1.Q by' Bhawan and 
Friedell, 197.5). .:;U"':~l ~rc,posa13 are of interest 
because in a pL2V.;.O~J.s s1:'.1dy (Pa:i_TY and Ghadially, 1970) 
it was found that treatment of normal rat with a highly 
purified toxoh0rrnone E...f_'2'J i::lduced changes in 
11epatocellular ultra-structures that paralled these 
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changes in animals hosting the subcutaneous tumour. 
Later in Chapter 7, it is shown that growth of 
subcutaneous Sarcoma 180 in mice induces several 
ultrastructural changes in liver of these animals, 
that include swelling of mitochondria and loss of 
cristae. It is also sho~1 therein, that such changes 
can also be induced in normal mice following the 
injection of cell-free ascitic fluid from mice 
b . r"T X ,.. 1 h earlng L, .'~'.) J_yrnp oma. 
EARLY SYSTEMIC EFFECTS OF TUMOUR GROHTH 
IN SMALL ANI~1ALS 
In 19G3 J in a review on cancer cachexia, Costa 
wrote, 
'Anothe.r point of importance is to establish 
\,7hether the systemic effects of tumours are a continuous 
runc.tion 0:[ tumour mass, .whether they are related to 
the :ratc of tu.rnour growth, or are, rather, phenomena 
\vhich reach their full expression at some time during 
the ,::ourse o:!: the neoplasm progressing thereafter as 
a function of tilne unaffected by subsequent behaviour 
of the tliffiOUT I • 
Prio-rto that time, some observations had been 
!"Da.de on early measurable changes that occurred in 
animals shortly after tumour implant. Pratt and 
P1...I.L:.ney (1958) for instance reported increases in 
energy expenditure in rats shortly after tumour 
iluplant, and other workers (Haven, Bloor and Randall, 
1951) showed that mobilisation of body fat occurs at 
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an early stage of growth of the Walker 256 carcinoma 
in rats, during the period '\ilhen food intake remained 
normal, and before the carbohydrate and protein stores 
became depleted. In support of these observations, 
Costa and Holland (1962) described an early acute fat 
loss in mice bearing Krebs-2 carcinoma, that occurred 
during the first week and'when the tumour was just 
palpable. They also found that an increase in oxygen 
consumption could be detected 12 hours after 
implantation of the tumour in these animals. 
Since then, more recent studies have ShO'\VI1 that 
changes occur in several serum lipid fT8ctlons three 
to four days after implantation of EhrL1 ch ascites 
tumour in mice (Creinin and NarayC'.n, 1~71)~ or 
following the inj ection of Simian v:l rIS L~O into Syrian 
hamsters (Cox and Goke-en, 1975). 
That such early changes are 110;-: clin::ino.d L.' 
disturbances of lipid :netabolisrn is evicienc.ed by the 
investigations of Herzfeld and Gre2ngar,rl (1.972) W[lO 
have shown that the activity of or:lithine ~inol::.:cansierase 
in liver of tumour-bearing rB.t.S :311,Y:7S 8. rl~~~xked dec:ce&se 
in as short a time as four hours after t'.ltll0U.c L;:I"t-)J.aJ.lt. 
In Chapter 2 of this thesis, evidt:.nce 1.8 ~}rcse:lted 
showing the 24 hours after tu..rnour irr,plant in TTlico;:-· 
significant changes occur in the hepatic ccn'.:ent.s 02 
acetyl CoA and citrate. 
change in the acetyl eoA content of b.ve:r ' of thl'"_sc 
animals may be related to a report i:hat C'.ppeareu'.J.~t~er 
our observations, showing that the adlf'.inL;t y 2.t.ir.'71 of 
, I, 
~~C-tripalmitin to mice bearing Krebs-2 carcinoma, 
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resulted in a marked suppression of CO 2 , that was 
detectable within 24 hours of tumour implant. It 
was also shmvn that this procedure may have potential 
significance in the detection of cancer in patients 
(Costa, Lyles and Ullrich, 1976). 
A cautionary note however must be made as to the 
use of animal models in such studies, because as Liebelt 
et a1. (197L·,) have pointed out, the sudden imposition 
of a rapidly growing population of tumour cells on a 
healthy and oiten young animal is of obvious marked 
contrast to the more chronic series of events that are 
found in ti:le human situation. 
Thif' 8.l-,rupt challenge to the host is no doubt 
responsible fer the immunological response evidenced 
as already described by hypertrophy of spleen, but the 
other chan:,;e~ i!lduced in the host, including our own 
observat1c1:l3 of rapid changes in the hepatic content 
of :ccguL9tory intermediates are less understood. 
The involvement of factors of tumour origin 
cannot be exc.luded from the aetiology of these early 
systemic effects of tumours, and as described in a 
later ChQpter (6), we have found evidence of this in 
our o'\'m nbservr-i.tions. 
SOT'-!E HECHt.NISMS THAT HAVE BEEN PROPOSED 
n~ THE PATHOGENESIS OF CANCER CACHEXIA 
The literature on cancer cachexia contains many 
~.ypothes:is (Costa, 1963; Gold, 1968; Theologides, 
1972; Gold, 1974; Theologides s 1974). 
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The many similarities that exist between 
starvation and cancer cachexia, incl.uding weight loss 
and thymolymphatic atrophy have led to proposals that 
the large dietary demands of a tumour on its host may 
be responsible for loss of body weight and negative 
nitrogen balance. The force-feeding experiments on 
rats that have already been cited have shown however 
that malnutrition alone is not responsible (The010gides, 
1972). Such evidence however has been obtained under 
unphysiological conditions (Costa, 1963), and is 
complicated by the fact that the nutritional status of 
the host is known not only to affect tumour growth 
(Tannenbaum and Silverstone, 1953; GtL8.cially and Wiseman, 
1956; Henderson and Le Page, 1959; Cc.rneron and 
Pavlat, 1974) bue also to affect ;::'[!E~ metabolism of the 
tumour CRossn, Budwick, Solomon and N:Lchol~ 1961; Ota, 
Copeland, St.robel, Daly, Gum, Guinn and '::'udrick, 1977). 
In the former i.nstance, this effect may involve alterations 
in the immlll1.ol(lgical stc.tus of '..:.he l1.ost, which in both 
malnourished (Cannon, 19l1-9; R03S ;:me! Bras, 1965) and 
tumour~be8.ring 3.nimals s c.hanges an:~ found. 
A llilique situation also exists between starvation 
and cancer cachexia, if' that in 8tarved animals liver 
\veight dec}~eases (:-Iarri::.on, 1953) where.s.s in tUJ."110Ur-
bearing animal s inc"C(~a ses in t.he N?ign.-c ::-f liver occur. 
It has already been noted that this ITkty involve an 
increase in met.a.bolis"iIl of liver in the tumour-bearing 
host (Wisema2 and Ghaii811y, 1958). Also in starved 
tumour-free animals the metabolic rate decreases 
whereas in both cancer patients (Ge1lhorn and Holland, 
1954; Theologides, 1972) and animals hosting tmnours 
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increases are found (Pratt and Putney, 1958). Part 
at least of this increase in oxygen consumption by the 
tumour-bearing host may be due to the high energy 
demands of gluconeogenesis (Bondy, 1976). 
The nutritional aspects of malignant disease 
have been discussed in detail by Tannenbaum and 
Silverstone (1953) and more recently by Copeland, 
MacFadyen and Dudrick (1974). 
As discussed later in this sectioll much attention 
has also been paid to the possibility that tumours 
secrete toxic products that perturb metabolism in the 
host (Nakahar& and Fukuoka, 1958; Kmnpschmidt, 1970; 
Olivares) 1970). 
It 1::&S also been proposed that: tumours induce a 
greatly aug,m.ept8d pathway of gluconeogenesis in the 
host, ane! t.hat 8nch a ITli=chanism is in\7c)'/ed in the 
pathogenesis o~ caClcer cachexia (Gold~ 1968; Shapot, 
19 7 2 G -," ] :\ ~ /. ) ; 0.1.<1, .. I~<, • 
The ev~_dence for an increase in gluconeogenesis 
in th~:::: tl.JTi).01_E:·~hea,,:,~_ng host however is largely 
circumsta.ntial. 
Further, althongh 3.l! incre2.se in Cori cycle activity 
in cancer pp.t:i.entb occ.urs when compared to patients 
wi th oth2r j,isc-:!ases (Reichani, M':)U~cy > Hoe-hella, 
Patterson and Heinhollsc) 1963), as Shapot and Blinov 
(1974) have pointed ou~-:. n~ data on gluconeogenesis in 
tumour-beal-ing anim9ls from lipid or amino acids can 
be found in the U.t(~j_ai...ul'C' prior to that date. 
Although severA.l reports have described changes 
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in the activities of several enzymes in liver of tumour~ 
bearing animals (Kampschmidt) Adams and McCoy, 1959; 
Suda, Tanaka, Sue, Harana and Morimura, 1966; Greengard, 
Baker and Friedell, 1967; Gutman, Thilo and Biran, 
1969; Herzfeld and Greengard, 1972; Isohashi, Terada, 
Nakanishi and Sakamoto, 1976), very little attention 
has been paid to the regulation of intermediary 
metabolism in liver of tumour-bearing animals, although 
the potential. importance of this in the pathogenesis 
of canceT c8.chexia is great. 
It has been postulated however that in cancer 
cachexic: s'~(:.h regulatory mechanisms are disrupted 
(Theologides, 1.972). According to this suggestion 
tumours prc'duce low molecular weight metabolites such 
as polypeptides and nucleotides that allosterically 
activate and inactivate various enzyme systems in the 
hO~3t. Alterat.ions in various metabolic equilibria 
a::e the:"eby effected, and to quote, 'throws the 
'fu:.tahoL.:-;Tll of the host into a chaotic state I • 
It has also been proposed (Marks, Steinke, 
Pod2.lsky U:1.d Egdahl, 1974) tilat the hypoglycaemia in 
patieEts with large single neoplasms may be due to the 
release of t-ryptophan, a known inhibitor of 
gluconeoger!esis (Ray, Foster and Lardy, 1966), or short 
chA::.TI pclypeptides with a similar effect. 
ThE:re was however li.ttle experimental evidence 
tl:at tumour growth perturbed intermediary metabolism 
in liver of the host, by mechanisms involving alterations 
~.;:} key glycolytic intermediates or those involved in 
tricarboxylic acid cycle activity. Extensive 
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investigations were therefore begun on these lines 
(CaIman and McAllister, 1975a, 1975b; McAllister, 
Soukop and Calman, 1976; McAllister, Soukop and 
Calman, 1977). 
The possibility that some of these changes may 
be related to the production of factors from tumour 
cells was also investigated (McAllister, Soukop and 
Calman, 1977), and are presented later in this thesis. 
As discussed later in this section, some of these 
studies had considerable bearing on the proposal 
(Gold, 1968, 1972; Shapot, 1972) that booour growth 
induces an augmented pathway of glu~~orleogenesis in the 
host. These concepts will now b'2 dJ_scussed. 
(1) ENHANCEMENT OF GLUCONEOGENESIS 
IN THE TUMOUR BEAR TNG i10ST 
The first suggestion that the grow1-.h of a. tlHPOTC 
might induce changes in the pathways of interrr..0dia~cy 
metabolism in the host stemmed fro~l t.he WOT~(' of 
Fen~inger and Mider (1954). 11'.-=:y prDi)OS'::>::. that such 
alterations, 'forced' th~ host to use ocre ~xp2n3iv2 
pathways in terms of energy and nitrogen m.:;t,;:,.11o.U sm. 
However, the mechanism involved ill t_hj~ ~£~ec..t Vv"'&3 
considered to be a selective remova~ of ess2nt~al 
nutrients from the host by the tumour. 8J;.d a::; c.iscus~e<.l 
previously this has not been proved. 
Later Gold (1968, 1972) postulated tha~ th~ growth 
of a tumour induced a greatly augmentE'd p<.~t ["·:'.!'LY of 
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gluconeogenesis in the host, the high energy demands 
of which depleted host energy reserves in terms of 
ATP. This he considers is due to increased 
gluconeogenesis from lactate produccd by tumour 
glycolysis and other gluconeogenic substrates, mainly 
amino acids after their conversion to oxaloacetate. 
However, although there is some evidence of 
increased Cori cycle activity in patients (Reichard, 
Moury, Hochella, Patterson and Woinh')use, 1963), the 
concept of Gold (1972) rests heavily on an ever increasing 
production of lactate from the tUlfLOU1:' cells, and this 
is not a consistent finding in either patients 
(Bondy? 1976) 9r tt.1ffiour-bearing c~nimc:tls (Greenstein, 
1954; Cosca,1963). There i8 hOT'v·P.V~:r- evidence that 
the concent~-.stion of various amino ac.ids in blood of 
some cancer pal:.ients (K211ey and ~.JaimnQn, 1967) and 
tumour- bC8-r:;_ng a.."'1i.m3.1s is increased (Wu e.nd Bauer, 
1960) ~ An inc.L(~,3.sed concentration of alanine, the 
predomina-;l~~ amtnC' acid in hepat.i~ ~lliconeogenesis 
(F e 1 ig, 19 71 ) ::.1.1so been I:'eoorted in the blood of 
. 
patients witt: advA1'1ced cancer, ."l.nd evidence presented 
that this ~!as dE.ri ved f!:om the bl"ea1:doWD. of muscle 
proteins (De Vlys .• 197(,). 
Shapot (J972) ho\vever, has a1eo implicated an 
increase in gluconeogenesis In the host as a major 
factor in the !=,atho0en~si.::; cf C:Ulcer cachexia. According 
to him, this is due to tt!9 high rate of glucose consumption 
by the tumour cells; which effects increases in the 
gluconeogenic. fJu:~ :r.. ;.:hc,' host in order to ma.intain 
normal blood glucose levels. In support of this 
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suggestion, Shapot and Blinov (1974) have shown that 
in mice bearing Sarcoma 180 which maintained normal 
levels of glucose in blood over the whole period of 
tumour growth, there was an increase in gluconeogenesis 
as measured by glucose formation from tyrosine-14 C. 
In contrast, in mice bearing Eh.rlich' s ascites 
carcinoma, in which hypoglycaemia developed from the 
fifth day following tumour implant, there was no 
enhancement of endogenous glucose form8.tion from 
labelled amino acids in these animals. 
According to these workers the differences found 
in the gluconl~~genic response in aI!iP.lals bearing 
Sarcoma 180 ':111d the Ehrlich ascites tUJ.-:1our is due to 
differenc82 :"11 i.:.he response of t_ne i).f)st: tissues to 
glucocort i ~;(J:"_d s. ThUG stimulation of gluconeogenesis 
by the R(llT'inistcation of cortisol f::lileci to increase 
blood glu(:.use levels i:-J mic.e be2,ring the ascites 
tumour. Howe"'irt=:r, wIlen 12.rge closes of cortisol were 
given, or \\;hen -;...h~ anili1als Ivere ~nlbj ected to stress, 
normal blood Zluco;~e '.Talues were foucd. In contrast, 
the gluconeogEni~ response to eurtj.s~l in mice bearing 
Sarc.oma 180 \'78.S sim~la:.· to that found in normal animals) 
and in fae t: 1 in tl·e :_WI'O"Jr-bearhlg group, slight 
hyperglyca21i1ii3. re:::;uL_ed (Shapot and Blinov, 1974). 
The CO:'1copts 0; both Gold (1968:; 1974) and Shapot 
(1972) implica i.:ing 1.f.i.cl"Lased glL'.coneogenesis in the 
pathoienesis of ~21:cer ~a~hexia would necessitate that 
there ,,7oulG be a>:1 irlcrE?se in the ac ti vi ty of key 
enzymes in liver t l1 V.01 Y'0[ gluconeogenesis, but the 
evidence for this is conflicting. 
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Although this will be discussed in more detail 
later? here it may be mentioned for instance that 
Suda, Tanaka, Sue, Harano and Morimura (1966) have 
reported a switch in enzymic activity to a predominantly 
glycolytic pathway in liver of rats hosting the 
Walker 256 carcinoma, while other workers in studies 
on rats bearing what was described as a non-
metastasising sarcoma have reported increases in 
activity of gluconeogenic enzymes (Gutman, Thilo and 
Biran, 1969). 
Shapot and Blinov (1974) however consider that 
previous reports (Greengard, Baker~ mId Friedell, 1967) 
of increases in 8ctivity of tryptv.oh:-l~ uxidase and 
tyrosine l.:r8.:1s."<.J.LliiJ.9.se in liver of n;m0ur~bearing rats 
would 31.;.pPS".:-t: their fi:ndings discLlssed above, but as 
others h8,ve poi.nted out; (Herzfeld and Greengard, 1972) 
these enz~r(rl'~~S 8re pEl:cticula.rly sensitive to 
glucocort:i_coids, :::.nd thp cban8es in activity may 'I\Iell 
In studies to be reported in this thesis, we have 
shm·m that t'he Rr·l.:iviti::s of phosphofructokinase and 
frue tose··l, 6~dit,ho:3~h8.~..:;::;,se are not al ter:--2d in liver 
of tumour-DeR.rL.~g ;.l.i':.e. We havE:' also previously 
reported (Calrrar ulld Mc!.llister, 1975::1.) ~ that in these 
animals, thsre flxe change2 ~.n the hepat.i::: content of 
acetyl GoA and citrate th.qt3.re upposite to those 
found in animals l.mdel- gl1Jconeogenic conditions. 
However, as Jiscusse6 later, an increased citrate 
content in livel.· _k~"~'..:~29. r~culd favour gluconeogenesis 
by inhibition of phosphofructokinase. In tumour-
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bearing mice decreases in the oxalaoacetate content of 
liver were also found, and we have suggested that 
this might be due to increased synthesis of glucose. 
In support of these suggestions, it was also shown 
that the cytoplasm of liver cells in these animals 
was in a more reduced stB.te than normal, and this might 
favour gluconeogenesis (Chapter 3 p. 96). 
In attl~mpts to elucidate several of the above 
changes in the hepatic contents of these metabolites, 
attention ·,·;a3 then directed towards establishing 
whether sud: changes could be induced in liver of 
nonnal 2.nimals by the inj ection of preparations of 
tumour ce.i.l s • Several previous reports had described 
various effects that could be induced in normal 
animals following the injection of either tumour 
extrac.ts, or n,)n-viable tumour cells, and these \vill 
be discussed briefly. 
( ,,\ I. I PRODUCTS OF TUMOUR ORIGIN AFFECTING 
----------------------------
HOST METABOLISM 
Som2 ~sntion has already b~en made in this 
presentaLion that some of the systemic effects of a 
tU'llour may be due to products of the tumour cells. 
'llhl~ concepi .... uf ,J. cancer toxin is an old one and has 
rec2.ived considerable support by the isolation of 
the so·-called 'Toxohormone t from cancer tissue by 
Nakahara and Fukuoka (1949) which when injected 
into normal mice stimulated some of the systemic 
effects of tumours in vivo, such as depression of 
liver catalase activity and decrease in serum iron 
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(Karnpschmidl:, Adams and McCoy, 1959), and also 
induced hypertrophy of spleen liver and adrenals and 
thymic atrophy (Nakahara and Fukuoka, 1958). 
However none of these effects are tumour-specific, 
and both a decrease in catalase activity in liver 
(Miller, 1948) as well as thymolymphatic atrophy 
are also found in starved tumour-free animals 
(MacFarlane, 1971). 
The literature on 'Toxohormone' is extensive, 
and has been reviewed by Nakahara and Fukuoka (1958) 
and others (Costa, 1962; Kampschmidt, 1970). Nowadays, 
however thc:r':".: 1-3 doubt as to whether this product has 
any relatioI!ship to the products of tumour cells in vivo. 
Probably t-.hp mai.n argument against the production of 
'Toxohormone' by tumour cells, is t.he fact that repeated 
injections are necessary to maintain effects such as 
depression of activity of liver catalase, or serum 
iron (Kampschmidt, Adams and McCoy, 1959; Fukuda, 01:-.ada~ 
Akikawa, Matsuoa and Urushizaki, 1966). Thus the 
normal :cec.ipient 'appears to form some resistance to 
this mat~rial i.n contrast to the irreversible systemic 
effect.s 1nduced by tumours in vivo. 
Howeve!~, in recent years there is an increasing 
body. of e'lider..c~ that both human and murine cancer cells 
produce hio logi\~ally active products t.hat affect the 
g-ro\vth c1:aracteristics of normal cells (Argyris and 
A:cgyris, 1962; Rounds, 1970; Rubin, 1970; Nair and 
DeOme, 1973). The secretion of ectopic hormones by 
some human cancers is also recognised (Gellhorn, 1970). 
It has also been reported (Suda, Tanaka, Sue, 
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Harano and Horimura, 1966), that growth of Ehrlich 
ascites tl@our in mice induces a deviation of key 
enzymes in liver towards glycolysis, and that the 
factor responsible is transmitte.d by the blood. It 
~4-
has also been demonstrated, some of these changes may 
~ . 
also be induced in normal animals following the 
injection of various fractions from soni.cally 
disrupted tumour cells (Tanaka, Yanagi, Hiyahara, 
Kaku, Imamura, Taniuchi and Suda, 1972). 
- According to Costa and Holland (1962), the early 
acute fat loss in mice bearing Krebs - 2 carcinoma can 
also be induced in normal animals folL/wing the 
injection of non- viable tumour cells. Thi~ they 
consider was due to the presenc.e ('{ 8. ',:' ... rvs in their 
tumour cell preparations. Howev~r Liebelt and 
coworkers (1974) have shov,7Il that the ir..:iection cf 
saline extracts of a CBA 2663 St.OLD2cl-,. t':ITtcur of ;nice 
into normal mice induced significant iw .. rcases i11 the 
steroid, steroid esters and total lipid content i:l 
serum from these animals. 
The growth of this tU.I1l0Ur il~~}1P_ [dLc.' did rot 
induce anorexia, and the animals maint.&in2(1 Z'. 
relatively constant body mass, but a shi~t j~ 
composition, as evidence~by a decrease in :'j[.;ld cmd 
increase in non- lipid compartments ,'Jas round. 
However when the tumour was transplanLed il1h) 
experiment.ally obese mice, a marked d~c~pase l~ h0dy 
weight that included loss of body fat, occurred. 
These data suggest(:;d that this tl ~'noul.· :'r:'C:C'1C'::'3. a 
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lipid~mobilising factor, and Liebelt et a1. (1974) 
consider that this is responsible for the triad of 
decreased food intake, lipid depletion and hyperlipaemia 
in tumour-bearing animals. 
In recent studies, the present author and 
colleagues (McAllister, Soukop and Calman, 1977), 
have shown that the injection of cell-free ascitic 
fluid from TLX-5 lymphoma into normal mice effected 
alterations in the hepatic content of acetyl CoA and 
citrate in these animals, and thereby induced changes 
previously found (McAllister and CaIman, 1975a) in 
liver of tumour-bearing mice. Such cha,nges in normal 
mice also followed the injection of nC'Jl-viclble TLX-5 
lymphoma cells, and in these animals c[l:;"ly changes in 
the triglyceride content of liver were found that also 
mimicked such changes in mice hcst.j,lls chis turllOl!r. 
Good experimental evidence that some 0; t~~ 
systemic effects of tumours involve the releas '2 (If 
products of the tumour cells is also to he fOUi;.d ,vhere 
such effects can be reversed follc\vir.g cuy.2ti',Te 
resection. These include , (. rever ·-:;a_1. or 
activiLy of serum aldolase that is fou"Q~ ill 1.:lt.S hosting 
the Walker 256 carcinoma or Sarco[[l8. 39 (SH-,lE'1 ar.d 
Lehninger, 1949). More recently" ShiLa~c,~,-a_ and 
Fujii (1975) have found that the elAvated level of 
thymidine kinase activity in rats beaLing Y0;3h5da 
sarcoma, decreases after removal of th~ tumour, 
, ) . Some of the present autnor6; otservatlo1l2 0-;'1 tnt3 
effects of curative resection on some of th~ ~ysr~~ic 
effects of tumours in mice have already been described. 
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In recent studies we have also shOl\l11 (HcAllister, 
Soukop and CaIman, 1977) that alterations in the 
hepatic contents of acetyl CoA, free CoA and citrate 
that accompany growth of tumours in mice can be 
reverted to normal in mice bearing small localised 
mammary tumours by curative resection. Further, 
when this procedure was unsuccessfu1 9 abnormalities 
in the hepatic contents of these metabolites again 
occurred. 
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PLAN OF THE THESIS 
This thesis reports a study of metabolic changes 
in livers of tUillour-bearing mice. 
It consists of six Chapters describing these 
changes, the attempts that were made to revert some 
of them to normal, and the experimental approaches 
carried out to define their aetiology. The final 
Chapter is a brief note on observations that were 
made on these animals outwith the r:~:.1.ill line of 
enquiry. 
Sinc:.e tht-= t:lajority of the staJies presented here 
are based on a ne,.' approach to thE:: problem of systemic 
effects of :1. tu,llour on its host., backg2':"ound 
informat~_o::l is limited. Therefore for purposes of 
clarity] each C·Japter begins with j t3 own introduction, 
and ends 'ivi.th 2. dj SC1.ls:-,ion of thE findings reported 
therein. 
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CHAPTER I 
HATERIALS AND METHODS 
(1) ANIMALS 
In the majority of the studies to be reported 
here, male CBA mice were used. These were from an 
inbred strain maintained in the Anift~,al House of the 
University Department of Surgery, by conventional 
inbred mating systems. 
Wnere st1.1dies were made on mice bearing a C3H 
transplEnlt."lbl~ mammary tumour, ther" this strain of 
animal was t::.ded, These were obt<:~t!,~ed from an inbred 
strain rnai~tclined in the Glasgow IDsti~ute of 
RadiotheJ.:'epsat.ics and Oncology , .Belvidere Hospital, 
Glasgow, by courtesy of Dr A. H. W. N.ia~;. 
Unless Drl',t.:r\\'ise stated, all CBA strain mice were 
fed a standa.<~(1 r_ubed di.et (Brcecii ng Diet Oxoid) 
h t ' {';..j w ereas ne ,-,,~. 
, -, 
strain mice were fed Diet 41 (Oxoid). 
\-later was giVP..ll to all animals add lib. 
P':cior to the stal'T. of an expe:~iment, using mice 
which were to be :~n()C:~,.L!_at,:3d with either TLX- 5 lymphoma 
or Sarcoma 18(1, ~~'r)U~)b ,)f 12 or 20 animals were taken, 
at three to four mvntlJs of ege, tt't::'Ll \ve)_ght-matched 
and ear markpd. O;'Je of each matched pair serving as a 
control w1:.i le ~he. otile:-c" ~eceived the tumour under study. 
After selectic'!1 of animals in this fashion, they 
were allowed to e~rliffi~t}~e themselves to their new 
surroundings for t'iV'O to three days. This was found 
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to counteract weight loss that occurs rapidly in mice 
when transferred from one environment to another. 
(2) TUMOURS USED 
(a) Sarc.S)lna 180 
Accordi.ng to Stewart, Snell, Dunham and Schlyen 
(1959), Sar(~oma 180 is an undifferentiated tumour that 
was orig:inally found in the right axillary region of 
a white tn[:l1.2 mouse in the Crocker Laboratory New York 
in 19ltl-. In the literature it is therefore sometimes 
referred to as Crocker Sarcoma 180. 
AltLough i:he tumour can be transplanted by the 
intraperiton.eal, subcutaneous or intramuscular route, 
in the pre$ent studies subcutaneous inoculation has 
been used, 
According to Austin and Glaser (1970), both the 
sex of the mouse, its body weight at transplant and 
the temp(;rature of the environment have an effect on 
the growth of Sarcoma 180. For this reason, only 
male mice ~.yere used, and the temperature of their 
, "d f 'bl 27°C. enVlronment malntalne as ar as POSSl e at 
S&rCOl"nc: IPO has been reported to invade surrounding 
t:.issues (StewCtrt et a1. 1959). In the present studies 
only liver of mice bearing this tumour was used for 
the study of concentrations of metabolites, and 
enzymic activity. Rontine histological examinations 
of these livers showed no evidence of metastases. 
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(b) TLX~S l:)'mphoma 
This tumour was first induced by Dr D. I. Connell 
at the Institute of Cancer Research, London by whole 
body X-ray irradiation of CBA mice and transplantation 
of the enlarged thymuses into male CBA mice. In 
studies to be presented here mice received the ascites 
cells intraperitoneally, and histological examination 
of liver by Professor K. C. Calmffil showed evidence of 
metastases. In our experience 2 x 106 ascites cells 
injected 1. p. killed the animals in about eight 
days. 
(c) Transplantable C3H Mammary T'.lm:::n1): 
= . 
The above tumour was origjnally 8. spontaneous 
tumour found in a mouse by Dr A. H. W. :Uas in J.973. 
Since then it has been extensively studied. in h:is 
Laboratory in the Glasgow Institute of ~~BrHotherapeutics 
and Oncology. The tumour has beel1 fO·..iIlG to b~ lcc.allv ~ 
mali.gnant with no evi.dence of metastdSE::3 in lU:IlgS, 
liver and spleen. 
(3) SOURCES OF TUMOURS ~JStLl 
At the start of these investigatL,n::; 'L.a;_E:! mice 
bearing either TLX-S lymphoma or Sarccrra18(1 ·''1e:::.-c 
obtained from the Chester Beatty Research Ir,stitute 
London. The former was in ascites f01:'1I1, and t.h(~ Jatte.r 
had been implanted subcutaneously in the subs::.api..i.lar 
region. 
Tl1.ereafter the tumours were passaged in animals 
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in the Department of Surgery, except on odd occasions 
when animals had died, before routine passage co~ld 
be carried out, and the facilities offered by the 
Chester Beatty Research Institute v7ere again called 
upon. 
As already stated, male C3H mice bearing this 
tumour were supplied by courtesy of Dr A. H. W. Nias. 
These had received a tl~our cell suspension of 106 
cells in 0.05 cm3 of Minimum Essential Medium, Hank's 
Sal t Solution, (Flow Laboratories) ':'vDtaining horse 
serwll, glutamine and non-essential ::lllJino acids. 
The t1..1E1Ch2.r cells in these micc'. had been injected 
subcutaneous:!..;,: ir. the midline of 1.-.118 back at the level 
of the abdolTl2n. 
/ I '\. 
\,+) 1\CVI'INE PASSAGE OF TUHOURS 
Roud.llc p['.~;s.::.ge of the TLX~5 lymphoma and Sarcoma 
180 ,.vere c.a:rr:ilC:d out at regulr.:lr intervals as follows. 
(a) 
t'lice hearing this tumour in .sso::ite~; form, were 
sacrificed and the asr::.::_Lic. fluid 1:"'.?mc,ved from the 
IN 49 mteHl'1c4. 
peritonea1 cavity :}S 8t3rile~ C.S possible. The 
" fluid was tir~)t mi~eci T,A/ith Hank's Ba:!.an;-.ed Salt Medium 
(Flow Laborctories), and the ~~~ber of tl~our cells 
counted using 2.n lr.ipJ:(Jvsd NeubaUer counting Chamber. 
Dilutions were t.:he·(1 made with the same medium, 
6 3 
to give a cell P0Pll).3.t2.0:'1 of 2 x 10 per 0.5 em • 
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peritoneal route under light ether anaesthesia. These 
animals were then sacrificed about six to seven days 
later, and the procedure repeated. 
(b) Sarcoma 180 
The following procedure was adop~ed both for 
routine passage of the tumour, as well dS when setting 
up mice for purposes of study. 
Animals bearing this tumour "Jere sacrificed by 
cervical dislocation, and the subcuta.neous tumour 
growing in the subscapular position removed under 
sterile co~di~ions. The tumour i112.8 3 \'l2.S then divided 
in t\\70, and ::n:·e8.S of necrosis dis SPC tee', out. Portions 
of the tm:J.cLlj.:, f'ree of the necrotic 3.'.'"e.::-\. were then 
chopped up 0:1 2. glass plate with 3. li~.·.tle Hank's 
Balanced ':;,3.1 t E-:-diilffi. One grrun of tl-v~ minced tumour 
3 
was then rbpicily,,\,p1.gh2d, rdxed ';,vitji 1.0 em of the 
same mediwn~ then fil te:::-~d t.h:::-c1].gh a gauze swab. 0.25 
of the tumour E"'J spensioll wa.s tht-.11. inj ec ted subcutaneously 
into mice in the subscapular posir:ior. under ether 
, ' 
anaestneSl.:l. F~r routine passage p~rposes, this 
procedure was c21Tiecl l~;~t after every eight to 10 days. 
(5) CONTROL GROUPS 
Considerable care vas take';:;, in the choice of 
adequate controls. In studies on mice bearing 
. Sarcoma 180! nf)~'l.:.l mir:2 :::-2cei ved the same volume of 
Hank's Balc.nc:.ed Salt. Hl2dium by the same route. 
In some experiments, in mice bearing TLX-5 
r 
lymphoma, normal cO"!.'ltrol mice received 2 x 10° spleen 
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3 
em 
cells from normal CBA mice. For this purpose spleens 
were removed at sacrifice, and plac.ed in small wells 
3 
made of fine mesh metal gauze. About 1 cm of the 
Balanced Salt Medium was added, and the spleen pushed 
through the gauze, using a sterile glass rod. The 
spleen cells so obtained were collected, suitable 
aliquots removed and the number of cells counted as 
before. This was then diluted with the same medium 
usually to give a cell population of 2 x 106 in 0.5 cm3 
of the medium which was administ(:!:c,~d intraperi toneally. 
As described later, in some e~periments, CBA 
strain mice were challenged with s~1een cells from A 
strain IDlce. 
In OU')2:::' stu~ies, includi.ng tI1(,.se on mice bearing 
the C"H Fta!';!lliA..cy tumour) normal, weight c::.nd age-matched 
..J 
mice we~E used &8 controls. 
Nice bE;"l~'_~:"'-lg the 'I'LX-5 lYil1!?h,)ma became cachec'cic 
after ab01..lt five to six days of tumour growth. 
However es Liebelt et al. (1974) hAve pointed out, 
little att€ntio~ ~~S ~2en paid to the clinical course 
of tu.rnour .:?;;~owth ill 311'.a'.1 anima 1.8, cEld we have 
therefore aimed at d'2fining cache;:;:io.. in these animal 
models. Thi::; was t:haract.e!:"ised by a:lOT'exia, lassitude, 
and changes in the :"'t~XLL1:r.e of the fur. Figure 1 
shows some of i~hese cha!:,ges in a mouse bearing TLX-S 
lymphoma. 
It was also observed that in these animals there 
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mouse ( ) mouse 
) 
tumour cells i.p. 
with 
were marked decreases in body temperature, and Figure 
2 shows these changes when recorded over the seven 
day period of tumour growth. It will be seen that a 
marked fall occurred on the fifth day following tumour 
implant, and thereafter a steady fall in body 
temperature occurred until the study was terminated. 
In contyas~ mice bearing either Sarcoma 180 or 
the transplantable C3H mammary tumour showed few ill 
effects of their tumours, and as sho"\VIl later mice 
bearing S.'lTCOma 180 continued to eat normally even 
when bearinr3 large tumours. 
( 7 ') SACRIFICE OF ANIMALS , , 
Herrer8 and Freinkel (1968) have reported increases 
in the hepatic content of acetyl CoA in rats that had 
been killec by -~ither Nembutal or ether, and for this 
reasou~ i~ th8 present studies, mice were killed by 
cerviC9l dislocation. 
(' 
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FIGURE 2 Changes in body temper3.t.url', [c j L-jT,-71r_6 the 
6 injection of 2 x 10 TLX-S lymphomH c(-::lls :L p. Six 
animals were studied in each group. 
SECTION I 
PREPA~tAl'ION OF TISSUE AND ENZYHATIC 
DETFRMINATION OF METABOLITES 
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(1) PREPARATION OF TISSUE FOR ASSAY 
OF NETABOLITES 
(a) The ~~chnigue Used for Freeze-~~mping Mouse 
Liver 
The labile nature of many of the metabolites 
studied, necessitated the use of the 'freeze-stop' 
technique developed by Bucher et ale (1964). 
For t.his purpose, the liver is c:Jillflped between 
two aluminium plates to produce a thin layer of tissue, 
the temperature of which, according to Bergrneyer 
(1965) r~a~hes - 160°C in 0.5 secunis u 
The tongs llsed in the pre3en~ stud:ies are shown 
in FigurE:. 3 and \vere constructed fro::n Cheetle forceps, 
by boltiuE; ::::h'.-1lJ.lnium plates measuring 6 cm long by 
5 cm wide 0D to '-he j ay·,73 of the forcp-ps. The 
aluminium p.!..at.·C!:::. sl:wuld be about 4-5 nnn thick to give 
the necessary rigidii:y. 
Prior :.0 tbe -oroc\:'dure, the t'0ugs were immersed 
:in li~Fl:i d nitr0ge!"'l. contained in aluminium trays, and 
stone"'J'are pestles 'lnd D'.ortars pre--c.oulee! in the same 
manner. 
Pre-weighed g~QSS homogenising vessels (Jencons) 
, 
. h . f J5 .J /''''''0 1 Wlt a capa':"lty 0, crn ~ \,LJi.:nI1i ~ng; internal 
diameter 15 rnrn) \'7eL(~ placed in Dewar Fla.sks containing 
Dry-Kold, and ;~ept t.lief.."e for E'.t least all hour before 
use. 
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FIGURE 3 Tongs used for freeze-clamping of mouse 
liver. 
FIGURE 4 Removal of liver prior to freeze-clamping. 
Once the equipment was assembled, the mouse was 
killed by cervical dislocation, and the liver rapidly 
exposed by a transverse upper abdominal incision. 
The ligament attaching the liver to the diaphragm 
was cut (Figure 4) and the whole organ dropped onto 
the pre-cooled tongs (Figure 5) held by another 
operator, who then immediately clamps them and ilThllerSeS 
the whole into liquid nitrogen. 
At this stage, the tissue may be kept in the 
liquid nitrogen for a reasonable period, but in any 
event, as an additional precaution, it was kept there 
for at least five minutes. 
It may be noted here, that the si~ps given for 
the aluminium plates are such, th.::t.t once the liver is 
clamped, ,the tissue does not extrude"'- b:::"lond tllf': 
edges of the plates. However with lar~er animals 
such as the rat, the liver tissue wCllld exi.:.rude 
beyond the edges of clamps of the8(~ c.ir~2i.~sions ~ 9.11d 
in such an instance, the non~clamped t.iSSlle wO'.1l0. 
req1.!ire to be cut off and disc.arded. 
F~.gure 6 shows a freeze-clarllped liver I And 
illustrates the very thin:' layer of tisSl]e OQ'cdtiled by 
this technique. 
The frozen liver is then reduct:'d to a fine 
powder using the pre-cooled mortar anrt pest:)p, 
Considerable carc~ has t.o be takeJ:l <i':. ;::J.is .:;tai;e 
to prevent the tissue thawing out, and this :is test 
prevented, by firstly crushing the tissue [~I;. 8. fe\v 
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FIGURE 5 Liver about to be dropped onto the lower 
plate of the pre-cooled tongs. 
FIGURE 6 Thin wedge of liver obtained after freeze-
clamping. 
seconds, then immediately either adding liquid nitrogen 
to it, or returning the mortar and pestle to the tray 
of liquid nitrogen. The final stage of powdering 
the tissue is then carried out, but again with frequent 
cooling in between. The pOlvdered liver is then 
transferred to a pre-weighed homogenising vessel using 
a spatula that has been pre-cooled in liquid nitrogen, 
whereas the vessel itself should be pre-cooled in 
Dry-Kold. After a rapid re-'i'leigh, the vessel is 
returned immediately to the Dewar Flask. 
(b) Extraction of HetabC?lites,. 
Perchloric acid is used to precipit~t2 proteins 
and extract the metabolites f:rom t1:{~ r",:uzl2n liver. 
Al though the amount of liver taken 'TcYies, as does 
the volume and molarity of the pE:r~hlol- i_c acid -...-_sed, 
the basic technique is the same, anej "7:~U_ be. dcscLibed 
here in order to avoid repetition. 
amounts of tissue required \vill. b.-; givs~. late-::-, 
The extraction of metabolitt~S \YLti-l p:?~;c.h.·l o:r~,c 
acid and the subsequent homoge"!l:; 3&t.ion 8:'-:l.J~ is the 
stage ',{here things can go w:r.'ong, and C01:S i ell'>:::' al).:,<::~ L-are. 
mlist be paid to the prevention of t.he tiS31 c_ !::.n..J::d.ng 
out before the perchloric acid prec~p~ta~~s ~he 
proteins. 
In the present studies, the hcmo;sEisrr 'l.--;f'd ';"GiS 
the conventional Potter and El vehj em (J.S· ,')6) tYl'2 ::: .... 1<5 
consisted of a teflon pestle (Jenco~s) driven by a 
l/lOth horse power motor (Anderman) 
maximum speed of approximately 6000 
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r. p. m. 
For convenience, the pestle can be stored in a 
deep-freeze ( - 2SoC) or stored in a Dewar Flask 
containing Dry-Kold, then removed immediately before 
use. 
The required volume of ice cold perchloric acid 
is then added to the powdered tissue in the homogenising 
vessel, mixed rapidly with a glass rod that has been 
cooled in L:.e, then the vessel is placed in crushed 
ice. 
The Ii,.~l.xtllre is then immediately homogenised using 
two seri~s of passes, with 30 seconds between each. 
The hoTtI.cgc'nate is then centrifuged at 3000 g for 
10 minut28 ar.d the supernatant removed. At this 
stage some ~;leLhods call for a double extraction of the 
tissu2 with Et further aliquot of perchloric acid, and 
where neceSS8.ry this is carried out as described later. 
The next stage is the removal of perchloric acid 
:Lrom tl1·,: i:.isDu2 extract by precipitating it as the 
potassiu[!l salt with either potassium hydroxide OT 
pc.tass:~ un: carbonate. In thE.: present studies, the 
supernat6.1'lt was brought to the required pH (given 
later) using a dual purpose micro-electrode and an 
accurate pH meter (Research Model; Electronic 
IT S i--~-lmL:'-1t-~) .! _ 1. l.l ~L _.:> " The temperature of the sample being 
compenf.,a.ted Ly appropriate adjustment of the instrument. 
This stage, although appearing elementary requires 
considerable care in order to avoid over-shooting the 
required pH, and subsequent loss of the sample. For 
this reason, we titrate the sample during constant 
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::w. 
magnetic stirring, with in some cases three different 
strengths of the appropriate base, one of low molarity 
being used to attain the final adjustment. 
Once the pH has been adjusted, the sample is then 
cooled in ice, for 10 minutes and the potassium 
perchlorate removed by centrifugation. 
(2) NETHODS USED FOR THE DETERl'1INATION 
OF METABOLITES 
Considerable attention was paid to the selection 
of suitable [I~ethods for the determination of the 
... 
hepatic content. of metabolites under inve s tigation, 
as well c.~s La :nethods for the assay of enzymic activities G 
The r,~,aj OI.':L t:y of the procedures used are those 
given by Be:cgiTIcyer (1965) in his book, 'F.~ati~ 
!i.<:.thods of ADa!.]~is' ~ which has achieved the status of 
a classic in this field. 
S :i.; .:~C such procedures involve measurement of 
changE:~ s ill. tb."." absorbance of NADH or NADPH, it should 
be noted hen:, that the extir,c tion coefficient of NADH 
and NADPH .... lsed in the calculatj.-',ns was 6.22 at 3iJ·0 n,l1 
and 3~3G cSC 366 nm and not the ~evised values given by 
Hc.Ccmb (~t ,:,L (1976). 
ld .thOl!.gh t'l1ese workers have shO'i'ffi such revisions 
are 11.eC'e,:;sary~ since for example, an increase in 
• t~'IIl?erature will decrease the molar absorptivities, 
as will em increase in . ionic strength, the revised 
values have so far not been currently applied. 
Recovery valu s for metabolites added to perchlori~ 
acid extracts of mOUSQ liv r wer satisfactory . 
Although few values for the hepa.tic contents of these 
lletabolites in the mouse have appeared in the liter ture, 
were available thase wer generally found to be in 
a~r _ ent with thos found in the present study. 
Further, the aim of the present studies haS 
involved studying changes in the hepatic content of 
metabolites, and activities of some enzymes induced 
by turnour growth in the host, and these data have been 
compared against the values found in n01.l1lal control 
groups. 
Although the procedures to be described give in 
most instances an estimate of at least two metabolites 
on the one liver extract, by the use of accurate 
timing, and the appropriate enzyme it is of course 
possible to carry out several determinations on the 
one sample. This is an obvious advan:'age in saving 
time and labour, but also more imrJortant limits the 
number of animals used. It is a180 DGsslole to 
store the frozen liver powder in 8ry-Kold for up to 
14 days without loss of pyruvate, oX3.1o!-lcetatE:, 
citrate, <:;.(. -oxoglutarate, acetyl CoA. and CoASH; and 
data showing this is presented later. 
(a) Determination of 'Total I foA"''!.L.!~ce~tyl~~~~~~:i 
CoASH 
Many of the available methods for the C!st.e·n.lin:.,.ti011 
of Co A are either non-specific or suffer ti·v: d:i GLrlV3.ntag2 
of being open to interference from cth3r tissue 
constituents (Michal and Bergmeyer~ 1965). 
The following method of Hollerin6 8.nQ ~?r-[';.:n~ye·~ 
(1975) was therefore used throughoul:. s ~l;:-;,c-L: it-. i.s :-:i;:shly 
specific for acetyl CoA and the free coenz}T.:::-:. 
The method gives a measurement of the 'Total' CoA, 
that is the sum of acetyl CoA, free CoA (COlI.SH) ane. 
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(7) Standard Coenzyme A: 
5.0 mg CoA are dissolved in 5 cm3 deionised water. 
The exact content is then determined by the end-
point method using phosphotransacetylase as 
described later. The solution is then diluted 
accordingly to give a working standard containing 
l0)lg CoA/cm3 == 0.653 nmol in 0.05 cm3• 
(8) Phosphotransacetylase suspension (PTA) 1000 D/cm3• 
(9) Malate dehydrogenase suspension (MDH) 1400 U/cm3 . 
(10) Citrate synthase suspension (CS) 140 D/cm3 • 
. Stabili ty of Reage~ 
S All solutions and suspension exu.;p': potassium 
" carbonate were kept refrigerated ~t 4°:. Fresh 
solutions of triethanolmine/malate lR~ffer; NAD/ 
acetylphosphate; DTT and N-Ethyl m8le~ micle sh.J"-J.ld be 
prepared daily, whereas the standa~'d CoA wu~t be !ned 
within a few hours of preparation. 
According to the manufacture'!: (Boe1lrJ nge:i~ l1annhel.~i'J.:; 
the PTA suspension is stable for six mouth:::.? whereas 
the l'1DH and CS suspensions are stahle; fo:·- up to 12 
months. 
Procedure 
5.0 cm3 of ice-cold perchloric acid (1 mol!~_) 1.s 
added to 200-300 rng frozen liver in 3. hOlllOZE-f,·L·'~ nE, 
vessel and the homogenisation card.ec. m.::t :-lS d'?2cr~_bed 
previously. 
The mixture is then centrifuged at 3000 g for 10 
minutes, and the supernatant removed. 
The pH is then brought to 6.0 using 2.5 mol/I, 
potassium carbonate to begin 'vith, then, 0.25 mol/I, 
the final adjustment being made with 0.025 mol/I. 
The mixture is then decanted into a centrifuge 
tube using the minimtill1 of deionised water to effect 
the transfer, then cooled in ice for 10 minutes. 
It is then centrifuged for 10 minutes at 300 g, 
and the volume of the supernatant noted. 
Conditions Wavelength 340 nm. 
o Temperature 25 C. 
Path length 1 cm. 
Readings are made 
against air. 
The following are added to t,,70 Cuvl":!ttes, one 
for the determination of the 'Tota'!.: Co A.. , and the other 
for the determination of acetyl Ci)J'-\. plu,; oxid:i~,>ed CoA. 
Supernatant 
N-ethyl maleimide 
Deionised water 
'Total' CoA 
? 
0.05 cm ,,' 
0.30 3 
Acety:t CoA + 
Oxiriisecl eoA 
0.0:) 3 cm 
0.05 .3 ern 
'.J 
(j.2t) J cm 
Af .. h . . , , I :::. 0 (" ~ ter ffilxlng, t e cuvet tes are mal'!.1tCU.L2(! d t ,r, . .1 ,; i=or 
10 minutes. The following are then b.dded; 
Triethanolamine/malate 
Dithiothreitol 
3 1.5 cm 
0.05 cm3 
- t'" 
, .• J em 
n 1(' 3 \... ) cm 
A further incubation at 25 0 C for 15 minutes is made 
and the following added: 
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NAD/Acetylphosphate 
MDH 
PTA 
'Total' CoA 
0.20 cm3 
3 0.015 em 
3 0.015 em 
Acetyl CoA + 
Oxidised CoA 
0.20 cm3 
0.015 
0.015 
3 
em 
3 
em 
The c:01Jxse of the reaction is then followed until 
3 it stops (usually five minutes). 0.02 em of the C.S. 
suspensioil i~ then added to each. 
Aftei:' rapid mixing the course of the reaction is 
followed f:)l~ 17 minutes at one minute interval s. The 
absorbanc.e at two minutes and at 17 minutes is noted 
from the ::rc:>.:.lng and the difference between the two 
( " .... A) d~' c:r'T'l· 'lc·d t-4 t- '- .... : ._. L.. .l_ L: \. • Each day, prior to the determination. 
of the hFCpaLic content of the coenzyme, a blank was 
3 
set l~' consisting of 0.05 em deionised 0ater in place 
of the supen::.al-,dilt, as were three standards consisting 
of 0.05, 0.03 and 0.01 cm3 of the working standard 
3 
lIiade t.O EJ volun~e of 0.05 em. The amounts of free 
coenzylcte .\ pre sent were 0.653? 0.391 and 0.130 nmol 
CoASH respectively. 
As not:ed previously $ the s::.andard solution must 
be prepared fresh, and the exact content determined 
by means of the end'~point method using phosphotransacetylase. 
'Tbjs was carried out as follows: 
Det.:.ermilLC'.t.tion of Free CoA with Phosphotransacetylase 
(PTA: Ee C.2.3<1.8) 
C·:mditions Light path 1 em using silica cuvettes. 
Temperature of assay 25 0 C. Readings are 
made against air at a wavelength of 233 nm. 
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Reagents 
(1) Tris (hydroxymethy1) -aminomethane, (0.1 mol/I) 
pH 7.6. 
(2) Acetylphosphate, (0.1 mol/I). 
(3) PTA s Crystalline suspension in 3.2 mol/1 ammoniurrl 
sulphate, Approximately 1000 U/mg. 
Procedure 
The following are placed in the cuvette in the 
following order: 
Tris Buffer, pH 7.6 2.79 3 cm 
Acetylphosphate 0.10 3 cm 
Sample 0.10 3 em 
After mixing, the initial abs')rbanc.'2 (Al ) is 
read, then the reaction is starte:J })y t.llc ,'vjdil..ion or 
0.01 cm3 PTA suspension. 
Again after mixing, the 1:'eacLi0r. i_.~; fGllo'ved unLL] 
it stops (usually in two minutes) ~ a.nd -.:.hf: abs()r~)2nce 
(A2) is read. 
A blank is also carried throug~l the P:i'OcsJU:;::"e and 
3 
consists of 0.1 cm of the tris buffer in ,,1[t(;.2 of the 
sample. 
Calculation 
The content of free coenzyme A in the 8tanria~:d 
solution is given by: 
LAxS.18 3 - mg coenzyme A/em 
where b A is, derived from: 
~ A = (A2 - Al ) of the sample - (A2 - Al ) of the 
blank. 
The content of 'Total' co~~ in liver is 
given by: 
(1) A A SamEL~ - 6 A Blank 
x Concentration of 
A A Standard - D. A Blank 
standard (runol) x 1 = nmol 'Total' CoA/cm3 of 
0.05 
the sn~e~cJ.atant 
(2) ~..2l:_-"::.2ct~l' eoA/cm3 x SUJ2..erQ;~~~t_yolume x 1000 
mg/Powdered frozen liver 
- nntol 'To:al f CoA/g liver (WE'i.:. \IlL). 
Similarly, t.he content of 9..c.etyl eoA (+ oxidised) 
is derive(l as 8')OV8 by substitlltil,g thE appropriate 
absorbance. TILE content of the free coenzyme A is 
then deri~pd hv ~~Dtraction of this ~alue from the 
.I 
'Total'. 
Notes 
~in~ity of the R2Clct.ioi1 
Figure 7 ::;~oWf' tt'.\": J.ineari ty ohtained when the 
three standa"cds \vEre put through the complEte method 
used for the assBY of coenzyme A in liver. 
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FIGURE "/ 
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nmol COENZYME A 
Linearity of the reaction in the 
detA".l:"lTlinatiol1 0£ Coenzyme A. 
(b) Determination of P~teL Citrate and 
c:!: -Oxog,lutarate 
(1) Perchloric acid, (0.6 mol/l). 
(2) Citrate standard solution. 
2.1015 g citric acid are dissolved in approximately 
80 cm3 deionised water and the pH adjusted to 
7.5 with sodium hydroxide (10 mol/l) before making 
to 100 cm3 with deionised water. This solution 
is then diluted 1/500 to give 37.827pg citrate/ 
0.9 cm3 (0.2 rnrnol/l). 
(3) Zinc chloride, (0.03 mol/l). 
(4) Triethanolamine buffer, (0.1 [;1;-;1/1). 
1. 856 g triethanolamine hydroc.111oride are (lissolv2d 
in approximately 80 cm 3 deion:! ~:e.d T,'78.tel.'. Tl .... c! pH 
is adjusted to 7.6 ,\lith sodh1.'11 hych~o;dde (1 mol/1) 
i 
before making to 100 cm- wit~ deionj sed 'i,78t€r. 
(5) )3-nicotinamide adenine dinuc.1C:!ot,idE::, ·.cc:~cluced forril 
(J3~NADH), disodium salt~ (0.01 IT:"Jl/J>, 
sodium hydrogen carbonate, (0. 12 ~a(, 1/1) 
..... 
J 1. 28 cr-[ 
added to a pre-weighed vial c()ntahliI1~~ ·i.v l1i-
fi-NADH (Sigma, London). 
( ) , T'/' 3 6 Lactate dehydrogenase suspend.on (LDH): 598 v I_til • 
(7) Malate dehydrogenase suspension (~)H), 1..'+')5 U/cm3 • 
(8) Citrate lyase suspension (CL), 100 n/c!n3 • 
(9) Gl t t d h d ' (\r~TIIP\ ?'O u/ 3 7 U ama e e y rogenase sUSpenSl('TI ".,.1.. •.. / ~ _,:: cm. 
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All solutions and suspensions are kept refrigerated 
o 
at 4 C. The citrate standard solution, zinc chloride, 
perchloric acid and triethanolamine buffer are stable 
for 12 months whereas the )3-NADH solution must be 
used within a few hours of preparation. 
According to the manufacturers (Boehringer 
Mannheim) th~ LDH and MDH suspensions are stable for 
several mon.tlis but the CL suspension loses about 10 
per cent of its activity within one month. 
Procedure 
') 
4. () c.IT'..) :Lce-cold perchloric acid is added to 
approximately 750 mg frozen powdered liver in a pre-
cooled homogenising vessel, well mixed then homogenised. 
The homogenate is then transferred to a centrifuge 
tube tugether with washings (1 cm3 of perchloric acid). 
1f more than 750 mg of tissue have been used, then an 
extra 0.5 em3 of perchloric acid for every additional 
100 mg. or ~roportion thereof, is used to wash out the 
homogenisinG vessel. 
Tile co~nbined mixture is then cooled in ice for 
a.bout th~c".:!e minutes, then centrifuged at 3000 g for 10 
minutes) thi-?n again cooled in ice for about five minutes, 
0e.fon~ decanting the supernatant into a small beaker. 
The pH is adjusted to 7.5 using potassium hydroxide 
(2 mol/I) with constant stirring using a magnetic 
stirrer. To avoid over-titration, the former strength 
of the alkali should only be used until the pH is 
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about 4.0, then 0.1 molar potassium hydroxide should 
be used thereafter. 
The mixture is then cooled in ice for 10 minutes 
then centrifuged (3000 g for 10 minutes) and the volume 
of the supernatant noted. 
Conditions Wavelength 366 nm; path length 1 cm. 
o Temperature 25 C. 
made against air. 
Measurements are 
(c) Determination of Pyr~v~t.e and ~e (Moellering 
~ Gruber_, 1966) 
The following are pipetted into CLlvettes: 
Triethanolamine buffer 2.0 
p-NADH 0.06 
Zinc Chloride (Oe03 mol/l) 0,,01.. 
Supernatant 
3 
cm 
'") 
-J 
CIL!. 
') 
.J 
enL 
After mixing, the absorbancp ot tllP. lui ~ture is 
. read until it stabilises, and th2 fin,"li e:-::~,orb&r::ce 
3 Next) 0.01 cm LDH suspension is l'1ixE:c1 ir.; and the 
change in absorbance recorded at onc! minute inte::vals, 
until the reaction stops, usually }i.l Eibout five 
minutes. Again the final absorbance is DC'l:<?c1 (A2), 
Note 
A standard solution of citrate is included 'i\lith 
each set of srunples, and consists of 0.9 the 
diluted standard equivalent to 0.18 pmol citrate, in 
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3 place of 0.9 cm of the supernatant. 
(d) peterminat~on 2.f 0<: -Oxoglutc!-..E,~!~_JBergmeyer and 
Bernt, .l9.2..?1 
The conditions for the assay of 0< -oxoglutarate 
are the same, except that. the wavelen&.th is shanged to 
340 nm. 
The following are added to cuvettes: 
Supernatant 
/~-NADH (0.01 mol/I) 
3 3.0 cm 
3 O.Olj cm 
The absorbanc~ is then recorded until it stabilises 
and the value at this stage noted (A4 L 
3 0.04 cm GLDH suspension is mi)<.~ec.l ~.n, and the 
change in absorbance recorded at one mirlU.te int.'.".rvaJ s 
until the reaction stops. If as hE[lpe,::s :)n occ8.sior:s 1 
the reaction continues beyond 10 min.l.:.t2;:j; thQ rio.aClings 
are plotted and extrapolated from ze .... o Li.mE'. The 
absorbance is again noted (AS)' 
For the detel.lflination of c<. ~o;~ogiutarrlte to.2 blank 
consists of 3.0 cm3 of deionised wEt.'L:.cr in pIa::- af the 
supernatant. 
Calculation 
Pyru,::-ate 
6. A :=: (A - A ) 1 2 
~ 
A A x 1003 x_Su£~£~at?:.E1t_Volurne{cmJ) = prnol pyruvate/g 
mg Liver Taken liver (wet \veight) 
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Citrate 
A A ~ 1010 x Supernatant_ Volul1le(~) = pl1lol citrate/g 
mg Liver Taken liver (wet weight) 
~-Oxoglut9-rate 
1 
A ~~5 x Supernat9nt Volume(cm-) = pl1lo1o<-oxoglutarate/ 
mg Liver Taken g liver (wet weight) 
(1) Per~hloric acid, (0.6 mol/I). 
(2) Potassiu.lll c.a:cboP2tc, (5 mol/I; 0.5 mol/I and 0.05 
(3) Hydrdzinc-g1ycine buffer, (O.L~ [fiol/1 hydrazine 
suJphs.t.=.) 1, () mol/I. glycine) pH 9.5. 7.5 g glycine, 
5.2 g hydrr.lzinE: st!lphate and 0.2 g el:.hylene-diaminc-
tetra-.s.cE:t-i.c p,c:i_o (~DTA) are suspended in about 
40 3 d' ... b f 1 :1' 51 3 d' CITI 2:l0H.LS2cl water e _ore a( ... : lng cm so lum 
hydrox~de; (2 mol/I). c'\.ft2Y adjusting to pH 9.5 
the b'~fter 18 ~tlA.de to 100 cm3 with deionised water. 
(4) l'Hcotin.::anlC:2 u_denine dinucleotide (5 x 10- 2 mol/I). 
(5) Lactate dehycl.rcgellas2 (LDH) , - 1375 U/em3 • 
/r\ , ... .,. .., 1 l ... rr>..H\ rA"A TTl _3 ~ 0) L'1aJ..are aenyarogenase ,i'lU ), - ovvv VI elll 
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All solutions and suspensions are stored, stoppered 
in a refrigerator at 4°C. The enzyme suspensions are 
stable for several weeks as is the NAD which does not 
require to be neutralised due to the high buffering 
capacity of the hydrazine-glycine buffer. 
used is stable for only one week. 
Procedure 
The buffer 
At least 400 mg frozen powdered liver is transferred 
to a cold hOlnogenising vessel and perchloric acid 
(0.6 mol/I) a<,'ded at a concentratilY[l of 1 cm 3 for every 
140 mg U.SSE'2. 
The 'IlixtuI:'e is then homogEni.sed a8 already 
detailed, .r:tnd transferred to a centrifuge tube, the 
suspension remaining in the homogeDisiu~ vessel being 
') 
-' washed out ~'7i Lh O. S cm of the perchloric acid. 
The rt:ixtul':'e is then 3.11m-;reo to ...:-each room 
temperat.uT(~ b~[o:"1'- centrifuging at:. 3000 g for 10 
minutes. The supernatant is thEn d('ca.nted into a 
small bcaker p ~1d cooled to 4°C, then Ule pH is 
adjusted to 3 • .5 by Lhl? 8.ddition of puta3sium carbonate 
with constant 3tL.ri.ng~ using a mag-::.1etic stirrer. 
The adjus tment. of t.hr.;! pf{ is best be;:",ur.. 'Ising drops of 
the strongest solution of potnssilnn carbonate (5 mol/I), 
followed by thp ottj.eY' C\'lO (0. Smal/l and 0.05 molll 
respec ti vely·). 
The mixture ~s 1:r.2T!. left in ice for 10 minutes, 
and the precipitate of potassium perchlorate removed 
by centrifugation at 3000 g for 10 minutes. 
The volume of the supernatant is then measured. 
Conditions Wavelength, 340 nm. Path length I cm. 
T 2 ~oC. emperature oJ Readings are made 
against air. 
The following are pipetted into the cuvettes in 
the following order: 
Hydrazine-Glycine Buffer 1. 35 3 cm 
-2 3 NAD (5 x 10 mol/I) 1.5 cm 
Supernatant 0.3 3 cm 
Deionised Water 1.2 3 cm 
After mi.xing, and allowing to stabilise the 
absorbance (AI) is read. 
3 0.03 cm of the LDH suspenS1.011 is then mixed =(..n~ 
and the change in absorbance read &t OI)(;: iTLinut~ iDte:c;rals, 
until the reaction stops, usually .i.n ar-I)l't five 
minutes. 
Blank A b I k .. r 0") .:1 -:l' • .' an cons1.st1.ng or ... C-1Tl 'It uf?1.ortlSe(.l 
water in place of the supernatant is taken l.hrc,1.gh the 
procedure. 
The malate content of the samp Le is the-I •. 
determined as follows: 
Hydrazine-Glycine Buffer 
NAD 
Supernatant 
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3 J • ::; 5 err. 
0.15 cm 
..... 
..... 
.:. 
The absorbance is then recorded until it stabilises, 
and is then taken (A3 ). 
The malate dehydrogenase suspension is then mixed 
in and the change in absorbanc.e measured at one minute 
intervals until the reaction stops (usually in about 
five minutes); the final absorbance (A4 ) is then 
taken. 
Calculations 
(1) Lactate 
mg Liver ':i'.s.ke-ll 
}-lmol lactac"2/g- liver (wet weight) 
Where ,tJA --.:: A'}. .- Al 
(2) Malate 
1 ~ . }.lmo mal.8.tt-:/ g (V.72t weight) 
(f) D~_n8.t~o~ _,:; ../ . ;,-;1:'.lcose-·6-Pho~~~te __ and Fructose·· 
6-PhosohhtE:: 
Procedure ac~ordin? to HGhorst (1965c) 
_ .......,--'~ __ .....-"'~,_~£o<' __ ~ ___ "'-""""_~_~.....-.4 ... ... ___ _ 
(1) PotasSi'LlIn car"bcn8.te, (2.5 mol/I). 
(2) Perchloric acid, (0.6 moll]). 
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(3) T:d.ethanolamine buffer, pH 7.6 (O.L~ mol/I). 
(4) Magnesium chloride, (0.5 mol/I). 
(5) Nic.otinamide adenine dinucleotide phosphate (NADP), 
approximately 5 mmol/l. 
(6) Glucose-6-phosphate dehydrogenase (G6PDH), -
3 900 U/cm • 
(7) Phosphoglucose isomerase (PGI), - 0.2 mg protein/ 
3 
cm • 
All solutions and suspensior:.s C.rt. kept refrigerated 
Under these conditions all are stable for 
several weeks. 
Procedure 
3 5.0 cm ice-cold perchloric acio. (C.6 mol/l) an:~ 
added to 800 - 900 mg of the frozcn s p0~jered liver, 
in a pre-cooled homogenising vessel: ~l~n homogenised 
according to the standard procedure. 
The homogenate is decanted into a cer.i:rifug2 tube t 
and centrifuged for 10 minutes at ~OOO g. 
The supernatant is then transfprred to d. 25 em3 
beaker and the latter placed in ice. 
3 3 One em of the perchloric aci d and 1 I'~l' vi: 
deionised water are then used to w2s1~ G12C the 
homogenising vessel, and the washings added to i.he 
pellet remaining after the centrifug&~ion f~0?, 
After thorough mixing ~ the mixture is J.2ft to 
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cool in ice for five minutes then centrifuged. The 
supernatant is then combined with the previous one in 
the beaker, and pH is raised to 3.5 using 2.5 molar 
potassium carbonate. 
The mixture is then decanted into a centrifuge 
tube, using the minimum amount of deionised water to 
effect the transfer, and then cooled in ice for 10 
minutes. 
After centrifuging for anotner 10 minutes at 
3000 g, the volume of the supernat3.rlt. is noted. 
The glucose-6-phosphate and fructose-6~phosphate 
content is then determined as follow3 
Condition3 ""'ave length 340 Pal" 
o Temperature 25 C. 
t1ath length 1 cm. 
ReadinGs 81.'e made against a cuvette containing 
triethanoJ.m.llir:,F:. "t.mff 21.' < 
The fol Lnwirg arc~ placed in .'i cuvette: 
Triethancl.:uni ne buffer 
Supernatant 
NADP (5 rnrLlol/ 1.) 
~1 . hl'~ (0 5 1 I,. 1 agneSl.um c 8rh .. ~,. mo / .... ) 
1.0 
1.5 
0.02 
0.02 
3 
cm 
3 
cm 
3 
cm 
3 
cm 
After mixing s c.nf. ahsorbancf: is measured until a 
constant reading is (J~t':1ined (AI) • 
.... 
0.01 cmJ 0:::' Lh~' G ·f-PDH suspension is mixed in, 
and 
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intervals until the reaction stops (usually about five 
minutes). This absorbance (A2) is then read. 
Then 0.01 cm3 PGI suspension is added, and the 
change in absorbance recorded at one minute intervals 
until the reaction stops (usually in about five 
minutes). The final absorbance (A3) is then noted. 
Calculations 
The glucose-6~phosphate content is given by 
6A x 273.3 x Volume of SUDernatant 
J 
mg Liver Taken 
;-unol glucose-6~phosphate/g liver Cv-7e1- Tlleight) 
Hhere A A = A2 - Al 
Similarly the fructose-6-pho3!Jhatc :t3 g:L~V7C::n. by 
AA x 27L~.4 x Volume of SUDernatant 
~~---
mg Liver Taken 
pmol fruc to se~6-phosphate/ g 1:i.ver (\vd. \\'eLGht) 
Where A A = A3 - A2 
(g) Determination of the Triglyce':ricle COllt'~liL of Live;: 
------------~.<~--~---- '-,--------~-
Triglycerides were extracted fJ~or..: livE'1'.s 
by the method of Wheeldon and Collins (195/). 
saponification of an aliquot of the ext::;:,ac~, 
of mic.e 
Af.ter 
glycerol content is determined enzY:'TIClU_co.lly .",':::;] fig the 
Test Combination of Boehringer Mannhcim. 
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Extraction of Triglycedjes 
About 500 mg of liver is taken and approximately 
3 5 cm of chloroform-methanol (2:1 v/v) are added. The 
mixture is homogenised until a fine suspension of the 
tissue is obtained. The homogenate is then transferred 
I 
with \vashings using the same solvent mixture to glass-
stoppered test tubes, and the volurrJ:-: made to about 
3 12 cm. After thorough mixing the samples were placed 
in a refrigerator overnight. The !'.::xtract is then 
filtered into flasks, and the prec~pitate on the filter 
3 paper is then washed twice with about 10 em of the 
same chlorofo)'m-methanol mixture. 
The cOIT':o:i.ned extracts are thSYl taken to dryness 
in a rotary ~VEtpOLator under mild 81.l'2tiol1 at a temperature 
not exce2cl"ng 37°C. About 10 cm3 of ether~ethanol 
(1:1 v/v) is the-n added and evapor::-.ted to dryness as 
before. 'lni.c, 
The 
was round to remove traceS of water. 
3 
r2sidu2 is then dissolved in about 2 cm 
of chloro:,:o-c;n~.n.2~hanol (2: 1 v/v) ~ the flask washed out 
3 
with the so.me sol,Tent and the voh!me made to 5.0 cm . 
3 Saponificaticn 1)[ 2n aliquot (usually 0.1 cm ) 
was then car:cied (Jllt. The saponiticrition step and 
subsequent det~2rrll~!aLioil of the frl!/.:! glycerol content 
was then dete:t'mineu enzymatically 8,ccord.ing to the 
manufacturer IS insc(uctions. 
Other De terrr~i..no tiuns 
The folJ.m'Ij n/~ ~72rc.' also determined using the Test-
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(a) Blood Glucose and Lactate. 
(b) ATP, ADP and ANP of mouse liver after freeze-
clamping and extraction of the metabolites 
with perchloric acid. 
(h) Hepati~_Content~ of Metabolites Derived by 
Calculations 
The cytosolic (NAD+)/(NADH) ratios were derived 
by calculation as was the oxaloacetate content, by 
methods dEscribed in the text. 
(i) _StabL~1-!Y, __ of Various Metabolites in Freeze-Clampe~~ 
Liv~_'rs of Normal Mice 
The Ga~a shown in Table I were obtained from an 
experiment It;. which livers of normal mice were freeze-
clamped, po\qder'~d and combined to form a pool of frozen 
liver. Aliquots were immediately taken and the contents 
of pyruvate, oxaloacetate, citrate, (X -oxoglutarate, 
acet.yl GoA and CoASH determined. The remainder of the 
powdered li'1er being kept in a Dewar Flask containing 
The ana~yses were then repeated at intervals up 
t.o 14 days 0 
As s'bo"wn ill Table I, there were no significant 
changes in the hepatic contents of these metabolites 
o.fter'14 days of storage of the powdered liver under 
these conditions. 
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TABLE 1 
THE EFFECT OF STORAGE IN DRY-KOLD ON THE HEPATIC CONTENTS OF METABOLITES 
IN FREEZE CLM1PED LIVER OF NORV~ MICE 
Conditions 
Base Levels 
After l4 Days 
Storage in 
Dry Ice 
Pyruvate 
pmol/g 
0.198-:t0.014 
+ 0.200-0.014 
Hepatic Content Of Metabolites 
Oxaloacetate Citrate o(-Oxoglutarate 
pmol/g pmol/g jUillol/g 
0.027"!:0.007 00 l6l"!:0. 005 0.lS5-:t0 •OlO 
O. 023~O ,_ 006 ~ 0~154':'O_OO~ 0.16':::':':-0.011 
Ac CoA 
nmol/g 
+ 66.83-2.39 
+ 66.26-3.65 
CoASH 
nmol/g 
+ 63.02-2.62 
66. 83:t"3.31 
---~-------'-~--------, ------- ------------------------------------------------------------
p L~ ,-, S ~ N.S o l'~ • S. f'1.So NoS. N~S. 
,-~---~--------~-----, ------------------------------------------------------------------
N. S. '-' Not S-LgEif5_car~'~ 
-!.. 
Vah_'~p.s are in tE~nrlS of m~a"il ( 'r" ,- v.) f -uQE.d.. 0 six detexminations o 
(j) Expression of Results 
The hepatic contents of metabolites under study 
were expressed in terms of the appropriate concentration 
per g of liver wet weight. Where changes in total 
liver weight had occurred, then in some instances 
values were calculated in terms of whole liver content. 
(k) Statistical Evaluation of Results 
All results were expressed as the mean, plus or 
minas the standard error of the mean, or in a few 
instances the standard deviation. 
Significanc.e was calculated on the; basi.s of 
Student's t (p) test. 
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SECTION II 
DETERMINATION OF ENZYHIC AI.:TT'JITIES ~~~~~~~~~--~~ 
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(a) Det:~rf0.i!lation of Acti'-:.~t.:.L of Phos)hofructokinase 
and F!~.£!;-ose1..l,6~DiphosEhatase in Mouse Liver 
Procedure accordin.,g to Dr .§. A Newsholm§. 
(Personal communication) 
Enzymes used were supplied by Boehringer Mannheim. 
(l) Extrac t.:_Ol1 Mixture 
This contained, triethanolamine (50 mmol/l); 
sucrcse (250 mmol/l); EeD.T.A. (5 mmol/l); 
maf:,r~("sium chloride (10 mmol/l); mercaptoethanol 
(30 mmul/l) at pH 7.5. 
(2) f?~~2se Diphosphatase As~ Mixtur~ 
Tris buffer (61.2 mmol/l); E.D.T.A. (1.22 
mmol/l); ~vfgC12 6 H20 (2.44 mmol/l); MnCJ. 2 
(1. 22 mmol/l); mercaptoethanol (30.6 mrnol/l). 
As.:. pH 7.5. 
(3) NicoJ::inD1:nide adenine dinucleotide reduced form 
(J 0 lrHnc 1/1) • 
(4) ATP (30.5 G1l1Iol/l). Neutralised with potassium 
bicarhonar.e (1 rruuol/l). 
(5) AMP (60.9 il@ol/l). 
/6\ (/ 3) ~) Aldolas~ 100 ug 0.01 cm . 
f7' , ) Glycerol-3-phosphate dehydrogenase. 
3 0.01 cm • 
Ten pg in 
3 (8) Triose phosphate isomerase. Ten pg in 0.01 cm • 
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(9) Fructose-6-phosphate (60.9 rornol/l). 
This contained tris buffer (63.4 romol/l); 
KC1 (253.7 romo1/1); mercapotethanol (12.7 romol/l) 
at pH 7.5. 
NADP (15.3 rrrnol/l). 
Creatine phosphate (30.6 mmol/l). 
(11) 
(12) 
(1.3 ) 
(14) 
(15) 
3 Glucose-6-phosphate dehydrogenase (10 pg/O. 01 cm ). 
Creatine kinase (100 pg/0.01 cm3 ). 
Myokinase (Adenylate kinase); 3 cm • 10 Jlg/O. 01 
(16) Ph 1 1 . (10 ~/O 0' 3) osp 10g ucose lsomerase .. -- Po .... cm I' 
(17) Fructose,1,6~diphosphate (3.1 IT@ol/l). 
(18) Antimycin (4.6 romol/1 ethaI:ol>. 
Procedure 
Liver is removed, weighed and kept cool o-i1;_ce • 
. It is then chopped into small pieces, and ~omogenised 
in 10 cm3 of the extraction mixturp pET e of liver. 
The homogenate is then centrifuged at U, 000 g tor 20 
minutes at OOC, then 0.75 cm3 of the SUfel'lla·:_9..Ilt is 
pipetted into a 10 cm3 volumetric flaQk 8.'Lld C.015 em3 
of the antimycin added. The volurt'!.2 is thEn made to 
10 3 . h h .. . dO'" 0 3 - 1 • crn vnt t e extractlon mlXl:Ure an • L. Cffi OT t .. U8 
used for the assays. 
65 
(1) Assay~£t Phosphofructokinase Activity. 
Conditions 
- . 
Readings are made at 340 nm against air. 
o Temperature, 25 C. 
The following are pipetted into cuvettes: 
PFK assay mixture 
NADH 
ATP 
AHP 
Extract 
Aldolase 
GlysRrol-3-phosphate 
dehy-:!rogenase 
Triose phosphate isomerase 
2.4 3 cm 
0.1 3 cm 
0.1 3 cm 
0.1 3 crn 
0.2 3 cm 
0.015 cm 
0.015 cm 
0.015 cm 
After mixing, the absorbancy at 340 nm is 
recoLd'~d for 10 minutes. 
Cor:dition.s are as described above. The 
fol10';1ing are pipetted into cuvettes: 
FDp'&se extraction mixture 
i'l"ADP 
Creatine phosphate 
Extract 
2.5 
0.1 
0.1 
0.2 
3 
em 
3 
em 
3 
em 
3 
em 
3 
3 
3 
G1ueose-6-phosphate 
dehydrogenase 
Creatine kinase 
0.015 
0.015 
3 
em 
66 
3 
em 
Myokinase 
Phosphoglucose isomerase 
0.015 
0.015 
3 
em 
3 
em 
The absorbance is then read at 340 nm until it 
stabilises~ fructose,1,6-diphosphate (0.1 cm3 ) is 
mixed in 'and the readings continued for 10 minutes. 
The activity is then calculated in terms of pmol/ 
minute/g 1 • .LIVer. 
(b) Determination" <?i .Catalase A,ct:,;lyi.ty in Li-ve~ 
The tissue is homogenised in the presence of a 
nonionic dp:t2~,'gent (Triton X) according to the method 
of Cohen j Derrlbiec and Harcus (1970).' The catalase 
activity of the supernatant is Lhe:~ determined by the 
method of Aebi (1975). 
Reagents 
~--
(2) 
(3) 
2H20 (0.486 g) are dissolved in 
dei.Oi."lised ~\lat:er, t1le pH adJusted to 7.tJ,., and the 
3 solut~on I"c:.dp '.:0 ~.:OO em • 
\';orktfiC' buff-=.r ~ ~"~----- J=>H 7.4 
r£he above is diluteJ 9 :tn 100 with deionised 
water. 
10% vlv' 'J:'rl. t 1)11 X jn the above buffer. 
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(L~) Sodium P.~borate, pH 7.0 (100 mn1o~/1) 
7.694 g of the perborate are dissolved 20 cm 
hydrochloric acid (1. 5 v/v), and about 400 cm3 of 
deionised water added. The pH is adjusted to 
7.0 and the volume made to 500 cm3 • 
(5) fhosphe:.:e Buffer z pH 7 00 (50 nurrol/]) 
3 
This was prepared by mixing potassium 
dihydrogen phosphate (0 . 05 mmol/l) and disodium 
hydro~en phosphate (15.5 rnmol/l) in the proportions 
1:1..55. 
(6) PotA.E'sium Permanganate (10 lllinol/l). 
Prepara!=-l~  e,f .Tissue 
Appj'oxirnately 500 mg liver is taken and added to 
5 cm3 ice - ~old i.sotonic buffer~ homogenised to give a 
fin.R suspen sion (Ul tra- Turrox) then centrifuged at 
·,'00 t; .J-0r five to 10 minutes. The supernatant is 
removec, and 3 cm3 of it placed in ice for 30 minutes. 
3 i$ fl ooc o 
Next, 0.0.3 Cll1 of Triton X in the buffer a.t pH 7.4 to . ,.. 
givQ a fina~ concentration of one percent. After 
mlxlng well. 1 em3 of the solution is removed and 
made tv 100 em3 with ice~cold isotonic buffer. 
~~ 
OnE: em' of the mixture is used for the 8.ssay. 
/\ \"ater bath, thermostatically controlled at 
20u C d f' d . h .. 25 3 f1 an ltte. Wlt a tray contalnlng cm .Lat~ 
bottomed flasks is used. 
The following are pipetted successively into the 
flask~; 
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Phosphate buffer 
(50 mmol/l, pH 7.) 
SodiL~ perborate 
(100 mmol/l, pH 7.) 
Blank 
3 1.0 cm 
3.0 3 cm 
Test 
3 1.0 cm 
3.0 3 cm 
These are then pre-incubated at 200 C for 10 minutes, 
then the following are added: 
Water 1.0 3 cm 
Sample 1.0 
The shaker, and a stopwatch an~ i~.ned:iately 
3 
cm 
started, and then the reaction stopped i mr:l.eciiately after 
30 seconds by the rapid addition of 3.0 em3 sulphuric 
acid (1 mol/l). 
The remaining perborate is the .. : de;-.erm::nccl by 
back-titration with potassium permanganotc (10 r.Jr!.ol/l). 
,£alc\1..1ation of Activity 
The concentration of perboratc as tt.("~ begirn:d.ng 
of the reaction is 37.5 mmol/l. 
The activity is then expressed in teTf2.S (If Lbe 
number of milliequivalents of sodhlill pe:rboJ:'p"te 
decomposed per mg liver (wet weignt). 
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(c) Determination of_ Ac~i tLof Citrate Cleavage 
.~~z~~ 
Procedure according to Kornacke.E~ Lowenstein (1965a) 
Reagents 
(1) Reaction Mixture 
This contained ATP (disod:1um salt) 5 mmol/l; 
MgC1 2 (5 mmol/l); coenzyme A fLbout (0.56 mmol/l); 
reduced glutathione (10 mmcl/l); citrate (tri-
sodium salt) 5 mmol/l. Hydl"o):ylamine Hel (500 
mmol/l) neutralised with sodiUIIl hydroxide. The 
solution is prepared prior to use. 
Fe~ric chloride (2 g) Rnd trichloroacetic acid 
(6" i 6) o_~_'e dissolved in Hel (0. 8 ~flol/l) and made 
100 .) to ~ cm. 
Procedure 
Livec (a!:'1prux. 1 g) is removc:c rapidly and 
homogenisGd In iC2-cold sucrose (3 em3 of 0.25 mol/i), 
c then centrifq:;ed ,Stt~b',-)I1t 4,500 g at 0 C for 10 
minutes. The ~,upeTIl8.c:ant is then removed and 
recentrifuged fcr 3C mi:lutes at oOe at 59,000 g. 
An Rl:i quot of the supernatant-. is then removed 
and the protc:i:1 ccr:l:?rt: determined by the method of 
Lowry~ Roseb~cu;h, Farr &nd R&l~all (1951). During 
the estimation, tht-:! reitLaii1der of the supernatant must 
o be kept at 0 C. 
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The supernatant is then diluted to give a protein 
concentration in the range 0.2 to 6 mg per assay. 
Then 0.1 cm3 of this is taken and made to 1.0 cm3 
''lith the reaction mixture, and incubated for 40 
minutes at 37 0 C. 
At the end of this time, the reaction is stopped 
by the addition of 3.0 cm3 of the ferric chloride 
reagent, and the mixture centrifuged for about five 
minutes at 4.,000 g. 
The supernatant is then removed. with a Pasteur 
pipette, and the absorbance determined at 510 nm 
against .s. 'C'ltu'lk$ consisting of 0.1 Ci!l.'3 of the diluted 
supernat2.Ilt, plus 0.9 cm3 of the L·ED::'.tj.on mixture 
3 following: lE1I::~es~.§.te~ by 3 em of Li:)~ :ferric chloride 
reagent. 
Values foJ..: i..:he 8mO'~mt of ci.trate c,J.p.aved in the 
reaction are extr8.polated from a calibration curve 
prepared by tal!.1.Tig up t,) 500 llg ac.etohydroxami.c acid 
in a volur,-le '1f .~ c~13 and adding 3 cm 3 of the ferric 
chloride reagent. The activh:.y is then calculated 
in terms of: ,P .. flol/mg protein/h.our. 
Pieces oE li.ve:t: w'?r.e minced in glutaraldehyde in 
phosphate buffl2r~ then pcst~osmicated, dehydrated and 
embedded in Araldit:E:. They were then sectioned on 
and LKB ultratone .sta:'n~~ri ',dth uranyl acetate and lead 
citrate; and examined in a Philips 301 G electron 
microscope. 
7J. 
CHAPTER 2 
METABOLIC CHANGES IN LIVER OF TUMOUR-BEARING 
MICE 
(1) The Hepatic Con~t~of Acetyl CoA, 
Free CoA and Citrate 
Although changes in the hepatic contents of 
acetyl CoA and citrate have been extensively 
i.nvestigated in rats following gluconeogenic stimuli 
such as starvation and the induction of diabetes 
(Start and Newsholme, 1968; He::':-~_'e1:a 8:1d Freinkel, 1968) 
as well as following treatment with (.~e-r.ta.in hormones 
(Hornbrook, Burch and Lowry, 1965; GrEenbaum, Gumaa 
and McLean, 1971; Exton and Harpci_', 19'.12). little 
attention has been paid to the conLent o~ the09 
regulatory intermediates in liver of tlunoll~-bea~ing 
animals. 
In an early study l (Shil s, F:C[2CildiV].' Fine and 
Shapiro, 1956), the hepatic content of CoA 8.nd vDrious 
vitamins in liver of tumour-bear~_ng mise T/l~~!:2 d21..:ermined~. 
but values for the levels of these ::net:a1c11 t'=:3 i.n 
nOTInal livers were not included. 
Later, other workers (Mascitelli, Cori~lJoli, 
Boldrini and Citterio,1958) in a stllJy of t!:le effect 
of isoniazi.d on the CoA and pyridoxine (.;.ontenc of tiSSU2S 
of tumour-bearing rats, reported thaL. an increaSE in CoA 
and decrease in pyridoxine occurred fo ~l(y\d.p,~ trPB tment 
with the drug, However normal rats were not lJsp-d 0S 
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controls in these investigations, and the authors used 
a non~specific method of assay (Kaplan and Lipmann, 
1948) for CoA, and in fact little can be made of the 
findings of these workers. 
More recently, Rapp (1973) studied the CoA content 
of liver, adrenals, spleen and kidney of rats and mice 
bearing a variety of different tumour.s, as well as in 
liver of patients with carcinoma of the colon. In 
all of the tissues studied, markea d.e\:>reases in the 
CoA content ''lere found. 
Rapp (1973) however used a non~specific chemical 
method of asssy (Hand schumacher , MUeller and Strong, 
1951) basod on the 'procedure of Kdplan und Lipmann 
(1948), that. a,1 so rr,easures acetyl f~nA, acyl thiol 
esters of Cr)p. and various precurs.)rs iE the biosynthesis 
of CoA (l'~ovell~ ~ Scrnnetz and Kaplan ~ !'::\!;4' .L.J....J !' Cavallini, 
Consequently it is net p08sihle to interpret his 
data in tErms c";:' the rie.tual fOrIll of the coenzyme presenL 
Rapp (lg73) however, although offering no inter-
pretation oZ his findj.ngs, suggested that the decrease 
in the cont2nt Gf CGA ie! tissues of t.he tumour-bearing 
host, might be of sig:L::'ficnnce in th~ d{~leterious 
effects of ~ tumour on its host. 
There js als0 a lack of infcrrnat:'on on the citrate 
content of tiss-.1es of 1:wT1.our-bem:'ing animals. In an 
early study! i C ,,,CiS roported (Haven, Randall and Bloor, 
1949) that ~l rats b2aring the Walker 256 carcinoma, 
the citrate content of various organs was in general, 
higher than those fUlmd in 8. control group of animals 
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in which the tumour had not taken. 
In the present investigation the acetyl COA, free 
CoA and citrate content of liver of tumour-bearing 
mice has been studied using specific enzymatic 
methods of assay on freeze-clmuped liver of these 
animals. 
Part of this study has already been presented 
elsewhere (CaIman and McAllister, 1975a, 1975b; McAlliste:c, 
Soukop and CaIman, 1976). 
Haterials and Nethods 
Mice bearing either Sarcoma 180, TLX-S lymphoma 
or a transplantable C3H mammary L.1JmOUr W2}:e used. 
Details as to tumour transplant~ and concrol groups 
used have already been described in detall. The 
stages of tumour growth at which the studies were 
made are detailed in the present study. 
The coenzyme A and citrate cor..t.eni.:. of freezeC!-
clamped liver were determined as ct'2cril)ed in c1eta.~.l 
in Chapter 1 of this thesis. 
Body weights, total liver ,v-=ight, sp I E.en a.rrl 
thymus weights were also recorded. 
tumours were dissected free from connee-Li..v=: r j S.'31:.e 
and the weight determined. 
E~"£.essi..2n of Resul~ 
The hepatic contents of the me t9.t-;u 1 I Cc. <: UlldeT. 
study were expressed in terms of concent:raticn iJE:l' g 
of liver wet weight. Hhere alterations J.Y' 1,.'.1<;:";:-
weight had occurred, the validity of the results were 
checked also by calculating in terms of whole liver 
content. As would be expected, in some instances 
this resulted in alterations in the degree of 
statistical significance. 
Results 
The data presented in Figure 8 shows the daily 
changes in the hepatic contents of acetyl CoA, CoASH 
and 'Total' GoA in livers of mice after inoculation 
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of 2 x 10 TLX~5 lymphoma cells L 'fl" Twenty-four 
hours later, there were significant reductions in the 
hepatic content of both metabolii.:er., During the six 
days of tumour growth, the CoASH ~ont.en'': remained 
significantly 1. ~wsr than that of ti1..c controls. Two 
days after tumour implant the acetyl CoA content 
returned Lc nc,r[([al levels, and remainsd so until the 
fifth arJ,d sixth days when significant d(;}Jressions 
again OCClLY:C2d" In these experiments, and with this 
size of ir.0cGlufil, the ITl.:_CC" bec31l'.s cachec.tic after 
about six days of tumOllT growth. Total eoA, that is 
the sum of acctyl CoA~ oxidised CoA c.nd reduced CoA ~ 
remained &t significantJy low levels OV2r the period 
of the experLne:l':.. 
I th t ,.," . 1 . 'recp·lved 2 x 106 n ese s u,.:...e~, eonr.ro Huce __ .l. 
'Spleen cells from 2.nir.:als of the 82-rne inbred strain. 
In order to cbvi~te a possible allogeneic effect of 
the tumour eel] s, l!or,El'il male CBA strain mice were 
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±S.D. 
200 
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1 ..... 1 T r lO::':_.::. , xxx 
>f'//""/ 
"Total" eoA 
x 
x 
Acetyl CoA + Oxidised CoA 
I ··········L1J]I········,ii 1··.<I.l· ... ·· i<L--1:~ '-' . ... .....:l:.c:...E2L_--L3:,:,~~~0:L:o:0L~OC'L-_...L::.C1-".~~~~,Ld 
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Days after inoculation 
FIGURE 3 Ch.anges in the hepatic content of CoASH, 
Acetyl CcA and 'Total' CoA in mice following the i.p. 
inject~ion of. 2 x 106 TLX-S lymphoma cells. Control 
6 
anl.illals Teceived 2 x 10 spleen cells from CBA mice 
in Hank's Balanced Salt Medium. 
of six animals in each group. 
.... ;: = p ,(,0. as .,',.,', = p '-0. 01 
Results are means 
-,,\;h', = p.c... O. 001 
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challenged by i.p. injection of 2 x 10 spleen cells 
from male) A strain mice. Determination of the CoA 
content of livers in these animals at periods of up 
to eight de.ys after injection, showed no significant 
differences from normal. 
Data derived from a separate experiment (Figure 
9) using mice that had received 2 x 106 TLX-S lymphoma 
cells i.p., showed that significant increases in the 
citrate con~ent of liver occurred on the first and 
second day following the injection. On the third and 
fourth day, this had reached normal values f but on 
the seventh day of tumour gro'VI7th, marked inc:reases 
(P<'O. 001) G~c-l~rred. 
Be~aL~2 cf the large number of tumour cells 
injected into these animals, less acute studies were 
made on mice that had received 2 x 103 cells by the 
s&.me route. Three days later, the acetyl eoA content 
()f U,'le'L decreased significantly (Table 2) 0 In 
contrasr. Lo t.hat found with the larger inoculum, this 
remained at a ]ow level over the entire period of the 
The CoASH content of these livers did 
not alter significantly from the control values, until 
the tenth de.y when the animals were markedly cachectic 
and the experiment was terminated. 'Total' CoA was 
sig::1ifiC2Iltly decreased on the second, third and sixth 
day of tumour grmvth. On the eighth day this had 
returl:.ed to normal values, but on day 10, significant 
depressions again occurred. It should be noted 
hm<]ever that the significance of changes in the 'Total t 
CoA content, which is derived from the sum of acetyl 
CoA and the reduced form of the coenzyme are entirely 
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J..Imol CITRATE I 9 LIVER 
(Wet Wt.) ± 'S,D. 
0·6 
Days ofter inc':vlC1tioll 
FIGlJRE 9 Ch::l.nget; in the hepatic. con'CE:nt of citrat.e 
in mice fol10'vtng the Lp. injection of 2 x 106 TLX-S 
lymphoma cElls. R2SL:~-Lts are means: S.Do of six 
animals in each grO!lp. 
I 
])ays After, 
Imp10,nt 
TABLE 2 
THE ACETYL CoA, CoASH, 1fl'OT!\L' CoA AND CITRATE CONTEIH OF LIVERS 
OF NICE FOLLOWING }.P. INJECTION OF ? x J..0 3 TLX-.:.? IJYJlTPHOl'l'ill CELLS 
-...... --!--, ... -~---r-'----::--I------ -·r-~·--~-- . ....., . .L 
I 0 (Contrc},s) 
I A CE:: ty.L ",.,),i\. j r I CoA.:-Jh I +,prObl l CoA P \.Jl ~rate p 
I n:_::no3J·)1/g ~ !1.nnorru1./f; I D2nomOl./{s' pInol/g 
., -t-' , r--'---- -----r--- ------t--- . 
I.J- t,J., I ' +'
: 77.('Y-22.55 I - ,<:'4.}'J-l4.26 - 161.552:22.09 0.16-0.04 - I 
71.05~". :"3 i Ii .s. ! 97. 9':'8.01 l~. s. I 168.99:':14.15 N. S. 0.45:':0.10 <: 0.001 I I 1 
2 
3 
6 
8 
10 
(9."f9~10.97 ;'.0. I t.O.3j.':10.8( N.S. 130.14:': 8.09 1<0.02 0.45:':0.07 I <C 0.001 I 
53.55" 9.80 <. 0.01 1 74.13:t 2.8r, I, .S. 127.68:': 7.68 I <. 0.01 0033:':0.04 1<: 0.001 I 
52.82: 7.79 ;<0.01 II 73,,42:::1Li, 53 ,N.S. 126,,25::~-4.50 l <: 0.02 0.2'(::0.08 1<-0.05 I 
! ; I I 
"'1 ~.~ n Q t, + r i\ % ;:;, 'I t-..., t.: ' 1 i f""O ~ r + - ( J T ~ I 
"-,-2.28 ,<;. O~v5 . 7<.,;~2_--12025 ;1.S. I 1, .",4,;.-.L,h'+<o IN.,,,. O.2)-O.U9 I :N.~. 
c4.00 ~'-'2 I 58.75:':14.85 -<. 0.05 ~::'3.l6::14.17 1<.0.01 0.25:':0.13 I N.S. 57 .15~ 
4-Values given are means -S.]). Six animals "lere studied in each group. 
P Statistical evaluation by unpaired It' test. 
N.S. - Not Significant. 
dependent therefore on the degree of change in the 
content of the two. 
The citrate content of these livers also changed 
in a direction opposite to those found in normal animals 
under gluconeogenic conditions, with marked increases 
occurring on the first three days following tumour 
implant. On the sixth day, when the next determinations 
were made this was still significantly increased when 
compared to the controls (Table 2). Thereafter normal 
values were found on the eighth and Lenth days of tumour 
growth. 
In ctnl~al. s 
'J 
~, _J 
that received 2 x 1v TLX··5 lymphoma 
cells, symptoms O:C cachexia usually 8.p[)E:!ared about the 
seventh 1-::1 t-;::'ght:h day of tumour. gru\'!ttl, although there 
were sam':; -\J9.~i2.tions a3 would be expected between 
differenL groups. The fact tha.t E'arly changes in eoA 
and cit.yeit.e ()r''::.Li..rr,''d i L~ liver after the injection of 
the tUrt101Jr cel} s: and. bef:::re visible signs of cachexia 
became evi.dent:~ sllggested that c:"1.(.~·J.lexla was not a 
prerequisite fo·.c t}Lese metabolic. n.bncrmalities. 
The inrl-uence of :.his tumour O~.l the spleen, thymus, 
liver and 'bod,- weights in mice is shewn in Table 3. 
c., 
Six days aftei:" thE: injection of 2 x 10" TLX~5 lymphoma 
11 ' -, ce s l.p., DQoy 
significan'.:I~T ~ ~-::-: leer. weights increased significantly 
compared to control ani':Hals, but the mean liver weight 
did not chan32. 
Studies of the r1e.ily changes in thymus and spleen 
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'rABLE 3 
CHANGl~S IN BODY "vlEIG}7r, SPL:2J.~N, THYNUS AND LIVER IlIEIGh'TS IN TmlOUR-BEARnJG TUCE 
I I 
Tests (TJ.;{-S) ! % Tests (Sarccma 180) , 70 
L 
Controls Starting Final 1 Change p Controls Starting Final* Change p 
I Body I I 33.76-::2.381 
I I 
26035:2048 12s.23:::1.76 1 -20.4 kOoOl 
I I 
I + 31. 81:2 ~ 631 I 20009:1.69 I ~'ie~j-h"" ([!'\ ! 30046-L17 -5~8 I<tOoOl v ..l..~-, 'V \;.), I I I 
I 
I Liver I I 
-lB.5 rO.Ol 
I + L62:0.16\ +607 1. Sl2:0 .11 I + IrJeiel1t (g) I 1.S1-0.12 I - l N.S. - 1.23-0.08 I 1 I I Spleen I \ . I i I 
I 000011 
I 
\18ight (mLdj 76.72:!:ll.67 ! 178.72:25.5J. I j I L - +132 j 
rTf:" ~ .'. ~.~ , ...... I 
Voigbt (m.~)1 25.52C6.88 1l.53!:3.~ -54 ~0.01 23.98:':7.28 6.90-::4.50 -71.2 ~O.Ol j 
--. + ~. ~ . Vd..!...1..~eS :]l"C ),11 terms of mean -S.D. of tr1e SlX ar,.~l~-181s l.n 8ac;t f~CY1..:.r .. 
P Difference iro'.o Cor~trols ""J./ 3.!;11':1ent' s "r.~ ~E:~·t fOl: S·C3tj}3tic-:1.'. 0r;l·~'1:~·3rj~so'l.l of Ol"gai1 ,.yeif:~b.tso Body wejeht changes 
accordi DC to pc .. :.red I t I t'~S·G. 
JJ.S. Not Si{~Li!_'i~;3n~.;. 
* I\T~'Ian Jed .. :; \1r:.".g}lG :3t ~J2.';_"'ifict~ rrt1..j_~.l.A.·"'~· vunl~)UI' \;e5.,rrl.i.-:';. 
l'.~j-.;<:· be;n.'d1! T::',:~-J 1,V:I1I):r_,)~1.a wen: .3ec-cif.Lccd. 8ftc~r :,:d:: d8:vs of t1::Il!()ur gro\:lth. 
S<:.:-co;n:1 130 micE:' w3H, 83.;rlf.i8ed 15 d8;n" :1 ~·t'"r j.nq:·lar,L 
weights in mice from the previous experiment tha t h a d 
received 2 x 103 TLX- 5 lymphoma. cells lop., showed 
that the mean thyrnus weights decreased significantly 
24 hours later, and this continued over the 10 days 
of tumour growth (Figure 10). Also shown is the 
essentially similar pattern that occuYX'ed in thymus 
weight changes in mice that had received 2 x 105 
tumour cells i.p. In contrast, the animals that had 
received this number of cells sho\yed inC'.reases in mean 
spleen weights after 
compared to six days 
cells (Figure 11). 
three days of tlli~aur growth, 
in those~ived 2 x 103 tumour 
" Mice bearing Sarcoma 180 showed a 
20 pe:ccl:'nt reduction in body weight. ~J~ . th significant 
decreases :i_I', thymus weight. Liver and spleen weights 
i.n these -:::nimals increased sigrdfi':'2 'c1t,~_y (Table 3). 
Alth()12g~l the. patte::'n of c.h2nge in the hepatic 
contents t~)f acet:vl. CoA and citrB :-e in these animals 
were not iGrtic&tiv2 of an i.ncreas e d supply of fatty 
acids to liver as ~ result of starvation, the mean 
food and water :!.,ntal:.:e J.T: mice beH_rI ng TIX- 5 lymphoma. 
was studied. Al s') ir.'::. luded werE: 8. g:tCllp of mice 
bearing SC.'c;cmil ]. E:,() , a. t:umour tha.t il':l0 been found as 
described L'lt2x- al~o t'J induce si;:J.ilc:r changes in the 
CoA and citra i..:e coni::ent of hast] iver, 
O ' - -. .. . F '"' 106 TLX 5 ne cay atter the l.p. In]ectlon U~ L x -
lymphoma cells, the amount of food and water consumed 
by the anim8.J. oS i eLl t-c 1~,'-3 and 15 percent respec ti vely 
of norrnal; (Table 4) ,·7ith further decreases 011 the 
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n-,ymU$ Wt.(mg) 
± S,D, 
I 
I 2 x 10
3 Cells I.p. 
J 30 I 
1 
I 
I 
~o-I 
I '1' I 
10J I , 
I 
c.l--
I I 
I 
r 30~ 2 x 105 Cells 1.p. 
I I 
I 
20-
10 'I' 
I 
Lr I -, I I I I 
Controls 2 4 C. 8 10 
Days ofler inocula lion 
!.LCU~};; -1-.Q Changes in the mean thymus weights of mice 
1- J 1 • th' . .. t . f 2 103 0 ... · 2 x 105 ~o_~ow~ng e lop. lnJec lon 0 x L 
'f'LX·~5 lymphoma. cells. 
each group. 
Six animals were studied in 
Spleen Wt.(mg) i. S.D. 
250 
150 
50 
2 xl03 Cells I.p. 
O~--------------------
250 2 x 105 Cells I.p. 
150 
50 
L-~,--~--,,'---r--"-, --,----,-- .-.-, -- T--,--, 
Controls 2 4 6 e 10 
Days after inoct;lation 
FIGURE 11 Increases in the sple~~ w~ights of mice 
3 5 following the i.p. injection of 2 x 10 or! x ]0 
TLX-S lymphoma cells. Results are wesns of s:x 
animals studied in each group. 
TABLE 4 
FOOD AND iJATEJ1 CONSlJ111'TION OF MlCE BEARI:\G TLX-5 LYMPHOMA OR SARCOHA 180 
Days after 
inoculation 
____ A • 
I ------------- Lvmph rJm8 Sarcoma 180----! 
._----- ~ - __ ~I ______ ----.-----------. _____ .__ ' 
Foo;:: Inta\:e Hatf:r Ir..t.a'ke j ~'ood Intake Hater Intak~ 
TLX-S 
% Diffe~ence % Difference I % Difference % Difference I 
I~ ------~,------------------~----------------__4~ 1 -48 -15 I +13 
-38 
L 
2 -68 -82 
3 -33 -15 
4 -36 - 6 
5 -70 -33 
6 -70 -68 
7 
8 
9 
10 
11 
12 
13 
14 
15 
-87 ' -91 
_____ _ _______ I 
, 
i 
I 
, 
-66 
-48 
- 8 
- 3 
+ 1 
+15 
+ 8 
+10 
o 
+ 3 
- 1 
5 
+13 
+40 
-38 
-55 
-34 
+ 4 
+ 9 
+ 8 
+18 
o 
+16 
+ 8 
+17 
+ 4 
+12 
- 6 
Results expressed as percent difference compared to normal. Six animals were studied in 
each group. 
second day. Thereafter there was some improvement 
on the follo'wing two days, but the overall picture 
was one of anorexia over the seven days of tumour 
growth. 
Mice bearing Sarcoma 180 showed no change in the 
amount of food and water consumed on the day following 
implant. On the two to four day period food 
consQmption dropped by 38, 66 and 48 ~ercent of 
normal. Very similar decreases in ~,yater intake 
occurred at this time. ThereaftE;.'I' both the food and 
water consumption increased to about normal values, and 
this continllf:d over the 15 days of t-clmO-llY growth. On 
termination G{ the. experiment on O"lY 15), the mean 
tumour weight 0; :..:hese animals W"-lS 1.M:. g ± S.D. 1.02. 
In spi te of the burden of their turr.ou:;:- these animals 
remaineri r28s01~ably fit and act.ive, anG did not present 
symptoms ot ~ach2xia. 
Results \·!:;:.:.h M.tr:..e Bearing a c~a :-1a~'ll&ry Tumour or 
,j 
-~-~-
Sarcoma 12') 
In orde:r to estahlish tLlat changf's in the hepati.c 
contents of eGA Gnd cjt~at2 were due to a systemic of 
the tumour on its host ~ 3.nd not a r c}s1.111:. of tumour 
disseminatif)n,. the f:tlJdiE:s ,-;rere exteuded using mice 
bearing E:ither a t::::-d.TIspla.Yltable G._H ITlmfL:Jary tumour 
,j 
that was known not (, 1.1:) sseraina.ts or Sarcoma 180. In 
the latter g:rollp h:'i.sto 1 ogi ('.a1 examination of liver 
showed no evidence of b~mour involvement. 
Highly significant reductions (p.( 0.001) in the 
hepatic contents of both ar::.etyl CoA and CoASH were 
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found in mic.e bearing the mammary tumour (Figure ]2). 
The citrate c.ontent of these livers showed significant 
increases (Figure D). In these animals, the mean 
+ tumour weight was 16.12 mg-S.D. 3.L,2 at which stage 
they were only just palpable i~.2i!~. Spleen weights 
had increased significantly (p< 0.001) and thymus 
weights had decreased (p< 0.001) but no change in 
liver weight was found. Body weights in these 
animals were not recorded. 
The increased citrate content;)f livers of animals 
bearing the small mammary tumour contrasted markedly 
'i'lith those bee-iring Sarcoma 180 (mean tumour weight 
+ 0.5 g~s.no O.G2) in '.vhich the COilL-eEl: 0i-" this metabolite 
in liver r€:nai.rLeu at normal le'vels (Figure D). 
Although t1-:2 'Total' GoA and acetyl CoA had decreased 
significu.'lLly, the CoASH content of th2se livers 
remained at TIoyreal levels (Figure 14). 
t11EiC t.here migh,t be some correlation 
between the we.~ >:;ht of i:be tmllouJ~; dTld alterations in 
t.he hepatH' cr;-ntent, of cit.rate ",.;:as examined in anothGr 
experiment, w~~h mice in whi ch che tr.eal1 tumour weight 
4 L~ + , ~~ was • ~L g~'S.S • .1., L'::. Tai)le 5 shows that in these 
animals, t.he r..hI2.l: . ..l (' c~trate COYli:ent was increased by 
102 percen t o"eY.' Loai.: of the control s. Marked 
reductions <P< 0.081) were also fCillnd i.r. the 'Total' 
GoA, acet.yl eoA and the r'O:ducE:cl coenzyme. Further 
studies hm·7'2vey.' are :1ccessary .',0 establish whether 
indeed such a corrAlation exists. 
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FIGURE 12 Th.~ "Total' CoA, Acetyl CoA and CoASH 
c.ontenT: of livers of mice bearing a C3H mammary tumour. 
Results are the means of six animals. 
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FIGURE 13 TIle hepatIc cit=at~ so~tent 8f mice 
bearing a C3H n15.T
TlIllaTY ~-tlmour or ~arcoma 180. 
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are the means ·:)f six a:-litnals studied in each group. 
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'l'he 'Total' GoA, Acetyl CoA and CoASH 
conteJ.1.t. of livers of mice bearing Sarcoma 180. Mean 
'.:1.UUQur weight = 0.5 g :- S.Do 0.82. Results are 
t\Jeans of six control animals and six tumour-bearers. 
rI'p~BL~: 5 
EFFECT OF SA~f:0M~ 18L9N ....IJ-IE ~5Il~\fTL_OF ACE~YL_~oA, CoA§J.i, ! TOTAL , CoA AND 
Controls 
Tumour-Bearers 
% Change 
p 
C:;::':I\.ATE IN MO:JSE LJ'/SG. 
r '\- r AC"-l ,,.., t 1 v C A vO. ....,0 ,)' _ _loa 0 
(nanomol/g Wet Weight) 
r---68.29~10.0 137.59~22.70 
J__ L\ c. ely 1 
I 69.39:15.07 
+ 35.14·- 7.0 20.93~ 8.16 56.08~14.54 
-49 -69 -59 
< 00001 J <::: 0.001 <. 00001 
.J... 
Results expressed as means ~·S.Do Six animals were studied in each group. 
P = Statistical evaluation by unpaired , .L. , l- test. 
Citrate 
/umo1/g Het Wt. 
+ 0.57-0.10 
+ 1.15-0.45 
+102 
<.0.02 
Discussion 
These studies have shown that turnour-growth in 
experimental animals effects decreases in the acetyl 
CoA, and CoASH content of liver, with concomitant 
increases in the citrate content. The direction of 
change in Clcetyl CoA and citrate are opposite to those 
found in nort11al animals under conditions of forced-
gluconeogenesis as has been reported by several \vorkers 
in the starvt"Od and acute alloxan diabetic rat (Hieland, 
1966; .st_.:',l~i.: and Newsholme., 1968). The data 
available at the present time precludes an interpret.at.ion 
of the mechanisms underlying the alterations in the 
levt-:.l of r~hE':S2 metabolites in liver of the tumour-
bearing he-st. Investigations of thes~ changes over 
several cL"y:- of tumour growth in livers of mi.ce bearing 
TLX-5 lymphoma. showed that they occurred 24 hours 
after inncllJ Cltif,rn of the animals with 2 x 106 tumour 
ceLLs. 1hi8 suggested a possible allogeneic effect 
of the Ll,mour cells, which however was not supported 
by our f::_nding normal values in the hepatic contents 
of these metabolites in normal CBA strain mice t.hat 
had been cballE">l1ged with spleen cells from an A strain 
animal. Mi~.e bearing the lymphoma also showed 
signi fic;c(nt cle'.:rea.ses in the mean thymu.s ,veight 2~4 
hOGrs af::'21: tmr..our implant. 
';11.e dec-y.cases in the acetyl CoA, and the increased 
citrate content of liver in these animals, could not 
be correlated with their physical condition since they 
occurred in mice that were anorexic, and showed 
symptoms of cachexia, as seen in those bearing TLX~·5 
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lymphoma, or in those in which the tumour was small 
and remainRd localised as found in those bearing the 
small mammary tumour, which at that stage of growth 
had no apparent effect on the host. Although similar 
findings were made in mice bearing Sarcoma 180, there 
was some evidence to show that the size of the tumour 
might be a tactor in the degree of change in the CoASH 
and citrate ccntent of liver. 
1men the number of TLX~s lymphoma cells injected 
had beenci-'.duced by one thousandth, the onset of 
changes in the hepatic contents of acetyl CoA and 
CoASH, but not citrate were delayed. At present we 
do not ha"e c: satisfactory explanation for the early 
changes 1n ~."be level of these metabolites, a factor or 
factors j·elease.d from the tumour cells cannot be 
excluded f~cm the aetiology. 
HmA7e\-e~C, in addition to the latter suggestion, 
th9r2 .3.:::-e several ot.her pos sible explanations that 
mighi.: ue invol-ved in these changes, and although these 
are mainly speculative at this stage, they offer possible 
app)~oache s Lu the aetiology of these changes. 
Fo~ in::tance increases in ~:.he hepatic content of 
citrate ha'.'p been reported in rats, in which rapid 
gl~cose s)~lthesis had been induced by the intraperitoneal 
inject.iorl of lactate (Hornbrook, Burch and Lowry, 1965). 
Although this increase in the hepatic citrate content 
was obtained using a dose of 1.5 g/Kg body weight, 
th2 possibility exists that an increase in the lacta'ce 
content of blood of tumour-bearing mice may be 
involved in the accumulation of citrate in liver of 
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these animals, and this has been studied as reported 
in Chapter 3 of this thesis. 
An increase in the hepatic content of citrate 
has also been shown to occur in normal rats following 
the intraperitoneal injection of L-tryptophan (Ray, 
Foster and Lardy~ 1966). The mechanism involves 
inhibition of gluconeogenesis s because under these 
conditions, phosphoenolpyruvate carboxyk.inase is non-
functional. 
The accumulation of citrate in livers of tumour-
bearing mice would be expected to inhibit 
phosphofructokinase since this metabol~te is one of 
several modifiers of the enzyme (Start and Newsholme, 
1970; Kemp, 1971). This would r2~~U2.e the glycolytic 
flux, and favour gluconeogenesis, -::;jl~ce the enzyme is 
rate-limiting in glycolysis (ScruL~on al~ Utter~ 1968). 
It is of interest- however, that th.i.s rilF:os:-1Cml_f::l does n:)t 
regulate gluconeogenesis in liver of normal all:;_ill8J s, 
since under gluc.oneogenic conditi(;~1s e<" sta-.c;/ation~ 
the hepatic content of ci tratc dE:cr~Ft.:::'2s (::; ta:~t and 
NevJ"sholme, 1968; Herrera and Fr~i.nkel, r..,'C,8). It:. 
does however regulate gluconeogenesis ~L kl.dacy cortex 
of normal animals, because under conditL)flS nE 
starvation, the citrate content of ~his tissue inc~ease3 
(Underwood and Newsholme, 1967), with concoini tdne 
inhibition of phosphofructokinase. 
Since citrate is a substrate for f2. T,.:t:, acid 
synthesis, following its cleavage to acetyl eoA and 
oxaloacetate in the cytosol bv ATP-cj.i~raj.:t'~ i.\"~_l::?':3 
~ -
(Spencer and Lowenstein, 1962; Lowenstein, 1968), 
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the accumulation of citrate in liver of these. tumour-
bearing mice might reflect some 'abnormality of lipid 
metabolism in these animals t which as alre.ady noted 
is often perturbed in animals bearing tumours (Haven 
and Bloor, 1956; Costa and Holland, 1962; Cox and 
Gokcen, 1975). At this stage of the present study, 
we considered that increases in the hepatic content 
of citrate might therefore involve a decreased activity 
of the citrate-cleavage enzyme in livAt' of these tumour-
bearing mice, and this possibility is r.o,xamined later 
in this thesis (Chapter 4,). As discussed therein, 
it is of interest that increases in the hepatic content 
of citrate are elsa found in rats un~er conditions of 
. 't r- f tt °d t' 0 0 an 1ncreaseo ra ~,~ 0:': a y aC1 SVri ,(Le5='_S, e. g. 1n 
starved oni '[,als refed glucose (i'lewshu1rne and Start, 
1972). 
Hhy t~12 fr:e<2 coenzyme A content of liver of 
tumour-bear Lilg ;'lice should also be decreased is not 
clear at r--.:-eseut. Acc<),l:'cling to B-r:own (1959), t.he 
initial sta,l2e L-t) the blo3ynthesls of coenzyme A, 
invol~Tes t.he fonr.ai:ion of 4-phosphopant,otheine, from 
pantotheTla.te arlO I.-cysteine, and 8.8 would be expected, 
decreases i~ th2 bApaLic conte:it of t:l.e coenzyrne are 
found in pallto ~-,hC:T'.2,te·-Jp.fjcient an) illicll.'j (01 son and 
Kaplan~ 19L~<3). H'-'\.J~:-VR1~'> other TI'.2,tri cional factors 
may also be i!'LVolved~ siLlce decz"eases in the hepatic 
contents of eoA hav~ aL~o bee~ reported in rats fed 
protein-defici2t1i.. diets (Abiko, 1975), and later in 
the present thesis, it :LS shmvn that the hepatic 
contents of tOne cOe~lZyllle are decreased significantly, 
in starved ~ tumour'<- ree mice (Chapter 4). The metabolic 
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implications of changes in the ratio acetyl CoA/CoASH 
in liver of fed and fasted tumour-bearing mice are 
also discussed later. 
At the present stage of the invest.igation it was 
however of interest to determine whether the 
administration of pantothenate to tumour-bearing mice 
would increase the hepatic contents of the free 
coenzyme, a .... -!d these studies will now be reported. 
SOME OBSERVATIONS ON THE EFFECT OF THE 
ADMINISTRATION OF PANTOTHENATE 
TO TUMOUR-BEARING MICE 
Procedure 
Weight matched CBA mice, 4.5 to 5 months old 
were taken and olaced in cages in groups of six. A 
me 3. sUrt',:d. ,YOhU'102 of water (usually 50 cm3 ) in a 
~tand81:d t.ype water bottle was placed in position, 
and [ocr! Frm;ided ad lib. At the same time each day, 
the mean 3.T!lo:mt of water taken by each group was 
detRrrn:i ned. This was continued for a period of five 
d.s.ys. 
The ard m81.s were then separated into three groups. 
The first. gro1:p (Group 1) received Sarcoma 180 
subcutf:~!lCously in the subscapular position under ether 
c_n::>.esU:-J.~sia as described previously. The second 
group (Group 2) also received the tumour, but at the 
t:ime of tumour implant, 0.5 em3 of saline containing 
!. mg sodium pantothenate was given intraperitoneally. 
The third group (Group 3) were injected subcutarleously 
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in t.he subscapular position with 0.5 cm3 Hank's Balanced 
Salt Medium, and also injected intraperitoneally with 
the sa11le amount of saline containing pantothenate. 
The animals were then housed in groups of six to 
a cage. All of those that had received pantothenate 
intraperitoneally (tumour-free and tumour~implanted 
groups) were allowed access to adequate amounts of 
3 
water containing 0.02 mg calcium pantothenate per cm , 
which ~vas prepared afresh daily. The other group of 
tumour~'bearing mice received water \·;rithout the vitamin. 
The mean fluid intake of the three experimental 
groups were determined daily. Six mi~e were selected 
from each group on the 2nd, 4th, Oth, 10th and 15th 
day following tumour implant, and Ui2 budy weight 
determined. The animals were U'_er.. l,::"lled by cervical 
dislocation, and the hepatic contt'Yits or acetyl CoA 
and CoASH estimated. 
as was the weigh-t of the tumou'r, once tt::i~ had become 
measurable. 
The fluid intake of the rema:i.r'Ling ill.ice iI! each of 
the three experimental groups ~,.;as rrlea . .;'~rul dcdly for 
up to l5 days, when the experiment ~\7as t.e·t.1ninat:::d. 
RESULTS 
As shown in Table 6 and, as liOt=J. prt"\i'::'o'Usly 1.11 
this Chapter the mean fluid intake of fa} L.f> fell on the 
second and third day following tumGur implant, 
apparently moreso in mice that had al:io rc.c eli 'led 
pantothenate at the same time. 
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TABLE 6 
APPROXIHATE FLUID MID PA.NTOTHENATE INTAKE OF NORMAL HICE MTD MICE BEARING SARCOHA 180 
Days Before 
Tumour Implant 
1 
2 
3 
4 
5 
Days After Implant 
l. 
2 
3 
4' 
5 
6 
7 
8 
9 
10 
- 1 1.L 
12 
13 
14 
15 
Total 
r.1ean 
Group (1) Group (2) Group (3) 
Mean Water Intake 
3.9 
3.45 
3.95 
3.6 
3.6 
5~1 
2.3 
r' c L. ,-' 
') . 
.c:....4 
3 Q 8 
L~. 0 
3.9 
5.1 
3.7 
4.3 
4.2 
4.7 
3.8 
5.0 
3.4 
3.9 
3.7 
3.8 
3.7 
3.8 
c; ') 
~,..' . ,(..,. 
1.6 
LL;. 
1 c., 
_ • v 
3. L~ 
3.5 
3.6 
3.8 
4.2 
4.3 
if.O 
4.,5 
.. ,., 
LI, • .:' 
l.e.9 
' .) 
l."t'" "-
4.0 
4.0 
3.6 
4.2 
3.8 
3.7 
3.0 
2~K 
3.2 
"'j I J.,'+ 
3.8 
3.8 
') r; 
.....J;_ 
3 .. L~ 
~;. ! 
4.2 
3.7 
'~ " 
J., ,) 
4 £-' 
.v 
3.6 
Group (1) Group (2) Group (3) 
Mean Pantothenate Intake (mg) 
0.104 0.074 
0.052 0.060 
0.028 0.056 
0.032 0.064 
0.068 0.068 
O.OiO 0.076 
;).072 0.076 
0.076 0.070 
() ,O3~' 0.O~·8 
U.0Sr, 0.074 
D,030 0.034 
0.092 0.074 
0.036 0.066 
0.093 0.092 
0.08L, 0.072 
l.09 1. 07 
0.072 0.071 
Thereafter all groups ingested about the same 
amount of water, showing that those that had received 
the vitamin tolerated this treatment. 
The amount of pantothenate ingested per mouse 
averaged 0007 mg per diem, and when the total amount 
taken by mouth over the 15 days of the study was 
tabulated, this was the same in both the tumour-free 
group, and ~..:hose bearing the tumour. It must be 
stressed ho,lever that for obvious reasons these amounts 
quoted must. be considered to be very approximate. 
It might be argued that repeated injections of the 
vitamin might have been a better experimental approach, 
but it w~s con~idered that this treatment, particularly 
in mice bead ng a growing tumour, might influence the 
results us a consequence of trauma. 
T~v..: most striking feature was a marked decrease 
in budy weight of tumour-bearing mice that had received 
pantot.h€n':ll:.(~ ~ T,,,hen compared to tumour-bearing cont.t"ols 
(Fieure 13). whereas in nonGal mice that had received 
the vitamin~ thi.s treatment had no effect on body 
weight o'"er the period of the experiment. That the 
a:arked dec~e::lSeE' in body weight in the pantotheante 
treated Etj.·lim~-1.J.s was not due to an increased rate of 
tUITtoui.:-growth, is clearly shown in Figure 16, where it 
will be seen that the growth rate of the tumour in 
these animals was similar to that found in the untreated 
tumour-bearing group. 
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Change in Mean Body 
Weight (9) 
+1.0 
--1.0 
-2.0 
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-5.0 
0-0 Normal Controls (Pantothenate) 
)0oX Tumour Group (Untreated) 
€I-Ell Tumour Group (pantothenate) 
~-·+t--t-t -----r-"i --~--t 
o 2 4 6 8 10 
Days After Tumour Impkm! 
FIGURE 15 Changes in body weight; illcluceJ by the 
administration of pantothenate to micE: bearing 
Sarcoma 180. Six animals were user} [or ~ach time 
interval. 
Mean Tumour Wt. (9) 
.-0 Pantothenate Treated 
x-x Untreated f 
--·~I----Ti----·r----. 
10 12 14 16 
C-ays After Tumour Impkmt 
FIGlJRF 36 Growth curve of Sarcoma 180 in 
ps.ntoLhenate-treated and untreated mice. 
Six animals were used for each time interval. 
As shown in Figure 17, the mean spleen weight of 
mice bearing Sarcoma 180, increased in parallel with 
a similar group that had received pantothenate, 
although the mean spleen weight in the latter group 
showed a greater increase by the eighth day following 
tumour implant. On the 15th day however, a marked 
decrease in spleen weight of the pantothenate-treated 
mice bearing the tumour occurred • 
. (3) Cha1l1;e.~v in the Hepatic Contents of Ac~~.Y.L CQ£:: 
anCi. CoASH 
(a) Act-;. t"iT 1 ('.0A 
---~,,;...~~~-
As ShOWl] in Table 7, the hepatic contents of 
this metab'Jl1.te ~n pantothenate-treated, and untreated 
t1imour~be0ring f!.lice were very similar when measured 
at int9}~v8.ls up to 15 days following tumour implant. 
Hhen l:lvs,;c data were compared to normal mice that had 
received che vitamin, both tumour-bearing groups 
showed 3ign:"£:i..cant decreases in the hepatic content 
of acetyl CoA on the second and 15th day following the 
implant. 
A similar picture occurred in the changes in the 
~epatic content of the free coenzyme in these livers 
(Table 8). Again, there was very little difference 
~_n the content of this metabolite in liver of tumour-
bearing mice, when compared to a similar group that 
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Mean Spleen Wt. (mg) 
300 
I 
200-1 
I 
0-0 Normal Controls (Pantothenate) 
x-x Tumour Group (Untreated) 
ell-ell Tumour Group (Pantothenate) 
L.---+-t --i-t --,---.., -ti-f.t---r·--.l--, 
U 2 4 6 8 10 12 14 16 
Days AftAr Tumour Implant 
FIGURE 17 Changes in spleen weight induced by the 
admin-Lst::::acio'!J. of pantothenate to mice bearing 
Sarcoma 180. Six animals were used for each time 
interval. 
TABLE 7 
EFFECT OF ADMINISTRATION OF PANTOTHENATE ON THE ACETYL CoA CONTENT 
OF LIVER OF NOR~~L MICE N~D MICE BEARING SARCOMA 180 
Acetyl Coenzyme A (nmol/g Liver Wet Weight) i ~ Day 
i 2 
Controls (Pantothenate) Tumour Group (Untreated) Tumour Group (Pantothenate) 
58.7S±2.18 43.10~2.02a 47.S7~2.10c 
I Lt- S9.l8~2.00 S7.28~2.56 58.15~3.47 
S 
10 
, -+- +! 48.82~2.85 S7.27~3.88 58.99-3.29 I 
6l.02!3.08 59.65~2.6] 62.96!2.83 I 
15 ~ ,- ,.. -+- '"l -, "l '" "' + ,., r "h ~ + d I .J,L,9,L-L .• E.::s ,JU. 7<-;··1... 70 .J4.12~1.66 
___ . ___________ ~_.~~ ___ ~" __ , .1 
Six mice w~re studied in ea~h group. + Vahle'" Bye :nea::lS - S .. EcMo 
a = Sta,ti~ ti c.:.11y ~~:;-G:lif tCA.lit (? ~ 0.01) when compared to controls. 
1-. C' • , 1"' . . -. ,..,... ~) , - 1 
.J = ,ytatlstl.c.a l.V f;::lgTlltl.C8.Ici-, ,P':.U"OOl. ~7nen rJo~".par.E:d to contro s. 
C = Statistically 
d = Statistically 
signiflca.nt 
.. . ..... 
S J_gn:u: lcan t 
(p,::: 0,-(2) wr,eH compared to controls. 
(p< 0.00:c) ';,ihetl c.ompared to controls. 
TABLE 8 
EFFECT OF ADMINISTRATION OF PANTOTHENATE ON THE FREE COENZYME A 
CONTENT OF LIVER OF NORNAL MICE AND MICE BEARING SARCOMA 180 
~ CoASH 
I Day _Controls (Pantothenate) l-, + 
! 2 I 68.98-0.79 
I I + I 4 I 56.26-4.05 
(nmo1/g Liver Wet Weight) 
Tumour Group (Untreated) 
41. 89-:t5. 99a 
+ 62.56-7.7L~ 
Tumour Group (Pantothenate) 
29.28~3.61c 
59.82~7.57 
I 8 59.76±3.13 
I ' 
L.lO i I '" I J I r 65.l1-:t2•45 + 61.29-4",31 
------------------
+ 54.72-5.13 
~a 6()+9 "'5 
_)'3 0 0-- 004/" 
, . 
'30, 69~L be!) 
Values are the m'28.n of six !Tli(:2 s'.:tjdieu ::"n ~~aC~1 g':"f)1..lP -:--. ~cvS"M. 
- Sr r'C",' ',' '1, ,,: ,,;.r,' r~' I~ '0 "J\ "h r-7'1' d t r"'" .,...- 1 a - L _a _J.d _ L,--aL " _..,",~rL~_.L ,',co .... t: \ t' ---. ,- ,J ,,. VIi en C'-l' pare 0 vvn ... L 0 s. 
n ,-;:, StatiST:1Cally ~"':igni£,j.ca'1::- (0:> .. {'\ (,r'l \ ',-hpr c (')T'n')'::>~','d i- 0 cont""ols 
.. 1. -~~v. J ... ' ) l.v _ .. ~ :'L(.), (.(,'.\:_ '- .:-. 
<> d d, := Ct·· •. ' Q ... ..: ~ 11·' '.--ic,; ;7' t- "P<- 0 'lO' ') ';ho m d ttl (. ~.n_ ,-_aL.l..,L.-,-,-a,~.v ~_'Dn.,-~lC<ln. \. __ .'- '/ y.;.~.n cC.l1pare. 0 con ro s. 
+ 54.90-5.97 
..,\.. 
57.25':'5.56 
25.49~4.2L~d 
had received pantothenate. Also, in parallel with 
the changes found in the hepatic contents of acetyl 
CoA, the free coenzyme A content fell significantly on 
the second and 15th day following tumour implant, in 
both pantothenate-treated and untreated mice. 
Since these data on the hepatic contents of acetyl 
CoA and CoASH in the tumour-bearing groups had been 
compared as shown (Tables 7 and 8), to normal mice 
that had received pantothenate, we compared the values 
found in the latter group to t.hose of normal untreated 
mice. 1..J1:.1f'; Although the data is not shown, there ~ no 
significant changes in the free coenzyrrre A content of 
liver of pantothenate-treated mice, wh'2:1 compared to 
normal mice. However, those tha~ had rec.eived 
pantothenate showed significant d:~C::"E>tSeS in the hepatic 
content of acetyl CoA on the eit.,hth dEl} (PC:: 0,1)2) and 
also on the 15th day (pc(. O. 05). Nc:' explarY.tt::iJ)Tl UHl 
be forwarded for this ~ but this does nOI. ,)bvjc.t~ HIs 
finding that the administration of pantothenate to 
mice bearing Sar·,:.oma 180 does not ':::.cnr.tC:1:.Jct t}'e faLL 
in the hepatic contents of eithe'r ;:l..cetyl (>:;/:\ o:!:' C:0ASH 
induce(~ by the tumour. 
DISCUSSION 
Selection of mice at different p~riods l1p to 15 
days, . for the determination of acet.yl evA, 8o .. '\.::.'H ~ and 
the other par3J.lleters studied, meant in effect that 
these animals had received different 8.f'l.Otlnts of 
pantothenate. However in normal mice that had received 
the vitamin, the hepatic contents of CoASH 2.Ll.] acetyl 
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CoA on the 15th day were very similar to those found 
on the second day. By comparing the values found in 
the hepatic content of the free coenzyme in these 
animals to normal untreated controls, there was no 
significant differences found as a result of treatment 
with pantothenate. Therefore the pool size of the 
free coenzyme in liver was not altered by the 
administration of pantothenate, at least by the amounts 
given here. It was noted however that in these livers, 
there 'das a small but significdnt ':8.11 in the content 
of acetyl eoA on the eighth and 15th day. 
The findings however showed that the fall in the 
hepatic. content'3 of CoASH and aCE'L.yl Co,\ in tumour 
bearing mil"':: c.:'Llld not be normal iser~, 't:)y the administration 
of pantoth~''l8,te, even on the 15th Jay, ,,\Then the intake 
of the vi talliin 'ivas maxLnal. 
The n1h:cked 1,)83 ot' body weigh:', aod spleen weight 
that occurred in roic0 bea~ing S2rcama 180 following 
the adminlstrat'~on of pantotherlbte canIlot be explained 
at present. However, this could Dot be related to 
a greatE r .cate of tumou-r-growth i,D mice receiving the 
vitamin. It. a]L1.Y also be noted, tr.at the. amount of 
pantothenaLe c,dLi' j_'c:is :~el..-ed i. p., plus i:he amount taken 
orally, was v,:"ry ;C,UCi'l lower than t1>e LDSO for this 
compound in mice, \;'hich he,s be,~n L spot: t,E::J to be 5 
7.5 g/Kg body we~_ght: w'h,en gj ven intraperi toneally 
(Knott, Tsao, l\~cCutche~ny ChelcJelin and King, 1957). 
At this stage 1 we ~an only tentatively suggest 
that the admi'1istnl :::i,01'' (~~: pantothenate to mice bearing 
Sarcoma 180 has some toxic effect, perhaps mediated 
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via some defect in the metabolism of the vitamin in 
these animals. Of interest in this connection are 
the observations of Wiseman Clnd Ghadially (1958), who 
showed that supplementation of the diet of mice bearing 
RD3 sarcoma, with four percent methionine increased 
the rate of tumour growth, and at thc:~ same time caused 
the tissues of the host to waste. 1he rationale behind 
these studies, was the previous observations by these 
workers, showing that excess methionine reduced the 
ability of normal tissues to take 1Jp oi.:.her amino 
acids~ but not the tumour cells ~.::::::.itro. They suggest 
that as a c.onsequence, the tumour is provided with a 
readier sou:;-:'ce of amino acids for grov;th (Wiseman and 
Ghadially; 1.9S5:3.., l')55b; Wisem21i and Ghadially, 1956; 
vJiseman S:UQ Ghadially, 1958). 
It is .::!.lsc· of ints.cest that the 1.Tlethionine content 
of the diet. has ht-~e!l claiwed (Abiko, 19/.~), to be the 
most influential factc"!~ :i.n the cecreased content of 
Clea:r:ly rllt]r,h i>~rther work is necessary on the 
metaDollSlll of COCI12~lrr.e A in livcl" cf t.umour-bearing 
animals to e].uc:.~cl5.te th(~ mechanisms involved in the 
findings here repGY.'t2dn 
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CHAPTER 3 
FURTHER STUDIES ON METABOLIC CHANGES 
IN LIVER OF TUMOUR~BEARING MICE 
Introduction 
In the previous Chapter, several questions were 
raised as to the aetiology of changes in the hepatic 
content of acetyl CoA, CoASH and citrate in liver of 
tumour-~earing mice, and some possible mechanisms 
, 
were prope ~3ed to account for t.hese changes. 
In t-h2 present study, attempts have been made 
to clarify SvWt2 of these proposals, as well as gain 
further ir;~Lbht into the metabolic events taking 
place in these livers as a result of tumour growth in 
the host. 
Pa:r-L: of these studies have been present.ed elsewhere 
(Ca.lE!&l! and McAllister, 1975a~ 1975b; HcAllisle:r; Soukop 
and CaL~fl2n, 1976). 
l'-letb.ods a;:ld l'13.terials 
Hie€-: heC'xing either TLX~5 lymphoma, Sarcoma 180 
or a transLJ.an·::'able C3H mammary tumour were used as 
previous]y. 
Details as to the stage of tumour growth at which 
the determinations were made~ are described where 
appropriate in the text. 
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Metabolites Studied 
Lactate, pyruvate, malate, citrate 0< -oxoglutarate, 
ATP, ADP, M1P, fructose-6-phosphate and glucose-6~ 
phosphate were determined on freeze~clamped livers as 
described previously. 
The very low level of oxaloacetate in mouse liver, 
made the enzymatic determination of this metabolite 
unreliable. Values were therefore obtained by 
calculatio~J; as were the NAD + / NADH ratios, according 
to the procedures of Williamson, Lund and Krebs 
(1967). 
(a) + NAD / NADH R,qti~ 
The lactate and pyruvate conteTit of freeze-
clamped livers were determined enz:vruatir.ally, and the 
following applied: 
.Pyru.Y~te 
Lactate x 
I 
K 
eg. 
NAD 
.,~ .. 
NADH 
where K is the equilibrium c.onSLEtn~. of lacts.t~~ 
eq. ..I~ 
dehydrogenase~ which is equal to 1. J. x 10 • 
(b) 'i~. The _CytC?E..lasmic Oxaloacetate S(lnt.t.~nt 
The malate content of freeze-clan·,.ped :livers i'laS 
.' determined enzymatically, and using the NAD' / :C:!ADH 
ratio calculated as above, the oxaloHcc:ta.:::c c.orlteel:.. 
was determined using the formula, 
*The reservations as to this approach are discussed on 
page 106. 
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Oxaloacetate -- Halate x NAD+ / NADH x K 
eq. 
where K is the equilibrium constant of malate 
eq. 5 
dehydrogenase which is equal to 2. 7,) x 10- • 
(c) En~nes Studied 
In separate experiments, the activity of 
phosphofructokinase and fructose-I, 6-diphosphatase 
in liver of normal and tumour-bearing animals were 
determinedo 
Cd) Others 
The lactate &nd glucose contr~Itt of blood from 
control and turr~\Jur-bearing mice Wf:Ic determined as 
describe~ previously. 
Since in these cS.nit1als, livers had first to be 
freeze-cl&npp~J bl~od was collected i~nediately 
afterwards by,l:LC'king th.e aori.:f\.) and withdrawing the 
blood ra.pidl~T L,om the abdominal '.:.avity with a syringe 
He3.sured aliquots were ilTLfnediately 
deproteini sE~d by 'Che appropriate me thod and the assay 
carried out irnrnE.'ciiately., 
Results 
The data. sho'i.'/n in Figure 18, shm':s the significant 
decreases that 0ccu~reJ jn cile hepatic contents of 
lactate, pyrllVctte 3.nd malate in mice bearing TLX-5 
lymphoma. In mice l)earing Sarcoma 180, that at 
autopsy gave a mean tumour weight of 4.42 -.t S.E.M. 
0.5S g after 15 day~ of tUITJ.Oilr~growth, the lactate 
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JJmol lACTATE/g 
± S.E.M. 
FIGURE 18 
J.lmol PYRUVATE /g 
± S.E.M. 
0'3 
CJ Controls 
J,.lmol MALATE/g. 
±S.E.M. 
1·5 
~ 'tumour-bearing 
1·0-
0·5 
111(; lac tate, pyl.-L1Vi-lt~ and HlEtlate content 
of livers of mice bearing TLX-J lymphoma after seven 
days of tllillour growth. o 
animals in each grolip. 
Results are means of six 
content of liver fell belO\v normal, but not significantly 
so when compared to controls. There were highly 
significant reductions in the pyruvate content of 
these livers, and the malate content was also 
significantly depressed (Figure 19). The hepatic 
content of the latter was also significantly reduced 
(PZ 0.001) in mice bearing the C3H mammary tumour. 
In this group, the mean tumour 'was 0.73 -.t S.EoM. 0.19 g. 
The lactate content of livers of these animals remained 
at normal values, and although the pyruvate content 
was decreased, this did not reach statistical 
significance (Figure 20). 
Determination' of the ex' ~oxoglutarate content of 
livers of mice bearing these tUID01lL'S sh~w~;d a 53 
percent decrease in those bearing T!,X~S lymphoma which 
was highly significant (p< 0.001). IJ.~ mice beEring 
_L 
S 180 ' h . 1 f 0 l:'l)' arcoma ,Wl t . a mean tumour \'!2),ti1.t I): • .J - S.E~M~ 
0.35 g, there was an 18 percent deCrQa.:3L ~.:1 the 
~ -oxoglutarate content of liver, lrut chis was not 
statistically significant. In cOI)'i:rasi.., In aeocher 
se:::-ies of mice bearing this tumour. in wh~,ch tho. mean 
tumour weight was 4.27 ':!:' S.E.H. 0.22 g afL~r 15 days 
of tumour growth, there was a. 60 pe::-cenL r?dl.1c.t: -Lon in 
the hepatic content of ~ -oxogluta:rate (r.< o. e'l). 
These data are shmvn in Table 9, wherE it c~f'. 3lso be 
seen that the 0( -oxog1utarate content:. of liv::rs of 
mice bearing the C3H marnmary tumour, did noi: in 
either of the two groups of animals scudied, aT~ in 
, 
which the mean tu.mour weights were 0.19 ~ 2.1~.Mo 0.04 g 
+ 
and 0.55 - S.E.M. 0.12 g respectively. 
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pmol LACTATE /g. 
± S.E.M. 
3'0 
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).lmol LACTATE/g. 
±S.E.M. 
3·0 
2·0 
1·0 
o 
FIGURE 20 
).lltlol PYRUVATE / g. 
±S.E.M. 
0·3 
umol MALATE/g. 
±S.E.M. 
1·5 
~ ll.!'flollr- Gearing 
0·2 1·0 
0·5 
COlitf 01 T~st Control Te:;t 
Thl::' lactate, PT(uvat.e e.nd mDlate content 
of livers of iTIic~ bt:.aring a C}I t.ransplantable mammary 
tumour. Resl,:i ts arE~ meaDS of six animals in each 
group. 
The data given in Figures 18, 19 and 20 for the 
lactate, pyruvate and malate content of livers of these 
mice was then used to calculate the lactate/pyruvate 
ratios, the cytoplasmic NAD+ / NADH ratios and the 
cytoplasmic oxaloacetate content by the methods already 
described. Table 10 shows that significant increases 
in the lactate/pyruvate ratio occurred in livers of 
mice bearing either of the three turnoUTS studied. In 
these experiments, the data shown in Table 10 for mice 
bearing Sarcoma 180, were derived from the group in 
which the mean tumour ~veight Has 4.42 ± SeE.M. 0.55 g 
and in those bearing the mammary tumour, which gave a 
+ 
mean tumour weight of 0.73 - S. -:'::.1-1. 0 0 19 g; as is also 
ShO'WIl in Table 10, the NAD + / NADH r8.tios in livers of 
these animals decreased signific.aptly i"'.:ldicating, as 
discussed later, that the CytOpJ.8,8LTI of the Ii vt::;y cell. 
in these tumour-bearing mice was in a lYl(J.:.::e redllced 
state than normal. The calculated v8J.12e~ for the 
oxaloacetate content of these livers also showed 
significant decreases when compared ::0 ~.oncrol values. 
As shown in Table ll, the hepatic:. sontt:nt of g)UCOS(;~-
6~phosphate and fructose-6-phosphate \\'ere 8i.gnif tcantly 
decreased in mice bearing TLX-5 lym;?hcma. F,)r v8.riow, 
reasons it was not possible to det(~:!:mh:2 I~je: t.l.c:ratic 
content of these metabolites in live.r' of Q'f'.tmaJ::; 
bearing the other tumour. systems. 
Determination of the activity of p·nospho.f~ucto­
kinase and fl'uctose-l, 6··diphosphatase in liver of mice 
bearing TLX-5 lymphoma showed that the DCi·.i.vj U.e,':" of 
the enzymes were not altered from normal values (1',01111("> 12). 
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TABLE 9 
THE (>~ -OXOGLUTARATE CONTENT OF LIVERS 
OF TUMOUR-BEARING ANIMALS 
Conditions D( -..2~~pgLu~arate 
pmol/ g~S 0 E. N. 
+ 0.lL}6-0.01 
% Chan~ P 
Controls 
TLX-S Lyn:_ph0mD_ 
Controls 
Sarcoma 180. Ne$n 
Tumour \>ft" 0.50= 
S.E.N. 0.356 
Controls 
Sarcoma 180. N2~fP 
Tumour Wt. i~. 2'/-
S.E.H. O.2,~g 
Controls 
(' "1'1 M;,rnn.,8 .... \T u 3 - ~ __ .L _ --, J 
Tumour ,,1~~eal1 
H t • = O. 19 :") " E ,. 1-1. 
O.04g 
Controls 
C .... H Haillinary 
TGmou r '. }\Ie un 
T,7t- =0 - 5-;: r: v M ~i _ " (l J l~' • LI ~ ~ l' 
O.12g 
0.069~O.009 
0.086:t0.020 
0.23~0.03 
+ 0.09-0.008 
Ool13~0.007 
0.097"::-0.021 
0.097~0.017 
-18 
-60 L. 0.01 
+5 N.S. 
NIL N.S. 
~~ =--:: St:atistical evaluation, by unpaired It' test. 
N. S. =-: Not Significant. 
.six animals were studied in each group. 
TABLE 10 
THE LACTATE/PYRUVATE RATIOS? REDOX STATE OF FREE NICOTINAMIDE ADENINE 
DINUCLEOTIDES fu"ifD OXALOACETATE CONTENT OF LIVERS OF TlTl'lOTJR-BEARING MTCE 
, ,._. 
. ---------------------------
r--C ..:J. ,- ---'-I1-----1---·--,~ ----I---1\·AL+~ NADu Oxaloacetate I Conl.ltlons ! actn.tel ryrU'jdtt:: ! .j lin L\ ;Uffiol/g L_ __+ _____ - _____________________ • __ _ 
I I' , +  Controls I 15.C:(:.~·1.34 (6) 620'2:'5<) (6) 0.014-0.002 (6) 
i T~·~X·-5 L..y,.r.phcmc:. I 25,53~2.18 (6) 365-:::-35 (6) 0.003~0.0004 (6) 
\ . " . 
; p _.______ l-------~.=- o. G~ _____ .. ___ L ~ 0.01 <0.01 
I -l- I + -l-Contn))s i 19.21~·1.30 (6) 477-32 (6) 0.009':'0.0007 (6) 
Sarcoma I 29.Z3:-2.:0 (6) I 308:-35 (6) 0.0~4:-0.0~06 (6) . 
.l-----.:~...:. O~ __ ~ ~ ~ 0001 . J e... 0.001. I 
; 12.08:'O,75 (6) I 757:46 (6)1
1 
00012:::-0.0018 (6) I 
~ ' 
: 20<33:::-1~59 (6) , [}SE2:4l (6) I' 0.0037:0 • 003 (6) I 
!.; I· . I I <- 0.001 L'::" O. 001 l _____ ~- O. 001 _~; 
Coni:rols 
p 
i C 3H Mammarv I J 
I Tumour 
L-
Vall~es are means -:::- SoEoM. numbers in parenthesis are number of animals used. P = Statistical 
evaluation by unpaired 't' test. Cytosolic NAD+ / NADH ratio and oxaloacetate content 
calc.ulated according to the methods given in the text. 
-I-
Mean tumour weights - Sarcoma 120 = 4.42g':"S.E.I:v1. O.SSg. 
_L 
Transplantable C3H Mamrnary Lumour = O. 73g~SoE"Mo 0,19g. 
TABLE 11 
THE GLUCOSE-G- PHOSPHATE Al'JD 
- -
FRUCTOSE-6-PHOSPHATE CONTENT OF LIVER 
OF MICE BEARING TLX-S LYMPHOH.A 
Condition::-
COil.tro Is 
Tumou:t:~:C00re:;.s 
p 
HEPATIC CONTENT 
(pmol/g Wet Wt.) 
Glucose-6-
,Ehosphate 
+ 0.280-0.036 (10) 
0.100-::0.008 (9) 
< 0.001 
Fructose~6~ 
Ph~ha~ 
0.13(~0.0/.O (10) 
0.057:!:"O.00L'J. (9) 
..(. 0.01 
Figure~ in parenthesis are number of animals studied. 
+ i.{E.s~llts c~xpr2ss0d as means ~ S.E.M. 
TABLE 12 
THE ACTIVITIES GF FRUCTOSE DIPHOSPHATASZ Aj'm PHOSP:-IOfRUCTOKINASE 
Conditions 
Controls 
TLX-S Lymphoma 
P 
- ---'-'." ---- .------.-----------.------
IN LIVE1<. OF NICE BEARlNG T:L;Z~:; LYl'1?B.O~J;~ 
Fructose Dipho=phatase 
;umol/min/g 
.I 
7.Sl~O.24 (6) 
7.39~O.17 (6) 
. N, S~ 
Phosphofructokinase 
JlIIlol/min/g 
O.67~O.017 (6) 
O.75~O.29 (6) 
NoS. 
Values given are means ~ SoE.M. Numbers in parentheses are numbers of animals 
used. 
N.S o = Not significant. 
Blood Glucose 'i,721ues in Nice Be Either Sarcoma 
180 or TLX-5 LVlTIp~'2.~c:. 
The data given in Table 13 shows that growth of 
TLX-5 lymphoma or Sarcoma 180, resulted in marked 
decreases in the glucose content of blood in the host, 
but in mice bearing the mammary tumour, this did not 
alter significantly. 
Blood Lactate Values 
These determinations were on]y made on mice 
bearing either the TLX-5 lymphoma 01:' Sarcoma 180. 
As shmvn in Tel.ble 14, the lactaLc \,:ontent of blood of 
mice bea~in?, TLX .. 5 lymphoma showe,l r.o significant 
change V.7fJeC :::.or.::pared to controlt;, LuI. in mice bearing 
Sarc.oma lk:.J~ signific8nt decreases in. the blood lactate 
value S o,:C'.urrccl. 
As sho-.m ~I1 Table 15 therE: v;·ere significant 
decreases .i.IL the hep&U.c contents of ATP and ADP in 
mice bea.ring ~it. tier TLX-5 lympholfl8. 1 or Sarcoma 180. 
The A}1P cont2TIt of the~o~~ livers ~,vas only significantly 
decreased in r:ltc.e 1Y~8ring the Sarcorr:.a. However, the 
ATP/ADP ratio;) WE:lE! not significanL.ly altered in both 
models, e.nd. the ATP/A."1P .... ra~.lO 
decrease .; I~ ~lL'l; r ~ 'i...,r.:. Or r; 1"'19" 
.1.- J. -- - - ~ ..... c.:....... ..... v 
shOl'YE::d a significant 
1.h2 lymphoma. 
The data also ShCJW8 [he I energy charge' in these 
livers which was c81culated from E = k (ADP = 2 ATP) 
2 Total ' 
as described by At~inson (1969). This value (E) was 
not significantly altered in mice bearing Sarcoma 130 
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TABLE 13 
BLOOD GLUCOSE VALUES IN TilllOUR-BEARING MICE 
Conditior..s 
Normal Cont}:'ols (CBA) 
TLX-5 Lymphvma 
p 
Normal Ccnt1.cls (C3H) 
C 3H MarmT,8rv Tumour 
p 
Blood Glucose rmno1 
+ 12623-0.718 (6) 
+ 4·.88-0.087 (6) 
.(0.001 
--~ -~ 10.87±0~820 (6) 
13.90:t1.120 (6) 
N.S. 
---~.-~-. -~.~------------------~-.. ---
Controls (CBA) 
Sar(;'OlllR. (180) 
p 
14.77:-0.565 (6) 
9.67-.tO.617 (6) 
<: 0.001 
Nu,:lbe:;:-s in parenthesis :: Number of animals in each grou.p. 
TABLE 14 
THE LACTATE CONTENT OF BLOOD OF 
TUMOUR-BEARI~G MICE 
Conditions Blood ~actate p 
mmol/l 
-
S,)E~1~e 
Controls 5.44:0. L~/+ (L~) N.S. 
+ TLX-5 Lymphoma 5.25-0.40 (6) 
Controls + (6) 5.39~0.12 ~. 00001 
180 -I- (" Sarcoma 3. 99-0. 2L~ 0; 
Numbers in parentheses are numbers (F: nldmsls studied. 
NoS~ ~ Not significant. 
TABLE 15 
THE ADENINE NUCLEOTIDE CONTENT OF LIVER OF TUMOUR-BEARING MICE 
---- -----~-----------
L~·~ -- H;~~~ic Con;eut (J1TIol/g -Live~ W~t -vhT!----' 
-_. ATP------~\DP-- --------P}lP-----,[ AT? / ADP 
.-L--- ------------- "----+----l----i . rc;+c,,..,,,, 1 1"'9+0 "\")6 0 '2r:;:-'+O 01 I ·14? 
Conditions ATP/AMP Energy Charge 
,I, • ,) .J -. }. v -" .... • .J - • v ~ • -' ,-' ,) -. I . -
! 1 ')')+0 :\l t) (~'"j+r) O'~·r~) ')83+{'\ 018 J 45 ~ _ ..... )...-- .\...~ ...... 7£.--\.. • ..... ,0 0tJ."_. -'Jo' . _. 
Contro1E 
Sr, c.01l1a 180 
4.39 0.699 
4.78 0.707 
1~ < .. 0.01 <- 0.01 z O~Ol I N.S .. ~ 
Cont:cols 2.04:0.CJ9 + l~36 1.50 .. 0.028 0.448-0.018 I 
.J_ + TLX-S Lymphoma 1. 70':'0. 069 1.34-0.040 0.450:0.017 I 1. 26 
N.S. N.S. 
4.57 0.700 
3.79 0.678 
P ...::. 0.02 ,~ 0.02 N .. S. I N.S. I , "'- C.OI N (" ~ ... ..) . L ____ . 
--------
Six animals were studied in each group. The en,~r;sy c.haI'ge was calculated as described in the 
text. 
Nice bearing TLX-S lymphoma were s"tudied after eight days of tumour growth and those bearing 
Sarcoma 180 after 14 days of tumour growth. 
+ Results expressed as mea.ns - S.E.N. 
. 
~ 
or TLX-S lymphoma, when compared to controls. 
Discussion 
These experiments show that highly significant 
reductions occur in the Dvruvate content of livers of 
~ . 
mice bearing eitherTLX-S lymphoma or Sarcoma 180. 
The lactat2 c.ontent of these livers only decreased 
significantly in those bearing TLX-5 lymphoma. As 
described p:,_'eviously however, this tumour invades liver, 
and this Gi:::JY vJell cloud the picture of changes in the 
hepatic content of this metabolite. 
The -I ac.to.te/pyruvate ratios in livers of mice 
bearing ~:!.t:·ler of the three tumours studied shows 
significant lllcreases. Previous workers have shown 
that this ratio is only slightly increased in nOl.1nal 
fasted rat:.:;, ard raised three to five-fold in acute 
alloxan dj.Cibetes in these animals (Williamson, Lund 
unci Iz..Lr;bs~ 1<J67),changes that can be attributed to 8. 
decrea;:;,,- in glycolytic flux under these conditions. 
Since \'Je have previously shown that mice bearing TLX~5 
lynrphoQ8. e:t'8 8.11orexic, whereas those bearing Sarcoma 
180 are not, t..h.~se increased l&ctate/pyruvate ratios 
cannot be dllC solely to reductions in food intake. 
Since pyrcvp~te 1}3 the second maj or source of acetyl 
c();~ in li,.rer (.Lowenstein, 1971) a fall in the hepatic 
c.onteT.2t: of this metabolite in liver of tumou.r~bearing 
roice,would be consistent with a decrease in the acetyl 
eoA content of livers of mice bearing these tumours 
~}lat we observed previously. It is difficult however 
to assess the degree of reduction ln the level ~.(: V.L 
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pyruvate that \\70uld be necessary for this effect to 
be achieved, particularly since the pyruvate content 
of livers of mice bearing the C3H mammary tumour, 
although decreased did not reach statistical significance. 
Further, in the normal fasted rat, the increased fatty 
acid supply to liver results in significant increases 
in the acetyl CoA content. 
Alterations in the substrate pair lactate/pyruvate, 
in livers of these mice due to alter~tions in the 
activity of lactate dehydrogenase vHyuld appear unlikely 
since it has been shO\m (Manso, Sugiura and Wroblewski, 
1958) thet the activity of this enzy""ffie is not altered 
in livers of mi·:.e bearing a varie Ly J~ t.umours, inclu.ding 
Sarcoma l80, ~imilar findings for the specific 
actlvlty, 3.rtC distribution pattern of this enzyme in 
liver of racs l-,osting ·H8rris h.~patoma 16 have also been 
reported «(~()'('nble~~t, VOJ..·beck~ Lucas, Esterly, Morris 
and Martin, 1974). We consi.der therefore that a 
decreased content of pyruvate jn livEr of mice bearing 
either TLX-'i lYInt:h'J!'la ':j"e Sarcoma 3.80, that \Ve have 
repor::'ed here, wOJJld be consistc."ni: with a previous 
report of increasEd act~vity of gluconeogenic enzymes 
in livers flf rae::; be.a::'::"l.ng transplanta"ole. tumours 
(Gutman; T"hil(' aUG BLc-a:<, 1969). There is also evidence 
that three&·ca:cbon !:r.?ghl.e·t1ts of the oxid2tive breakdOlm 
of glucose are acti';:-ely utilised in the synthesis of 
tumour proteins (St~.dP~'t, 1972). 
The deer.eases -i n the hepatic content of c:;{ oxoglutarate 
that were f01!nd i-!.l :.1:e p:::sent study, amounted to 53 
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18 percent in those bearing Sarcoma 180, with a mean 
tumour weight of 0.50 g, and 60 percent in those mice 
bearing the larger Sarcoma (mean wt. L~.42 g). 
Whether there is any relationship Lo the size of the 
Sarcoma, and the degree of reduction in the hepatic. 
content of this metabolite remains to be elucidated. 
It is of interest however that in mice bearing Sarcoma 
180, which gave a mean tumour weight of 0.50 g, the 
citrate content of liver did not increase, whereas in 
those hosting Sarcoma 180, with fl '/lear, tumour weight 
of 4.42 g, the hepatic content of this metabolite 
increased significnatly. 
The centrEd position of ex -oxogJ."'J.LJrate in inter-
mediary me t::lbo J.1slTI 1 where it prO"ViGf:3 Et link between 
the oxidetivc break-down of carbcbyd.cate and fats, and 
the meta.bob.sm of amino acids (Tager:, De Haan and 
Slater, i 9G9) ~ indicates that sever:ll possible mechanisms 
could be T.cspoll.:dble f,p:, :tts depletion in livers of 
these tUP;(Jllr~ bearing mice. The c~c~rrence in liver 
of several '"\( -oxcgliJtal"ate-<U nked t'l:al1saminases, 
raises tho questio,,:: of whether i.nc:.re8sed substrate 
utilisation due to incy~ased activity of these enzymes 
is involved. 'iZa.rupf;cr21idL (lS50) has reported 
increased acU.vi L-y' of tyrosine t:.ran33minase in livers 
of rats beaT.ing the. v)'alker c.&rCi~liSaLcon',a 256. The 
interpretab,on of s112.h data is, hm'lcv2r complicated, 
since the activity 01' th(;se enzymes are sensitive to 
protein intp.ke, a.S wf'll as 'adrenal function (Levine, 
1964). Signific[lJt deCr9.8.ses in the ~ -oxoglutarate 
content of livers of fasLed and acute alloxan/diabetes 
rats have also beer :~'8porte(~ (Williamson, Lund and 
100 
Krebs, 1967) in which conditions, the activity of the 
tricarboxylic acid cycle is depressed (Start and 
Newsholme, 1968). In these gluconeogenic conditions 
however, the citrate content of liver is decreased 
(Herrera and Freinkel, 1968; Start and Newsholme, 
1968), whereas in liver of tumour-bearing mice, the 
citrate content is significantly increased. Since 
the formation of c<-oxoglutarate in the tricarboxylic 
acid cycle takes place in the sequence, citrate-
isocitrate- '"'(-oxoglutarate, and isocitrate is in 
equilibrium with citrate (Atkinson, 1968) an irlcreased 
citrate content in livers of these tumour ... bearing 
mice, and a decreasedrx -oxoglutarate content, could 
suggest that isocitrate dehydrogena.22 is ill~libited. 
Al tered tricarboxylic acid cyc l0 .::::.c·ti vi ty in liver with 
accumulation of citrate and is(lcitrate .-::.8 a re sui t of 
inhibition of this enzyIne by amrannia has bper. r~ported 
. l' .. d f' . t (T' ' d V' k prevlous y In arglDlne- e lCLen _ yaT:S ,L. r::...)r an lSt'O _, 
1973) and in armnonia intoxication (K~,:,s[1:::,r) 19(5). 
are investigating possible inhibito:t'~T Ilr.-:c.h2.nisms of 
this enzyme in livers of tumour-DPdrJ.ng m:.ce. 
When the NAD + / NADH ratios of illCUS.~ 1 i,,'2r cytopL'.::,.S7: 
were calculated, the data shovled that s:~.gr.L:_fiC'2nt 
decreases had occurred in livers of tb~.s~ ~iC2 tearing 
either of the three tumours under :LnvC!sl:ig[' .. ~~ 02. 
Since the lactate dehydrogenase systeil! is locat.ed 
exclusively in the cytoplasm, these ratios ~efJect the 
redox-state of the free adenine dinu~leotides i~ that 
compartment. of the liver cell (Williamso~; VlnG and 
Krebs, 1967). Further, since it is well-rGcognised 
that glycolysis and gluconeogenesi s in liver' a.r.e 
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cytoplasmic events, where during glycolysis, hydrogen 
+ transfer f-com glyceraldehyde-3-phosphate to NAD takes 
place, with the reverse process in gluconeogenesis, 
the direcU.oll of the two, depends on the redox-state 
of the hydrogen carrieJ system (hTilliamson, Lund and 
Krebs, 1967). 
Our dE(ta therefore show that the liver of tumour-
bearing rrd c:~ is in a more reduced state than normal, 
and by 8.na]ogy with similar change in fasted rats 
(Williamsor. t Lund and Krebs, 1967) this might favour 
gluconeogeops:i.s. This would also support our previous 
proposal, that the increased citrate content of these 
livers WUttl(~. favour gluconeogenesis due to citrate-
inhibiti_cl1. ·)f phosphofructokinase. However, the 
provisOf1lust be made that such a change in the NAD + / 
NADH ratio vwuld also tend to suppress the conversion 
cf lac.tai.:e to pyruvate, and hence d(~crease gluconeogenesis 
from this source, as has been shm'Tn to occur during 
ethanol n.1:otabo'_ism (Lochner, Wulff, and Madison, 1967). 
A decrea~~ in the oxaloacetate in the cytoplasm of the 
liver ceil ~.v\)Uld also indicate increased utilisation 
for glucos(; synthesis, as has b""on reported by '\-\fielar:d 
( '968\ ' .L .: l.n rats under gluconeogenic conditions. As 
discus~cd l~ter (p. 105) it should however be noted 
-Chat cerL1at:cln of the tissue content of these 
metab(;l i::08 ty calculation require that certain 
9.ssnmptiuns are necessary, as described in detail by 
Lund and Krebs, (1967) and this necessitates 
that much caution is used in the interpretation of 
~uch datao 
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Whether a fall in the mitochondrial oxaloacetate 
content in these livers would decrease the rate of the 
tricarboxylic acid cycle, since this compound is one 
of the su.bstrates for citrate synthase, with a 
concomitant decrease in energy available to the cell, 
remains to be clarified. It is of interest however 
that the second substrate for citrate synthase, namely 
acetyl CoAs is also knOlVD to be decreased significantly 
in these livers, as was the ATP conteI1t in livers of 
mice bearing TLX~5 lymphoma. 
As has been discussed in detail by several workers 
(Wieland, 1968; Tepperman and Tep?CClPo'], 1970; 
Newsholme and Start, 1973), a decreasc;d rate of the 
tricarboxylic acid. cycle necessitat2::; .:..:.cijustments in 
order for the cell to obtain enp.Tc?;Y, fmd thIs is 
achieved under gluconeogenic coy,d i. ti0n'::i: by :Lnc'J.: eased 
oxidation of fatty acids to acetyl CoA ~iLh for~~tion 
of acetoacetate, and liberation of free CoA. 
These compensatory mechanisms w0ul:i therefore 
appear to be lacking in livers of tUr:.1uu.r -oE:::-tring mice. 
The significant decreases in the he-oati f..'- C'ontents 
of glucose-6~phosphate and fructos2~,G ·pl'.o3phate cequires 
verification in other tumour-bearing anima:'s, dUE to 
the possible effects of invasion of Ij\1~r by th(O l_yrr,phoma 
cells. A fall in the content of tlJe~e heA:ose mnno·· 
phosphates may have been due to anor(!?:~8. i~. ~n(~se 
animals since in starved rats, the C0-;]rE' .. ::t.s of 0~t~-1. 
metabolites in liver decrease (Start and Ne\;shoLne, 
1970) • 
that this only occurred 'dhen the glycogen stores became 
103 
depleted. Under these conditions, the maximal 
activities of pbosphofructokinase and fructose 
diphosphatase do not change, as was also found in liver 
of mice bearing TLX-5 lymphoma. In this connection 
it'is of interest that in an earlier study (Gutman, 
Thilo and Biran, 1969) it was reported that the activity 
of fructose diphosphatase was only marginally increased 
in liver of rats bearing a non-metastasising sarcoma. 
Since fructose-6-phosphate is a substrate for 
phosphofructokinase a decrease in the hepatic contents 
of this metabolite would decrease the act:tvity of the 
enzyme) and if as has been proposed by Start and 
Newsholme (1970) a substrate cyc,!.e exists between 
fruc.tose-6-phosphate and frue-Lose diphos'l,:lhate, a 
decrease in the activity of the kinase, ~ould result 
, in an increase in the hydrolysis 01'. b::-,lC tose dlphospbate. 
Thus in mice bearing TLX-5 lYltlP'hofIld~ the above. 
findings suggest that the rate 
increased. As was previously sU8~:ested here~ th\?' 
increase in the hepatic content of ~itrdtc~ in J i'ler (.f 
tum(f~:~r-bearing mice would also inrdl)it, 1Jho<:;phofructold_TLo..sc. 
in vivo .. This suggestion however is 'net T.le6Ctscd by 
the findi.ng that, the activity of th:::.s er-zy:n.e \lA~J D;)t 
altered in these livers, since the conr.';'iU'Jus of the 
assay i!1 ,-:itro would have relieved Lhis inb5,bU::icTl. 
, On the basis of a previous repori..'. (Bo'.cnbrol)k, 
Burch and Lowry, 1965) that citrate acclJmulats(l i:1 live:::-
of rats following the inj ec tion of 10.:::::' tate, "h~ exe ... :nined 
the blood lactate content of mice bearing Ser~~~a 180 
or TLX-S lymphoma. The finding that: in the fonner 
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model, the lactate content of blood did not alter, 
whereas in the latter~ significant decreases were 
found, negated this proposal that an increase in blood 
lactate was involved in the accumulation of citrate 
in liver of these animals, since as previously 
described t.his was a feature common to both. 
The significant decreases in the hepatic contents 
of the th:ce2 adenine nucleotides in mice bearing 
Sarcoma 180) and that of ATP and ADP in mice bearing 
the lympho'.T.a was unexpected, since for example a fall 
in the c()Etf'Dt of ATP due to increased utilisation 
would b~ expected to result in an increase in AM:P. 
However, d fic111 in the hepatic contents of ATP and free 
coenzymFo A ':.C'"lll.d be involved in the decreased activity 
of ATP-d.tr,stte lyase which is described later (Chapter ~.). 
As was sho'llm here, the ATP/ADP and ATP/AMP rati.os 
d' -1 lu not cbange 1-n liver of mice bearing Sarcoma 180, 
pnd only the ratio ATP/AMP showed a significant decrease 
in mice ut':arin6 the lymphoma. A fall in the latter 
ratio als0 occurs in liver of starved rats, bu.t under 
the~e conditions, the ATP/ADP ratio also decreases 
(Start and Newsho1me, 1968). However under conditions 
of starv3.ticrJ the energy charge remains constant (Start 
and Ne"l;\7shoLffi-::), 1968, Guynn, Veloso and Veech, 1972). 
The datA. ·vce::;ent.ed here showed that the energy status 
of the cells in liver of tumour-bearing mice was also 
const,=rnt, but until a satisfactory explanation can be 
obtained for the fall in the hepatic contents of the 
thl-ee adenine nucleotides in these livers, little 
interpretation of this carl be lHade. 
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The Problem of Compartmentation 
_______ .~""'.,,"""'..........,. 'I 
The cQution necessary in the use of calculated 
values for metabolites has been stressed by workers 
who have been responsible for the development of such 
methods (Gumma, McLean and Greenbaum, 1971; ~\filliatl1son, 
1969) • Thus the use of the method of Williamson, Lund 
and Krebs (1967) for calculation of the cytosolic 
oxaloacetat': content depends upon near-equilibrium of 
. malate dehydrogenase, and an as sumed gradient for the 
malate dis i:r:rbution. It is now known however that 
both the c..ytosolic and mitochondrial malate dehydrogenase 
are displaced from equilibrium (Tischler, Hecht and 
Williams(Jd, J J /7) and the calculated gradients of oxalo-
acetat'2 dCI :1.0cagree with those found by measurement. 
Therefore t:t:e data presented here. on the cytosolic 
oxaloc.cetal':(-: content are no longer tenable. Init:ially 
in these studies, attempts were made to determine the 
hepatic contents of oxaloacetate, which are notoriously 
c1i:Eficu1 i: du~ mainly to the low content present, and 
resort h£d to be made to the calculated values. These 
hov.7ever r.ave been retained here, but must therefore 
be cons1dc~ed uDly of a preliminary nature offering a 
lead to;·;m·ds further work since in spite of the above 
reserv8b_oT1S, !:.he values were found to be decreased in 
~ . f b" 
.Ll ver 0 tnmJur·· earlng mlce. 
J;' maj or, and obvious defect in the determination 
of the whole cell content of metabolites is the lack 
of knowledge on their distribution in the mitochondrial 
8nd cytosolic compartments, and this has been a major 
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problem in this field. Recently however, methods have 
been developed that permit rapid separation of 
particulate components and cytoplasm of isolated rat 
liver cells (Zuurendonk and Tager, 1974; Tischler, 
Hecht and \\lilliamson, 1977). Some discrepancies 
however have been found between the different methods, 
and further '>'-lork is required before t.heir full potential 
can be explored. 
These methods however have only been applied to 
rat liver, and since the initial st.I".P requires perfusion 
of the exci.sed liver, it is unlike~.y that this could 
be readily achieved in the mouse. 
The dec~eas2 in the glucose CGIlt.er:.t of blood in 
mice beari'l!g Sa.i.TOma 180, is in coni:.;:-ast to a previou.s 
report (Sh:-l!.-0t and Bli"!:lOV, 197/~.) of normal values in 
mice beaLlng this tumOl11:. These \voLlc~ys have proposed 
that in these 2..:blal.s, the normv[;lycaenii3. was due to 
an enhancement of ghi.COIlf':()gene:3J s, thRt depended upon 
the ghl.CQLleogel1~c response of tLI? hos'!: tissues to 
glucoc.ort:i.c.o16s. Stirlli~lation of gleconeogenesis in 
the host h,:'ls &:1 s~~')een proposed to a:count for the 
normoglycaem1.a in Ydts tearing a ncm--metastasising 
sarcoma (Gutlllan, Th:Llo a:1.d Biran~ 1959) due to an 
increased acti vi i.:.j' 01: gluc.ose-6-ph0sphat8.se and 
phosphoeno j py:cuvatc carboxyl:ina.se. 
The pI)Stoi.;)ilit".y cf a~ increb.se in the circulating 
level 'of inslllin i11 mice heo.ring either TLX~5 lymphoma 
of Sarcoma 180 has not Deen examined. It is of 
interest hO\vever, i.'rj,<1t. d';_~llinished serum glucose levels 
in rats bearing Walker 256 carcinoma have been reported 
107 
(Goodlad, Mitchell, McPhail and Clark, 1975) to be 
accompanied by marked decreases in serum insulin 
(and somatomedin). These workers conclude that this 
fall in serum glucose most probably reflects the general 
disturbances of energy metabolism in the host associated 
,>vi th tumour grO'ivth. 
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CHAPTER L~ 
METABOLIC CHANGES IN LIVERS OF TUMOUR-BEARING 
MICE 
~ct~ty~~f Citrate-Cl~avage_J.nz~e in Liver and_the 
Effect of....K.§§ting..En the f:!£P..atic Contents of 
~tyl CoA~ CoASH z Ciga,te and l'Il.gJyce~idesu 
Disturbances of lipid metabolism in turnour<y 
bearing animals have been well-documented. As 
discussed previously in this thesis, such changes 
include loss of body fat (Haven ~:md Bloor, 1956; 
Costa and Holland, 1962), and hyperlip:i.daemia with 
alterations in the pattern of circulati.:!g lipoproteins 
(Creinin and Narayan, 1971; Cox ar.d Gol,cen, 1975; 
Brenneman" Mathur and Spector; 197:). 
The mechanism involved in the. 3.t2ticle>gy cf t~0ese 
changes in tumour-bearing animal s howevpy rem;:dr,.~; unkno';c?,', 
The finding that the hepatic C.OYlt2ILt of c i crate 
was increased in tumour-bearing ~:tic.:: (~hct.?1:er 2), 
prompt.cd the tentative suggestion, 1::1-:.a'..:. tIn,:,; miZ;:---i.t. be 
due to some disturbance of lipid met8Dol l.S!ll 
animals. As mentioned therein~ cttr9ce is the m~in 
source of carbon for the extra mitocho~dri&l synthesis 
of fatty acids in mouse and rat liver (Spencer .~m(l 
Lowenstein, 1962; Bhaduri and STere, 1.963; Spel:r.er, 
Corman and Lowenstein, 1964). 
The initial stage of this reaction is (;l'~aT,,--?_;e of 
citrate in the cytosol to acetyl CoA and oxaloacetate 
by the citrate cleavage enzyme (Spencer and Lo~enstein, 
1962). Nuch evidence has 
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shO\·m that the activity of the e.nzyme in liver is 
dependent on the nutritional status. Thus decreases 
in activity have been reported in starved rats re-fed 
high fat diets (Kornacker and Lowenstein, 1963; 
Kornacker and Lowenstein, 19650.). On the other hand, 
marked increases in activity of the enzyme occur in 
starved rats~ re-fed diets high in eluccse (Kornacker 
and Lowenstein, 1965a). These latte:r: changes are in 
accordance Ivith the marked increase in fatty acid 
synthesis that occur,"when starvec. [lDimals are re-fed 
diets with a low fat content but high content of 
carbohydrate (Tepperman and Tepperrnan: 1958; l1asoro, 
1962; Spencer, Corman and LowensteirJ, 1964). 
In vie;', 0:: the accumulation ot c::'trate that was 
found t.o ,)c: u:r~ in tumour-bearing if..ice ~ it was of 
interest. to eXc'TJine th(~ activity of c.~.trate-c1eavage 
enzyme in liver.., of these animals. In addition, the 
hepatic c.OrLtentc., of acetyl CcA~ CoASH, c.itrate and 
triglycer~(les were studied in Ea::;tcd tumour~bearing 
mice to se~ 0heLh2~ there were chan~~s in acetyl eoA 
, -j" ,. d l' 'd b'l' , aSSoclate( 'Jlt,l tll'7:10Ur-]11duce . lpt mo]_ lsatlon. 
Haterial S P 11(~ j\fethods 
Weight-m2tch~a CBA mice bearing oither TLX-5 
lymphoma or Sarcoma 180 we.re userl. TUffi\)UrS were 
implanted in 1.:.h2:o:e an.ica1~ e;<-act1y as described in 
Chapter 1. 
Other detaiLs as to Lime of fasting animals, and 
the stage of ;'::'UE1'JU:::: 6·~m.;th when the observations were 
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made are detailed in the text. Urine samples from fed 
normal mice and those bearing the tumour were obtained 
by placing the animals in small plastic dishes. Samples 
so obtained were then tested for ketones using a 
conventional test strip (Multistix, Ames), Where the 
effects of starvation were studied the animals were 
placed in clean cages and food but not water withdrawn 
for 48 hours. 
The acetyl CoA, CoASH, citrate, triglyceride 
content of liver, and activity of the citrate cleavage 
enzyme were determined by methods already described. 
The epididymal fat pads were carefl1.lly 'cemo7ed and 
weighed wet. 
Results 
~es in th~J.:J;lycerid~Dt,of_"l::iv2E __ sES,t. 
~i~lgl:~t, .£LEEid~ Fat Pads ~~1 T~:-B~r:ir~u~ij~:e 
Figure 21 shows the changes Ll t,h,:: i:ti_glyceride 
content of liver of mice bearing eithET I'LX·~5 lymphoma 
or Sarcoma 180 • 
. In the former model ~ the triglycerid,-.; cont,£'Llt of 
liver showed no significant change frof'\ no:tTl1a.l v2..1ues 
after seven days of tumour growth. 
In contrast, the data show that 1.n mice bearing 
Sarcoma 180, there were highly signJ fic'::-cnt ::e.1'Jr..:.tions 
in the triglyceride content of live:c of tilt:!se s.nimals. 
In these studies, the detenninations on animals 
12 days following implant, and the mean tumour weight 
+ 
was 4.3 g - 0.36 g S.E.M. 
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TRIGLYCERIDE -GLYCEROl 
pmol!g(Wet Wt.) ± S.E. 
3°l 
TlX-5 LYMPHOMA SARCOMA 180 
20 CJ Controls 
~ Tumour - Beoring . 
FIGURE 21 The trig1yceride~glycerol content of liver 
of mice bearing either TLX-S lymphoma after seven days 
of tumour growth, or Sarcoma 180 ;'liter 12 days of 
tumour growth. 
animals studied. 
Results expressed as r'.Kal.1S of six 
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FIGURE 22 Daily changes in the t:l:ig1yceri'~·?'2:J-yc2.!:ol 
content of liver, and weight of 
in mice bearing TLX-S lymphoma. 
used for each time interval. 
SL<: aniw9L< were 
The daily changes in the triglyceride content of 
liver of mice bearing TLX~S lymphoma were then studied 
over eight days of tumour growth. The "veight of i::he 
epididymal fat pads in these animals were also 
recorded daily. 
From the data shmvn in Figure 22, it will be seen 
that there was a progressive increase in the triglyceride 
content of liver~ which reached significant values 
when compa:i\;d to the control group, on the third day 
of tumour 2,ruwth, and which then decreased to normal 
values by the eighth day. As is also shown, the mean 
weight ~f the epididymal fat pads did not alter from 
normal valuf,s ever t.he eight days of tumour growth. 
Siu('.'3 jt: was previously shown in this thesis that 
in mice bearing TLX-S lymphoma there WB.S a marked 
reduction ~lJ. food intake 9 particularly on the second 
day fo~_loV7i;J.g the inj ection of the tumour cells, and 
that p. rjpcrease in food intake continued over the next 
five c1b.ys ~ the accumulation of triglycerides in liver 
on tilt=:: sesond to third day was attribut.ed to anorexia. 
In contrast to that found in mice bearing TLX-S 
1 vmphoma, tl:e ~veight of t.he epididymal fat pads of 
mice bea:r:-:lPt Sarcoma 180 fell significantly when 
cOHlpared to normal (,-ontrol s. 
JIOW2ver, as also described previously, mice bearing 
Sarcoma 180, although presenting anorexia on the first 
to fourth day following tumour implant, after about 
the sixth day, these animals continued to eat normally. 
Therefore, the decreases in the hepatic content of 
triglycerides could not be related to mlorexia in these 
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animals. 
At this stage of the investigation it therefore 
appeared that the two different twnour systems studied, 
produced different effects on their host in terms of 
mobilisation of fat, or its accumulation. The common 
denominator however, was that as shown previously in 
both models, significant decreases in the acetyl CoA 
content of liver occurred, even though in mice bearing 
Sarcoma 180, the evidence was that fat was being 
mobilised. 
In order to confirm that anorexia was the major 
factor in the accumulation of trigl~rcE:['ides in liver 
of mice bearing TLX-S lymphoma, &:ld since these 
animals did not present complete cE:ssation of food 
intake, the effect of starvation fer l~8 hours en the 
triglyceride content of liver, anJ \"leigll.i: of tlJe 
epididymal fat pads was examin(~d. 
In addition, the effect of a 48 ~)U~ fast on these 
parameters in mice bearing Sarcoma. 180 \!vas 9.l~;o 
studied, as were changes in the hepatic ccnLents of 
acetyl CoA, CoASH and citrate. 
The Ef f ec t ....£L..F as t j,;.n.f~. on Fat Ji.o b i 1 i_sii tJ_ ()n_~1..~ 1 'u~~, 
Bearing2Iice 
The data in Table 16, shows that when tumour-free 
control mice were fasted for 48 hours ~ r.he P.·,t'::"X. \'J~ight. 
of the epididymal fat pads did not aJ.ter signtfi~antly, 
as shown in Figure 23 however marked accumulat:io::l of 
triglycerides in liver occurred. 
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TABLE 16 
THE EFFECT OF FASTING FOR 1.+8 HOURS ON I,TVER 1tJETGHT. AND \·JEIGHT OF THE 
, ---- ------' 
EPID~D\'VlI-I.L FAT F f1.D:3 or Co;'JTRCL HF:E }\i1D !v~ICE BEARING TLX- 5 LYMPHOMA 
,---_.-
I Con~iticns 
1--'---·--' 
--T----,·--------------I-------- wt. Of~1 Fat Pads as I 
t L:':"v€j,:' \It. (~) Epididymal % of I 
.~L __ -__ --------__l_ Fat Pads Body Wt. . I 1.51=0,01; \i Oo898~0.117 I 2.93=0.32 \ l' d C '- ~ I -l!' on,_rC'J .. s 
! Fasted Contrcls 
I p 
. 1.22':"O.Od I 0.870'2:'0.164 2.95':"0.41 I 
__ ~_~?l_ .~__ NoSo N.S. I 
------
1 ;?+n ')'2 1 ~3+0 16- 4 16+0 48 
.L.O_ ..... \../"" \ I I c-J ~ C I .L ~ • 
1 7 L -r 'I -, 2 ' 1 r> 5'-0 '" \ 4 3 " '0 ,- ,-
"'-" +-U~l s 1 J_e,). - J.,...L"J , ,. /.."' ... tiL\.) 
, , 
! t 
N ~ \ N S I II S 
.". '!>VotI t 11 .• $ 1 ~ •• 
--------------'------- ...... ------
Fed Tumour-Bearers 
Fasted Tumour-Bearers 
p 
._--'.-._-----' 
Six animals were studied in each group. 
N.S.= Not Significant. 
Results expressed as means':!:' S.E.M. 
Since liver vJeight is knOlvn to decrease in 
starved ani.mals (Harrison, 1953) as is also demonstrated 
in Table 17, the triglyceride content of these livers 
was also cslculated in terms of whole liver content 
(not shown). However this was still significantly 
increased v7[,.en compared to the fed group (P,,"O.Ol). 
In contrast, fasting did not alter the weight of the 
liver in mice bearing TLX-5 lymphoma (Table 16). 
The data in Table 16 also shows t.hat the mean weight 
of the epidhlymal fat pads in both the fed and fasted 
tumour-bec:ring group had increased by about 50 percent 
compared to the fed or fasted normal animals. Hhen 
these dati-\. ,,"I-::orr=. expressed in terms of a percentage of 
body we:i_gb.:-, ehe fasted normal animals still maintained 
a value close to that of the fed controls. 
The e~fecr of a 48 hour fast on the triglyceride 
content. of live--:.' of mice bearing TLX-5 lymphoma is 
showr: in Figure 23. 
In these animals, fasting induced a significant 
j ncrease (p < 0.001) in the triglyceride content of 
liver wher. c01l1pared to the fed tumour-bearers. It 
will be notC:1 however, that in this experiment, the 
tr.-iglyce:rio p vm1-.ent of liver of the fed tumour-
bearing C::tllll.Tlc.ls was decreased when compared to the 
nOL1naL centrol group. We have no satisfactory 
f;xl-:.lo.no1.:::ion for this, but this does not negate the 
observation that fasting of tumour-bearing animals 
induces an increase in the triglyceride content of 
1 • 
... lver. Thi,s increase hOlvever is lbynomeans comparable 
to the very marked accumulation of triglycerides that 
llL~ 
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FIGURE 23 1he effect of fasting for 48 hours on the 
triglyc.eriderglycerol content of liver of normal mice, 
and mice b~al·in.s TLX-5 lymphoma, Six animals were 
studied ir.. 2ach group. 
T~!G~YCt:RIDE - GLYCEROL 
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The effect of fasting for 48 hours on the 
triglyceride-glycerol content of liver of mice bearing 
Sarcof'1a 180. Six animals were studied in each group. 
occurred when control mice l'Jere fasted for LI8 hour's 
(Figure 2~. 
\m.en similar studies were made on mice bearing 
Sarcoma 180, different effects of fasting of these 
animals were found. 
Thus as shown in Table l7, the mean weight of the 
epididymal fat pads in fed mice bearing Sarcoma 180 
was decreased compared to fed controls. This decrease 
was found to be statistically significant (p.t.: 0.01). 
Although starvation of controls did not produce a 
significant decrease in the weight of the epididymal 
fat pads, a further significant c;2crec..'Je oc.curred 
(p<:- 0.01) in the starved tumour-bcar:'ng erOllp. \m.en 
the mean weight of the fat pads wel:2 expn::,ssed as a 
percentage of body weight, these c~aGges were filso 
significant. 
As is also shown in Table 17, th,~n~ weI:e no 
significant differences in the mean t.Ul"-,-1Gr w0:ight. in 
the fed or fasted mice, and fastirlg chi noL significb.llt!.y 
alter: liver weight in these animaJs, 
'f1-l e data in Figure 24 sho'0'7 t~le effect of a ~g 
hour fast on the triglyceride conthlt of l~.ver of these 
animals. In agreement with the p~~vj~u~ 0bs~rvation, 
the growth of this tumour induced a sig1.1if:i.(:'f:lilt. decro::ase 
in the triglycerides content of liver of fed mice. 
A further decrease occurred as a rasull of fasting 
but this was not significant when c'Jmpared to the fed 
tumour-bearing group. 
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'TABLE 17 
THE EFFECT OFIA§T:::N§ __ XO~~~_1:l0UR~ ON LIVER WElqHI, TUHOl:.JF. l,lEIGHT ~ AND WEIGHT 
OF THE EPIDIDYMf-\!., FAT FADS OF l\fORMi\L T'1IC:G AND NICE D2:<\.RING S.t'.RCO}1..A. 180 
. --_._------,,---
I ---. --- - ---- I ----• 
\ 
Conditions Liver Tumour Wt. of Fat Fat Pads as % Wt. (g) Wt. (g) Pads (g) of Body Wt. 
I + -;- + I Fed Controls 1.46-0.073 - 0.62-0.077 2.25-0.203 
Fasted Controls 1. 21:::-0. 061 + + 
- 0.41-0.068 1. 73-0.231 
p <: 0.05 
- N.S. N.S. 
-~. 
-
Fed Tumour Bearers 1. 42"t0. 024 + 4.31-0.36 + 0.26-0.031 + 1. 00-0.12 
..l.. + + -I-I Fasted Tumour Bearers 1.29':"0.050 3.88-0.21 0.10-0.019 0.41-0.08 
I P N.S. N.S. <: 0.01 < 0.01 
1- ,,-
Si.x animals were studied in each group. 
experiment. 
Tumours were implanted 12 days prior to the 
N.S. = Not Significant. Values given are means :::- S.E.Mo 
I 
~etyl C~ Free S;oA and Citrate in Tumour-13~aring 
Mice 
Acetyl C~~zyme A 8:gd Co{:;~Ji 
Figure 25 shows the effect of fasting for 48 hours 
on the 'total' CoA, CoASH and acetyl CoA content of 
liver of control CBA mice. 
6 These animals had received 2 x 10 normal spleen 
cells lop. from CBA mice seven days prior to the 
study. 
The data clearly shows that fasting i!1duced 
significant increases in the acetyl Col'. (.orrLent of 
liver, whereas the free coenzyme A (:.onteIlt had decreaseCt 
significantly (p ~ 0.001). 
The 'total' CoA values ~ are al.!c:C in 
Figure 25, but as already noted, 111 ~he assay ~ethQd 
used$ thi.s represents the sum of trw aC2tyl COt~ i,nd 
free CoA content and are incl'uded for c:oJT1Jc;.ris~f\ of 
the distribution of the two forms of tpe rC211ZY;::'t-" 
Also shown in Figure 25, is the e:efect of f~,X-5 
lympholTla on the content of these mEt2,b\)Jit(~'J • l' Dl ..... lver, 
where it will be seen that in agreeMent wlch previous 
studies (Chapter 2), marked decreas2s jt1 the acetyl CoA 
and free coenzyme had occurred. 
However in fasted mice bearing TU.(~ ~~ l)-lnph~rp.al 
although the acetyl CoA content of liver increa8sd 
slightly, and that of the free coenzyr,:e 3hc~';~d ..:l slight 
decrease, neither of these chcmges were signi.ficant 
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FIGURE ~S Tlle effect of fasting for 48 hours on 
~he hep8cir:. c.ontents of 'Total' CoA, Acetyl eoA and 
CoASH of. iloLfl1al mice and mice bearing TLX-S lymphoma. 
+ ResuL ts CJ.re expres sed as means - S. E. M. Six 
animals vlere studied in each group, 
when compared to the fed tumour-bearing group. 
Fasting of mice bearing TLX-S lymphoma did not 
therefore induce an increase in the acetyl CoA content 
of liver. 
Results of a similar study on mice bearing Sarcoma 
180 are shown in Figure 26. 
These data show that in fed mice bearing Sarcoma 
180, there are significant decreases in the acetyl CoA 
and free coenzyme A content of liver of these animals, 
when compared to a normal group. 
However when mice bearing SaTe-omu 180 were 
f t d f 1.8 h . 1 ,. . . as -e or + ours prlor to t lef'C (U:Le.~r..l_Ilatl.ons, the 
acetyl CoA content of liver increas2d ~li6hLly~ but 
not significantly so when comparej to the feel tumour~ 
bearing group. Fasting however hH.1Ucsd a sign::"ficant 
decrease in the free coenzyme A COl1tent of liver.. 
Citrate 
Changes in the citrate contEnt of 11,T£I..' of animals 
used in the above studies are pr~SP:1.t2J 1,'"'. Fj gll::e~ 27 
and 280 
The data presented in Figure 27 show rIle significant 
fall in the hepatic content of citrnte following h 48 
hour fast in control mice that had ~ec2ived 2 x 105 
spleen cells intraperitoneally. 
agreement with previous reports of the e~-fc,,:t t.:,[ t?stiLg 
on the citrate content of normal rat li''lcr (Start and 
Newsholme, 1968; Herrera and Frein:ze.1_, 2.f.:)E~>-) .. /.lso 
shown (Figure 27) is the marked increase in citrate 
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¥~ure 27 The effect of fasting for ,.+8 h':.~un; ,.:..n the 
hepEltic. content of citrate in norrnnl mlCC 
bearing TLX-S lymphoma. Results are the meaflS of 
six animals in each group. 
that occurred in fed mice bearing TLX-S lymphoma, when 
compared to fed controls. 
However, when mice bearing TLX-S lymphoma were 
fasted for 48 hours prior to the determination, although 
the citrate content of liver decreased compared to the 
fed tumour-bearing animals, this still remained at a 
high level but was not statistically significant when 
compared to th0 fed tumour bearers. 
In co~trast, although fed mice bearing Sarcoma 
180 showed also an increase in the hepatic content of 
citrate, in agreement with our previous observations 
(Chapter 2 ~ 'I'2.bl_e 5), fasting of a similar group 
bearing thlb tamour further increased the citrate 
content of l;_ver of these animals (Figure 28). 
~ili:. 0:' _C:bJ:X2:.te-Cleavag~l:E.~~yg:~ in biYer~~.f 
k!grmaJ ~ Fastcd and Tumour~Bearin~1ice 
The activity of the citrate cleavage enzyme in 
livers of normal mice, and mice that had been starved 
for 48 hOGYS is shown in Table 18. These data are 
in agre<=:nent ';,'lith the decreased activity of the enzyme 
th.at has bee.' Teported (Kornacker and Lowenstein, 
1965a) tc o:':-.2-ur in normal rats starved for the same 
period. 
fI.1S0 shown are the values for the activity of the 
2nzyme in liver of mice beari.ng TLX~S lymphoma. It 
will be seen that in these animals there was a much 
gY.'eater decrease in activity than that found in starved 
normal mi.ce. Significant reductions in activity of 
citrate cleavage enzyme were also found to occur in mice 
11.8 
)J,mol CITRATE / 9 
LIVER (Wet Wt) 
± S.E.M. 
0·5 
0·4 
0'3 
0·2 
0·1 
FED FED FASTED 
Cl Controls 
r~ Sarcoma 180 
180. Results are the means of six animals '~n each 
group. 
TABLE 18 
ACTIVITY OF CITRATE CLEAVAGE ENZYl1E IN THE EXTRAMITOCHONDRIAL 
.--------. 
SOLUBLE FR,(C:'ION OF lvIOCSE lIVER AT DH 7.5 AND 370 C 
.-----------~------------ ----.... 
----------
--------- ~~ I Enzyme Activity p 
. ____ >____ _ _____ ~[U1n~.2/mg J.~rotein!Hr. ~ 
r--- ( ..l'" ! .;orcLc~ .". lon3 
r ;ed Norufl13 
I Starved N c!.mal s (24 Iir ~ ) 
I~X-5 Lympho~l':. 
Controls 
Sarcoma 180 
o . 6:.9':" 0 • 0 1 7 
O.451~O.015 
J. 
0.172':'0.021 
'"6\ \ / 
(6) 
(6) 
<: O.OOla 
.c( O.OOlb 
. . 
. I 
O.486~O.024 (6) I 
..J... <. 0.01 I 
O • .373~O.G:;:1 (6)· I 
._------ ----.--.------.--~---- --.-- -------------_._--_. j 
Animals bearing TLX-5 lymphoma were studied seven days after tumour implant and 
those bearing Sarcoma 180, 12 days after tu~our implant. 
a and b = Statistical comparison with fed normal mice • 
.L 
Values given are the mean I S.E.Mo Numbers in parenthesis are numbers of mice in 
each group. 
bearing Sarcoma 130. 
Ketone BC2.9ie~ Urine of Normal and Tumour-Bearing 
Mice 
Fed normal mice were found to contain a trace of 
ketone bodies in urine, as were fed mice bearing TLX-S 
lymphoma or Sarcoma 180, after seven and 12 days of 
tumour groVlt.h respectively. 
As snov;n in Table 19, the acetyl CoA/CoASH ratio 
in liver of fed mice bearing Sarcoma 180 Ivas very 
similar to +hat found in normal fed mice. Fasting 
of either llonr..al or mice bearing the Sarcoma increased 
the ratios significantly. In contrast, fed mice 
b . I"PI T~ L 1 1 h d .. f' t' earlng •.. Y_~_) . :rmp 1.oma s owe a Slgnl :Lcan lncrease 
in the (i'2.Fcyl CcA/CoASH ratio when compared to control 
lTic2 t-h8.t had received lymphocytes 1. p. ~ but fe.sting 
of thes~2 Ll1lTlour-bearing animals did not induce a 
significa~t increase. 
Discu3sioE 
StaYV2~ton for a period of 48 hours induced tfatty' 
livers in rlonnal mice but did not cause significant 
depiet.ioE of epididymal adipose tissue in these animals. 
Th~so. cEfects are opposite to those found in starved 
r.3.tS ~ where decreases in the hepatic content of 
triglycerides (Lippel, 1972) and decreases in the weight 
(,£ the epididymal fat pads (Herrera and Freinke1~ 1968; 
Ryan, Blackburn and Clowes, 197Lj.) have been reported. 
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TABLE 19 
THE ACETYL CoA/CoASH RATIOS IN LIVEl~ OF FED 
AND FASTED NORMAL AND TU}10UR~BEARING MICE 
Conditions 
Fed Normal 
Fasted 
Sarcoma 180 (Fed) 
Sarcoma 180 (Fasted) 
Fed Controls (L) 
Fasted Controls (L) 
TLX-S Lymphoma (Fed) 
TLX-S Lymphoma (Fasted) 
Acetyl CoA/CoASH 
1.00±0.OG (6) 
2.11±0.21 (6)a 
1.04:':0.08 (6)b 
2.44±0.22 (6)c 
+ 1.02-0.16 (6) 
2. 8 3·~·O. 12 (6) d 
L47:0.08 (6)e 
2.oito. 3l (6)f 
a = Significant change (Pi.. 0.001) when (~.()mp8.red tc 
normal. 
b = Not significant when compared l:,"'1 normal fed fGl'2.e. 
c = Significant change (p c:. 0.001) when ~o:--1f'c;re(l to 
fed tumour-bearing mice. 
d = Significant change (Pi... 0.001) \';hen c'J:TIt'l8.:r:ed to 
fed normals that had received ITmphc,cy':e'3 ",-,po (1.). 
e :::: Significant change (PL. 0.05) when r.:>nlp:jce.d to fee! 
normals that had received lymphocy tt;S L ~. (L). 
f = Not significant when compared to fed IEice bearing 
TLX-S lymphoma. 
These differ(~nces in response to starvation bet'deen 
the two species, may be due to the fact that lipid 
metabolism is easily perturbed in the mouse. For 
example, Estller (1974.) has shown that 'fatty' livers 
can be induced in mice in as short a time as two hours 
follo\ving the injection of ethanol. But as has recently 
been discussed by H0ms (1975), littJ.F is known of the 
pathogenesis of 'fatty' livers, altho1Jgh nutritional 
factors e. g. dietary deficiencies aye kno\i\7[l to be 
involved (Tucker and Eckstein, F.J:P; \,l:Ll1 i.ams ~ Cardle 
and Header, 1959; Porta and Hartcrnft, 1970). 
In an eay1ier investigation, /,dams (1950) studied 
the effect of starvation on the t.::,t.a~ L~pid content 
of liver of mi~2~earing a trant>plar:tA.ble lymphosarcoma. 
He found th.:11- starvation induced t fe.tty ~ livers in 
these animal.s. In contrast, starvation did not induce 
the aCc.uIliUL-.. tion ')£ lipids in liver:') of lJorrnal mice. 
Adams (1950) ho~·;rcver determined total lipids from the 
nitrogen :.I.:1Q w8.tC'r content oftt:."8f? ] iv,~rs, and his 
data may ther:-efore be suspect. 
In trH') prt's~n': st1J~Hes, tht~re W2:Le some discrepr .... ncies 
when the triglyceride (;ontent of liver of mice bearing 
TLX-5 lymphoIlla "erE: studied, since in one experiment, 
this decreased 81;nificDl1tly wherees l.n another no 
changes occurred. ·We. have DO expla.nac.ion for this, 
but the fact that this t1.1JTlOnr invades liver cannot be 
excluded from the aeti.nlogy of these chcmges. 
Mien lid c.e beari.ng I:he lymphoma were starved the 
hepatic content: of t:rj.~l;,-':erides increased significantly, 
but only to normal values, whereas in mice bearing 
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Sarcoma 180 i.n which the triglyceride content of liver 
was already decreased starvation induced further 
decreases. 
Data from the present studies also showed that in 
mice bearing Sarcoma 180, the weight of the epididymal 
fat pads had decreased significantly, whereas in mice 
bearing the lymphoma, an almost two-fold increase 
occurred. \';lhen the se tumour-bearing mice were starved, 
this had no effect on the weights of the epididymal fat 
pads in mice bearing TLX-S lymphoIT'E-<-, but in mice 
bearing the Sarcoma, further decreas9s occurred. 
'itle.';e 0182rvations sugge sted t!:l.at t.he two tumoUJ:' 
systems stud:1.ed ho.d different efL~c t::': (:[1, lipid metabolism 
in the host, a fact that has been previously observed 
in animals hosting different tumo~lrs t where different 
effects (JIi SerLUfJ total lipids, and ~he p3.ttern of 
lipoprot.elos haVe l'(::211 observed (Liebel t, Liebe.l t and 
Johnston, 1971; Cox and Cokcen: J.975). 
The ):e8,8011 for the increasr;:: In thf-; weight of the 
epididyma:J fElt pads in. mice beaxin8 TLX~S lymphoma is 
unclear. Th'2 possibility ex~_st8 that this tumour 
invades adil)ose tissue ~ as has been c:~scribed in 
d t . l' . b' • "'-AT" 0 9 ° e al In m~ce e&'Y'1nf.; l'LL v 'asr:it€>s' t'JmOl1r by 
Siegler and Koprows1':a. (1962). Also bO'I1nonal 
disturbancP8 :Ln th2se an:L::mls may be in,,'olved since it 
is recognised that l r i"!;l yce-;:idt;O JJpase in adipose tissue 
is regulated b\l ~)c'.Tcral_ ncrmones, both lipolytic and 
antil:Lpolytic (Siddle and Hales, 1975; Nevi7sholme and 
Sta'rt~ 1972; Ne"'dt·D~.:r.e &nd Start, 1973). 
Thus stimulaticr. of L-:iglyceride lipase in 
121 . 
adipose tissue by adrenaline, glucagon or growth 
hormone (Exton et al. 1972) would explain the decrease 
in triglycerides in liver iri mice bearing Sarcoma 180, 
as well as loss of fat from epididymal adipose tissue. 
On the other hand, hyperinsulinism could offer an 
explanation for the increase in weight of the 
epididymal fat pads in mice bearing TLX~·S lymphoma due 
to stimulation of triglyceride synthesis (Topping and 
Mayes, 1972). As was previously reported however 
(Chapter 3), t;ignificant decreases in blood glucose 
levels were found in mice bearing either the lymphoma 
or SarCOIT!a 180, and it is difficult to correlate these 
observations. As discussed later however, an increasE.' 
in the level of circulating insulin could offer illl 
exp1anHtion for the increase in the hepatic content 
of citrB.te in these animals. 
A J:EoPOli: by Ryan, Blackburn and Clowes (197 L!.) 
that starvation of rats with experimental peritonitis 
·L0ve.rter. the depletion of epididymal adipose tissue to 
Dorn,a1 v&lucs, due to increases in serum insulin levels, 
prompted the question of whether mice bearing TLX-S 
lymphol1lE' bAd become septic, but t.his was negated by 
bacte.riological. examination of the ascitic fluid from 
these 8n5.m2.1s. 
The increase in the hepatic content of citrate 
in mice bearing TLX-S lymphoma or Sarcoma 180, raised 
the question as to whether this involved a decrease in 
citT8te cleavage enzyrrle aeti'vity i.n these livers. As 
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shov111 here however, in both models) significant 
decreases in activity had occurred. Decreases in 
activity of the enzyme in normal mice following 48 
hours starvation were also found, and similar changes 
have been reported in starved rats (Kornacker and 
Lowenstein, 1965a), but under these conditions, the 
hepatic content of citrate decreases (Herrera and 
Freinkel, 1968; Start and Newsholme, 1968). However, 
as is well recognised, under conditions of increased 
fatty acid synthesis, e.g. following re-feeding of 
starved rats with glucose (Kornacker and Lowenstein, 
1965a; Lowenstein, 1968), the activity of the citrate-
cleavage enzyme increases (Kornacker and Lowenstein, 
1965a), as does the hepatic content of citrate (Newsholme 
and Start, 1972). But as has been ShO\\'1.1 by Foster 
and Srere (1968), the enzyme is not rat:t:.·-limit.ing in 
fatty acid synthesis, since during the f:irst 12 hours 
following re-feeding of starved rat~ W.~t:l Glucose, the 
marked increase in fatty acid synth~sis was not 
accompanied during that period by an ir.crcase in the 
activity of the citrate cleavage enzyme. 
Whether the decreased act.ivity of t~i.s er:.zy,ne in 
liver of tumour~bearing mice, can '02 relat:d ts th'2 
increase in the citrate content remains tc bE clarified. 
It is of considerable interest however, thc:.t. fa.sting 
of mice bearing Sarcoma 180 induced a further increase 
in the hepatic content of this metabolite, ~nd in mice 
bearing TLX-5 lymphoma, although a df'.:Cl:SB32 oc.cu~"-l·ed 
under these conditions, this was not significant when 
compared to fed tumour-bearing animals. l'nus fasting 
of tumour--bearing mice failed to decrease tlJ~ hepatic 
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content of this metabolite, as occurs In starved normal 
mice, and rats under which conditions in normal animals 
fatty acid synthesis is decreased. 
Possible Effect of the Increase in the Hepatic Content 
of Citrate 
Irrespective of the cause of the increase in the 
hepatic content of citrate in these mice, the possible 
significance of this increase may be derived from the 
part played by this metabolite in the regulation of 
fatty acid synthesis in liver:, since it is an activator 
of acetyl CoA carboxylase (NuIfla, ld ngelman and Lynen, 
1965; Goodridge, 1972). As has beeil ~'h()wn re(\ently 
by Newsho1me and Start (1972), incrf-asf::'; :in the hepatic 
content of citrate occur in starved r~ts refed either 
glucose, fructose s casein or lel!ciri.t~" e:::.ll of \\7ld . .-:h 
elicit insulin release, 
that the physiological significanr:e of tho. increB.se in 
citrate in response to insulin caD~le explained by th(~ 
regulation of fatty acid synthesis :)y L~dc; rGete.bolit<:-. 
Such a proposal would be in acco~rlmlce with the dependence 
of fatty acid synthesis on high levels of sircdlating 
insulin (Fain, Scow, Urgoiti and Ch:cnlic.k, 196~), 
In Table 20 we have compared the daLe. of Ne':'7sholme 
and Start (1972) with the findines here -ceport2G. on 
the hepatic content of citrate in fed ane! fa3te(1 tUlnOU1:~ 
bearing mice. As can be seen, the hepFltic co[' ce.:lt 
of this metabolite in fed and fasted tllifiour-b2aring mice 
are in the main very close to those fOH':LG ~1V r\fc'nholme 
and 
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TABLE 20 
CHANGES IN THE HEPATIC CONTENT OF CITRATE 
IN ANIMALS UNDER DIFFERENT METABOLIC 
Conditions 
Rat (Fed) 
Rat (Starved 48 hrs) 
Mouse (Fed) 
Mouse (Fed) 
Mouse (Starved 
48 hrs) 
Rat (Starved 48 hrs) 
Rat (Starved and 
refed fructose for 
60 minutes) 
Rat (Starved and 
refed glucose for 
,60 minutes) 
Rat (Starved and 
refe~ leucine) 
Fed Mouse (TLX-S 
lymphoma) 
Mouse (TLX-S 
lymphoma) fasted 
48 hrs. 
Fed Mouse (Sarcoma 
180) 
Mouse (Sarcoma 180) 
fasted for 48 hrs. 
CONDITIONS 
Hepatic Content 
pmo1/g Liver 
If' 
Ht._ vJeigb!, 
. + -0.262-0.0L:0 (6) 
+ 00136-0.008 (/+) 
0.160::0.017 (6) 
+ 0.191-0.0.Y~ (6) 
O.OSS~O.OOi) (G) 
+ O. 1LJ·4-0 .006 (L<) 
0.36S"tO.039 
-I-0.370':' 
0.4(n-t0.OL~9 (6) 
O. 309-.t0 • Olj.7 16' \ I 
0.26i~0.036 (S) 
O. 39 7~' 0 • 04 (5) 
Source 
Start and 
Newsho1me 
(1968) 
Figure 9 
Figure 27 
Figure 27 
c.ncl Start 
( J r -', ) . ~1 / / 
~';"i.2urc 28 
Figures in parentheses are numbers of animal;:; used. 
R 1 d "1 + ,., v 1\' .esu ts are expresse as leans - ::>0""01'1. 
Thus in tumour-bearing mice, the increase in the 
hepatic content of citrate would appear to be of 
sufficient magnitude to stimulate fatty acid synthesis 
in liver. In these animals however, this mechanism 
would appear to be continuing in an uncontrolled manner, 
since in contrast to the situation in normal starved 
animals, the hepatic content of citrdte does not fall 
significantly, and in fact as was show'TI. here in mice 
bearing Sarcoma 180, further increasGs occurred under 
conditions of starvation. 
f!.ff~5:..~~ of .Fa~}:in&. on the_Hepatic ,f.C2}:tents ~f A.ce.!:x~ 
~_~~E.i.Suh.§.rl.. jn TUmOtl;r-Bearing Hi~S 
A I.'3.t.ner ',irllilar situation occ.urred when tumour-
bearing ~ice were starved, in that the hepatic content 
of acetyl CoA di.d not increasE in the direction 
expec ted. HO:'7ever tn mice bearing Sare'.nma 180, 
starvation inci~ccd a fuyther decrease in the hepatic 
content r;{ the £-r:-ee C08nZY'1Tle. This was not found in 
mice bearifls Ute' lymphoma, under cOliditions of fasting. 
Al thougb ill !"lice be.ari!1e, Sarcoma 180 there was evid2Hc,e 
that fat was bei.n~ moD:i..].ised, and tha.t [w·:-ther loss of 
fat from the epidi.:lyUtpJ_ adiposetiss'ue occuJ:'red when 
the animals we;:e :'8.stod, this did r~Ol: ~nd.uce an increase 
in the hepati..-:. con~erLts 0f Glcety 1. (:0/\, ,;·'hich would be 
expected, pL'oviding of course th.at th2 .tncreased flux 
of fatty acids was snl.LTl's8d into the oxidative pathway. 
As discussel1 telo,;.; hCI-;\7ever, we fou.nd no evidence of 
ketonuria in fed H.i('e bearing the sarcoma. 
Other workers have studied the effect of starvation 
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on the control of fatty acid synthesis liver of rats 
hosting Hepatoma 7777 (Halperin, Taylor, Cheema-Dhadli, 
Morris and Fritz, 1975). These studies showed that 
starvation induced increases in the hepatic content 
of long~chain acyl CoA, as is also found in normal 
rats under conditions of starvation (Tubbs and Garland, 
1964) • The rate of lipogenesis in these tumour-
bearing rats was also decreased, as was the percentage 
of pyruva·te c:iehydrogenase present in the active form. 
Thus the Y('spoflse of host liver in these animals to 
starvation '",7as similar to that found in starved tumour-
free animals (Tepperman and Teppennan, 1970; Wieland, 
Patzeit F1.nd L8ff1er, 1972). 
Unfori:unately we have no information on the 
hepatic content.s of long-chain acyl CoA compounds in 
livers of t.uTlullr-bearing mice, and whether these would 
inc.rease under c.o:1ditions of starvation. 
Cb~n~_iE the Acetyl CoA/CoASH ~atios 
Tho acetyl CoA/CoASH ratios in liver of fed mice 
bearing Sa!:corn~180 were not significantly altered 
vlhen compa:ced to normal fed mice. Starvation of these 
tutnour- ~)ec,ring animal s increased the ratio to that 
found in stm:,ved normal mice. In contrast, in fed 
mice) tl:.e acsty 1 CoA/CoASH ratio was slightly increased 
c::>mp::lred to nonnal (P(O.05), but when t.hese animals 
v:rcrc s~arved significant. changes in the rati.o did not 
oc-cur. 
It should be noted however, that. in contrast to 
that found in starved tumour~free animals, in which 
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the increas2d ratio is due to increases in acetyl GoA 
and a fall in the free coenzyme A content, in tumour~' 
bearing mice, changes in the ratio are largely dependent 
on a fall in CoASH, since the hepatic contents of 
acetyl CoA in these animals did not increase significantly 
under conditions of fasting. Thus the use of these 
ratios in attempts to interpret possible effects on 
metabolism ~:...n these livers, requires that these 
reservations are taken into consideration. Thus~ 
althougb 8.;:) inc.reased ratio 1 as was found in fed mice 
bearing TLX·~~ lymphoma would be expected to indicate 
increased fatty acid oxidation in liver, we found no 
evidence::>i ketonuria in these animals. It is of 
interest: th?t according to a previous report (Haven, 
Bloor and Rc'.ndall, 1951), theJ_'e was no evidence of 
ketosis in r8.ts bearing Walker 256 carcinoma eV2n though 
" b'l' \-' fbd f "d raplo. mo 1 ::..sa .... lon 0 0 y at was lTI eVl ence. 
However it h8.s been shown that free fatty acids can 
be clev2ted in vivo without increases in ketone synthesis 
(Seyffcr';:' and Madison, 1967). Thus an increased flux 
of fatty acirls to liver is not sufficient in itself 
to induce ketosis (For review see McGarry and Foster~ 
1972) 0 Clec:rly much further information is required 
as to the leVEls of free fatty acids in blood of these 
tlJ.mollr-lx~aJ.-i·1 [~ mice. 
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CHAPTER 5 
THE EFFECT OF CURATIVE RESECTION OF A 
SUBCUTAl\fEOUS HAHriARY TUMOUR ON THE HEPATIC 
CONT!fN_1T __ Q._E __ A_C_E~1_'YL __ C_,0_~,~I1RATE J PYRUVATE 
oC -OXOGLUTARATE AND CoASH Ii~ THE HOUSE 
--------,------~----~--~--~--
Introduction 
In view of the changes that ~vere found in the 
hepati.c contents of acetyl CoA, Ccl'.SH and citrate in 
livers of mice bearing a subcutaneous C3H marnmary turnour 
curative resec:~ion of this turnou:!:: '\A'a:; studied in order 
to establi.sh wh~ther this reverted the changes in 
these 11leto.b()li',:ps to normal valu;::s. 
Part Clf t.his study has been presented elsewhere 
(HcAlliste:r , Soukop and Calman, 197 n. 
Methods 
vleight-rJ8.u;.hed C,H male mice wel'e used throughout. 
:; 
These \'1ere l.:.hree to four months old at the start of 
the experit:l.em::,s. 
Five g.ce.ups of mice were studied~ t.hese were: 
(1) N0rTI!3.l C3H male mice. 
(2) Mice bea:d .. ng the C3H m.JlIlm,8.1:'Y tumour, implanted 
sub~l1taneol1s1y as des(',ribed previously 
"Ch' ., \ \ La pu~ r 1.). 
(3) 'fuID.our-beerin::; mice in which a curative 
resection ha~ teen carried out. 
(4) Sham-operated group of normal mice. 
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(5) Nice in which the tumour had recurred following 
their operation. 
Details 
It was considered essential that the studies 
were carried out at the same period of tumour grm·~th, 
and that the post-operative period was long enough to 
allow for recurrence of the tumour. 
The studies were therefore carriod out as follows: 
Tumour~bearing mice were sacrificed 17 days after 
tumour implant, at which stage the mean weight of the 
+ tumour '.l8.S 0.55 g ~, S.E.M. 0.11 g. CUTative resection 
was carried out on another group ill whj.ch the tumour 
had also been if:1plantcd 17 days e.a:;:lier. After a 
further pe'L·';.oCi of 17 days, these animals were 
sacrificod and to,e et.,ti,nations carried nut on freeze-
clamped liv~.2'..:"s a.S described previously. In the 
operated group, the recurrence £ate of tumour growth 
was about 50 p~.ccent, and this \'Jas Gl.ttributed to tumour 
cells being left in the needle~track at the time of 
inoculation. Another group of norma] mice had a sha.m-
operation, and ::1::en V7eJ.:·~ sacrificed :'.7 days later. 
Su:sgical Resec.tion of Tl1'11oUYS 
~~--.----'------.-.. -"....-~.., ..... -~~; 
Hice were anaesthetised with eth2Y and the tumours 
resected by Professo:!': K G Calman. The wound was then 
sutured and sp:cayeQ \"'_~ th Nobecutane. The same procedure 
was carried (Jut on the sham-operated group of normal 
mice. 
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Estimations 
The acetyl CoA, CoASH, citrate, pyruvate and 
0( -oxoglutarate ,'Jere determined on freeze-clamped 
livers. 
The mean tumour weights, spleen and thymus weights 
were also recorded. 
At autopsy on tumour-bearing mice that had had 
surgical resection of their tumours, a careful 
examination was made to ascertain {,7her.her the tumours 
had recurred. 
Results 
The lflt''::ln '.'~2i:;ht of thymus in the tumour-bearing 
group did 'S')t alter significantly when compared to 
normal ccni:.toL~, (Table 21) but splee:1 weights showed 
significa:nt: i..ncre::i.ses (2 z 0.01). As is also show~ 
. T 11 <'-I • • f h d 1n aD_ e 1._, a C1iL'at1ve resectJJ)n 0 t e tumour reverte 
It will also be 
seenhO\\'c:vET t.hat ''7he1-"'2 the tumOUl: 1:'ecurred fo11o-wing 
resectic1n: :i-"ncreasi.3s it) trle mean weight of spleen 
again occuJ:n~d~ ar.d t-rd,~) was statistically significant 
(p ~ 0.001) when compar2d to the group iIi. 'which the 
surgical re;sec r:.ic,r; was succes sf111. 
In Figure 29 are shown t.he hepatic c0ntent of 
acetyl CoA of no-:.-mat mice; those bearing the mammary 
tumour, and of mice :tn which the tumour had been 
successfully removed or whe:ce the tumour had recurred. 
Values are a1 so sl-lO~'ll' =01~ the sham-operated group. 
The hepatic content of this metabolite was significcmt_ly 
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TABLE 21 
EFFECT OF CURATIVE RESECTION OF A C3H V~ARY 
TUMOUR ON SPLEEN AND THYMUS WEIGHTS IN THE 
MOUSE 
Normal 
Controls 
Tumour BE:are;:-s 
Curative 
Resection 
Unsuccesshll 
Resection 
ShCUll-' Cp e r 8. t i on 
Thymus Wt. (~ 
+ 30.4-2.16 (6) 
19.80±2.73 (6)e 
Spleen \\T!:.. (~) 
a. =: Net 2ignificant when compared to normal controls. 
b :=: Sigrlit"icant (p< 0.01) when compared to normal cont:r:oL..;, 
c = Not si.gnificant when compared to tumour-bearers. 
d - Signific::mt fall in spleen weight when compared 
to t:11mol1 c-bearers. 
G == Not ~;ignl.fic:.ant when compared to curative resection 
f .. SigL:.ificant increase in spleen ,,,eight when compared 
to curative resection group. 
g -. Significant decrease when compared to normal 
controls. 
h = Not significant when compared to normal controls. 
Figures in parentheses are numbers of animals in each group. 
-I-Values in terms of means - S.E.M. 
nmol AcCoA/g 
LIVER WET WT. ± S.E.M. 
IOOr 
I NORMAL TUMOUR SHAM-OPERATION 
50 
r-'E-- TUMOUR r+ RESECTION r-~ ** J r+ I 
RESECTED 
UNSUCCESSFUL I 
I 
! 
! I 
FIGURE ')0 ,_ "7 The effect of curative resection of a 
G3H trallf:;pl.ant.able mammary tumour on the hepatic 
contents of acetyl GoA in the mouse. Results are 
expressed ~5 means. Six animals were studied in 
es.ch grcup. 
f'lmol CoASH/g 
U·lf.R WET WT. ± S.E.M. 
IOOr 
I 
NORMAL 
50 
TUMOUR 
*** 
TUMOUR 
RESECTED SHAM - OPERATION 
UNSUCCESSFUL 
RESECTION 
*** 
fIGURE 30 The effect of curative resection of the 
tlElour on the hepatic content of GoASH. Results 
are expressed as means. 
in each group. 
Six animals were studied 
depressed ill. mice bearing the manunary tumour 
(unoperated group) when compared to normals, confirming 
the previous observation. 
Curative resection of the tumour however had 
reverted the hepatic content of acetyl CoA to normal 
values 17 days after the operation. ~fuere however the 
tumour had recurred, the hepatic content of this 
metabolite again decreased significantly. It will also 
be seen that 17 days after a shrun-operation on normal 
mice, the acetyl CoA content of liver 'ivas found to be 
at normal levels. 
A similar picture is seen in Figu.::.e 30 \vh-3re the 
hepatic contents of free coenzymE~ A ,;:ere studied in 
the five groups of mice. Again tumc~lr growth induced 
a significant fall in CoASH, wherec.~ (;.u;:-ative Tesection 
reverted this to normal values. The llt:nc:.tic content 
of the free coenzyme however again £: ell sJgld.f ~.i.:antly 
in those mice in which the tumour 1:ecurl~ed. 
operation on normal mice had no effect 0D the content 
of the free coenzyme in liver. 
Al though it was shown previously ':hc..t starva.tioIl 
in nOJ .. 111a1 mice induced significant der..re8.ses i-fl ~:.he 
hepatic content of free coenzyme A 1.n live:r ~ the 
decreases in this metabolite reportJ!d l1ere cou1a nGt 
be attributed to anorexia, since .... Lone of the:: groups 
of mice studied showed any ill effecL-o of l-'iLll~.T th2b~ 
operation, or even in those bearing tl1ftIOl~CC; I and i'lOd 
intake remained normal. 
Table 22 shows the hepatic content of citrate, 
pyruvate and 0< -oxoglutarate in the five grc.JuPs of 
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TABLE 22 
THE HEPATIC CONTEI\TS OF CITRA'IE PYRUVATE Al'JD 0< ···CXOGLUTAP.ATE OF MICE 
._------'''''''.. --'---_ .. 
FOLLOWli~G CURATIVZ RESECTION O~i' A C ~H H\JvlMAR'l l'UMOTJR 
______ .•• ___ -. __ • _____ ..:-.l _____ • 
Group 
Normal Controls 
Tllillour-Bearers 
Curative Resection 
Citrate 
mol/g Liver 
0.313'2:-0 . 028 (6) 
0.329:::-0.032 (6) 
0.189±C.016 (6)a 
Unsucc~ssfu1 0.264'2:-0 . 015 (6) I Resectlon 
1
+· a 
_ Sham-Operation 0.138-0.013 (6) 
Pyruvate· . ;.;:~ -Oxoglutarate -1 
J.lffio1/g Liver Lumo1/g Liver 
0.128'2:-0 •024 (6) 0.096-:::-0.020 (6) 
, 
0.097:::-0.016 (6) 0.~17~0.014 (6) 
0.i44'2:-0.024 (6) 0.128:::-0.014 (6) 
0.101:::-0.006 (6) 0.091:::-0.012 (6) 
0.160:::-0.016 (6) 0.129:::-0.015 (6) 
Values given are the mean + S.E.M. Figures in parentheses are the number of animals in 
each group. 
a = Significant fall in citrate (P~O. 01) when compared to normal controls. 
mice studied. As will be seen, the hepatic content 
of citrate of mice bearing the tumour did not alter 
significantly from normal values, nor did the level 
of pyruvate or c{-oxoglutarate. Previously it was shown 
that content of the latter two metabolites in liver of 
mice bearing this tumour did not altel", but it was 
also shown in an earlier Chapter in this thesis, that 
the citrate content increased significantly. It was 
stressed therein however, that this \';18.3 found to occur 
in mice bearing very small C3H mar[lf'1c~ry tumours, and 
that it appeared that this effect, eJS well as causing 
decreases in the acetyl CoA content of liver appeared 
to tail ~ff as the tumour became Ja.I'f,eL, In the 
present stl1dJ.es ~ the mean weight \.J£ t.his tumour in 
th' . 0 55 t- S " '1 0 11 d e unopEJate1j group was • g - , .,:,.!' h • g an 
+ 0.51 g - S,Z.~. 0.03 g in those in whtch curative 
resection was ca~ried out. In the. gr(Yllp in which the 
tumour had Y€CiJire.:: 17 days follovdng the operation, 
,the mean VJciZ11L \\:as very clos2 to Lhose in the other 
. 
-.- , 
groups, being S.53 g - S.E.M. O.Gll g. 
As is also sh,()\vn in Table 22, curative resection 
in fact decr~aspd the citrate co~tent of liver 
significant ly (~ • .;: (). 01) wl:en compared to llormal 
controls, bilt ;~hi~ p:roe-edure did not alter either the 
)~t is of 
interest that the: sham··oper:ated group also showed 
significar,t dec'cea;js.~' in the c.it'l:'3.te c011tent of liver, 
but again Lh2 ?Yi:IJVdte. (.:;." ~ ~oxoglutarate did not 
change. We have T10 adequate explanation for these 
changes in cicrate ,.,oni:..ellL which would appear from 
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the evidence to be due to some effect of the operation. 
In Figure 31 are shovm the mean weight of the 
epididymal fat pads in these animals. In the tumour-
bearing group, and in those in which the tumour had 
recurred significant increases were found (P~0.02 
and .c.. 0.05 respectively). Successful resection of the 
tumour reverted this effect of the tumour to normal 
values, and a sham-operation on normal mice did not 
alter the mean weight of the fat pads from normal 
values. 
DISCUSSION 
The data p·.cesented show that the c.hanges 
previo~~ly found in the hepatic contents of acetyl 
CoA~ and CoASH in mice bearing a transplantable 
mamrnary tll,,10ur :'.an revert to normal following curative 
resection. Th,-:se changes again occurred when the 
resec.t.ton was unsuccessful, adding further support to 
the CO-::-i:':'2pt that the changes induced by the tumour in 
the cont~ilt of these metabolites in liver are effected 
by the rele2.se of some produ'2'C or products from the 
tUl1l0Ut:' cellS. 
Other reports also show that some of the systemic 
effects of t.umour growth in small animals can be 
X'e~ .. Tel~:':'E:'d to p(;:r.mal following curative resection. 
Th'1.S S th.Ley and Lerminger (194.9) have shown that the 
increased activity of aldolase in serum of rats 
bearing Sarcoma 256, decreases to normal values 
following removal of the tumour. More recently 
Shirasaka and Fujii (1975) hmle ShO\\T[l that the activity 
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WEIGHT of 
EPIDIDYMAL FAT 
PADS(g) ± S.E.M. 
1·0 
NORMAL 
0·5 
TUMOUR 
* 
TUMOUR 
RESECTED 
UNSUCCESSFUL 
RESECTION 
* 
1 
SHAM - orERATION 
r~ 
I 1 i , 
L--.l---L-_-l---L __ L-L-_---1----L-____ " ~ 
FIGURE 11 The effect of curati'Te ~re~:e('.ti:on of the 
tumour OD. t.hc 'Height of the epididym.<ll, fat pads in 
the mOUSE;. i<e,c:;ul ts a:(e express'2d as means. Six 
animals we 1:"2 st',J(lied in each group, 
of thymidine kinase is increo.sed in liver and seTlllTl 
of rats bearing Yoshida sarcoma (solid type). They 
also showed that these changes rapidly reverted to 
normal whE':tl the tumour was removed, with a decrease in 
about half the activity occurring seven hours 
following the resection. 
It has also been reported that the leukocytosis 
of mice bec)~ing a transplantable marmnary tumour 
regresses following removal of the tumour (Liebelt, 
Gehring, r
'
elmonte, Schuster and Liebelt~ 1974). 
In an effort to establish whether the changes in 
the hepatic contents of different metabolites in liver 
that .wen: fouJ:".Q in tumour-bearing mice were in fact 
due tv prc'(:illCt.S released from tumour cells, an 
investigat.ion working on these lines was next carried 
out, and Chi:;:; is the subject of the next Chapter. 
CHAPTER G 
HETABOLIC CHANGES IN LIVER OF NORHAL HICE 
INDUCED BY INJECTION OF A CELL~FREE PREPARATION 
OF TLX-5 L'll}fPHOl'fA CELLS OR NON~VIABLE TUMOUR 
CELLS 
Introduction 
The previous observations that decreases in the 
hepatic. contents of acetyl CoA, and CoASH, and 
increases in the weight of the epididymal fat pads and 
spleen in mice bearing a C3H mammary tumour could be 
reverted t:o nOl"1l8J. following curative resection of the 
tumour 1 8'..l?;g2S r.ecl that a product or p:~:oducts of the 
tumour cell; might be involved in che 8.e.tiology of 
these chc:nge.s. 
'This chapter: I'.r:".'s,,~~nts evidenc2 th.'3.t changes in 
the. hepatic C01l'i::811ts of ac.etyl. C0A free coenzyme A and 
ci trate, siruil2'L 1'.0 th(')se found :. H t:l!llc.ur- bearing mice ~ 
can be induceo. in r;.orL:'ial mice foLI.O'i'ling the inj ection 
of a c211·']~r~E. p-rt,~?aratio'~i of TLX~.r; lyr;lphoma cells, 
and in some i:nst'&nc.cs 1.;y the injection of the non-viable 
tumour cells o 
Part 0":' these ~t"..ld5_es have becii p:..:csented 
else\vhere (~1cAllis:::C':r, Soukop and CalQan, 1977). 
Huch att,enf:io)'l has been paid to the possibility 
that products of tu...rflour cells may be involved in some 
of the systemic eff\-c.ts of 8 tumour on its host, but 
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the existence of such fac to rs 1n vivo has been d ifficult 
to prove. 
The best knm.VIl product that has been implicated 
in some of these effects is the so ncalled toxohormone, 
that was first isolated from human cancers by Nakahara 
and Fukuoka in 1948. 
Toxohormone 
Interest in this product arose from the observation 
of Nakahara and Fukuoka (191j.9), that inj ec tion of 
normal mice with toxohormone, caused marked decreases 
in the cat8.1az2 activity in liver of these animals, 
and thc::r.c::ior2 siraulated an effect tb.ilt had previously 
been report~J to occur in liver of t~mour-bearing 
animals ~G'.c~2P8tein, Jenrette and HhU:e? 1941). 
LatRr it \,,;a~ sho\\1;-J that treatment: r):r: normal rats 
with toxoho:;..-rnor.~, also hlduC02Q depression in plasma 
iron, thyw.ic c,.t:.:t:ophy, mld increaseD in spleen, liver: 
and adrend.] ~'7e5 ght.3 in these ftnirr:als ( Kampschmidt ~ 
Adams and Hceo)' , 1959). 
Various \vo:Ll\:E:'rs hhve sho\VIl -::-.h2.t toxohormone can 
be extrac t'.:: d from se\/ c:':'al diff 2rEont tUftlOUrS in animals 
( Nakahara and 2-UK-,Ylka, 1958; OkudCi, Ikegami and 
Fujii, 1972). It hEts als() been .IYLl:Lifii:d and its 
chemical corr:positior.l determined ( OhCl.s~l.i and Ono, 1959; 
Olivares, 1970; OLl1da., Ikegami and Fujii, 1972). 
Thes e reporr.~ sug~ est. tlv:lt the material is a peptide 
of low molecillm: ,v-:::igh'l:.-.\ 
However according to Ikegami and 
;" The polyp pt1de is up of 30 to 40 amino acids 
with a high conte t of glut t~, glycin ld 
aspartate (Oltv res, 1970). 
(1972), toxohormone is not a single substance, but a 
mixture consisting of various biologically active 
factors that include a catalase-depressing factor as 
well as one that depresses serum h:on ~_vi~. They 
showed that toxohoTInone obtained from Rhodamine sarcoma 
in the rat would depress the plasIllli iron levels in 
normal rats, but not the activity of catalase in liver 
of these animals. 
Several doubts as to whetheT tcxohormone is a 
tumour-specific product arose by th.'3 finding that this 
materi.al could be extracted in smaLL amounts from 
various nOl.lTIa~. tissues (Greenfield and Meister, 1.951; Day, 
Gabrielso:l anc1 lJ:i.pkind) 1954) or .L"rc,:D cl"J.tolysates of 
n01.i.Tlal tiS;'3l.1.2E' (Olivares, CalLow an(: 1\1oD.toya, 1967). 
AccordiDf to Olivares (1970), however, the small 
amount of toxo:-iormone that is found in normal tissues 
may be d1..V~ ~.:.o 9.utol ysis in ~2i.~.' 
K,3..rr..pscru'1li(i t and Sch'~l.tz (1963) consider that 
toxohorrnoCie is ·LlOi. produl.::.ed by C3,1.1.::.er cells, but more 
probably from bCicteria p:t'esent :i.n rn.c:tr..y tumours., Thi s 
vi.e' . .., has Lleen n~r'.lted by ~'Hxon ('-'.110. Zi1.1mm1 (1966), and 
more recently by Gl~va~os (1970). 
The m:3 .. 1or 0bject:.,::m. t.o the conc.;;pt of toxohormone 
being the [;::.tive f.e..ctor in ~.:.ausing depr'2ssions of 
plasma iron, Qud catalase hctivity in li.ver is that 
these chaI!ge~ -<.i:re r.c,::. Jlai::lt::l.inec. following repeated 
inj ection of th"" !"!l2teri.Ptl inte normal animals which 
apparently c:evelop a tole:cance to it (Kampschrnidt, 
Adams and He-Coy; J,qSY; ).'·I~kuda, Okada~ Akikawa, 
Matsuda and Urushizaki, 1966). 
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Also although catalase activity is well-recognised 
to be depressed in livers of tumour-bearing animals 
(Thompson and Klipfel, 1958; Kampschmidt, 1965), the 
biological significance of this effect is obscure, 
and further it is not specific to the presence of a 
tumour, since the activity of the ei1zyme is also 
decreased in starved t1..lIDour-free anirr.als (Miller, 1948) 
as well as following the injection oE some drugs 
(Hochizuki., Itabashi and Tsukada. 1972) into normal 
animals. 
There is however still current tnterest in the 
toxohonnon<,: prnblC:!TI (Olivares, 1 0 70; K:..:mpschmidt, 1970; 
Ikuda, lkegom:L ;'lPd Fujii, 1972; Gl)o~~~.ac: and Raymond 
1973) ~ and ::;o!E'..:' authorities constclt':T that. the presence 
of a circcll.:<ting toxin may still "ffer the best 
explanatiC'Il for some oj: the systemic effects of a 
growing tL1J!lC nr (K&I1P schmid t , 1970). 
How~ver prnducts ot tumour necrosis (Bdndy, 1972) 
or product.::> of J'"tLltolys~s s eithe.c fl.'or:t tumour cells 
or those ef t.ho sarrou.nding ar.:;a, cannot be excluded 
from th8 aetiolofY of some of these ~[fects (Olivares, 
1970). 
There is alse cor:,.,iderable evid(-nu.; that tumours 
secrete oth~r biologically 2ctive products. These 
include irmmmGsuppressive lllateri-'ll thnt are found in 
the body flu:Lds of (;.oll..:Er patietlts (field and Caspary, 
1972; Glasgow ec D~~. 1.97.~), a3 well as tumour~bearing 
animals (Ch.Ern and Sinc18.ir) 1973; Yamazaki, Nitta and 
Umezawa, 1973), 3.:3 ~"~\ U. 2.8 mnterial that show biological 
activity against a variety of cell types (Smith, 
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Bausher and Adler r 1970; Round, 1970). 
The experiments were designed to eX&'11ine whether 
the changes previously observed in the hepatic contents 
of metabolites in liver of tumour-bearing mice, could 
be due to factors either in tumour cells per se; or 
released from tumour cells in vivo. 
In order however to avoid the possibility of the 
formation of artefacts that might have arisen during 
th~ preparation of extracts of solid tumours such as 
Sarcoma 180, it was decided to US2 the ascitic fluid 
from mice bearing TLX~S lymphoma, Sir:'2.2 this offered 
the closest approximation to condittc'1S j..n vivo. 
Materials and Methods 
Weight-matched three to four HlU!I tl'. 
mice were used throughout the study. 
male CBA 
(a) preparation of Cell-Free_Ji~;!lJe.rnat?-mts"~~.1'LY,;.::-_~ 
!::.zmE homa 
TLX-S lymphoma cells were harvested t:>::'O[:l tTll.ce 
that had been inj ected intraperi t01.eally 'iVi~-i1 ;~ >c J 06 
TLX- 5 lymphoma cell s seven days earl.i€.J:. 
Aliquots of the ascitic fluid we~e then well-
mixed and the number of tumour cells cc'..mted 3.E: 
described previously, then further diluted wi t.:h }lank IS 
Balanced Salt Medium (Flow Laborator.1.t;s) t (I 2iy~ 
2 x 106 tumour cells / 0.5 cm3. 
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The cell suspension was then subjected to high 
speed cent~ifugation for two hours at 100~000 g at a 
o temperature of q. C. This gave a preparation from 
which 'all tumour cells and sub-cellular organelles had 
been removed. 
The supernatant was then carefully removed and 
3 0.5 cm injected into groups of mice. 
TLX",) lymphoma cells were harvested from mice as 
described e.bpve. 
The ~Lscitic. fluid containing the tumour cells 
was then IT'ixed \vith about 5 cm3 of Hank I s Balanced 
Sal t H(~dj.u.iTl) then centrifuged at 2, 700 g for 15 
minutes. '~'he supernatant was then removed, the cells 
resuspended in 1.:be same volume of the medium, then 
recenLrifugeJ under the same conditions. This 
washing process was carried out for a total of three 
times. 
Th~ "Jaslled lymphoma cells were then diluted with 
the same mc:iium, and the number of cells counted as 
descr:beJ previously, then diluted to give a cell 
populat:Lon:.;.f 2 x 106 / 0.5 cm3 of Hank's Balanced 
Sal i: Hedi lml. 
'{he preparation was then well mixed, and frozen 
.tll liquid nitrogen for a few minutes. 
t.hawed out, and refrozen. 
It was then 
The freezing and thawing process was conducted 
for a total of 10 times, then after bringing it to 
room temperature, 0.5 cm3 was injected intraperitoneally 
into groups of mice$ 
Three different control groups were used: 
1. Normal CBA mouse spleen cells were separated as 
describ~d previously then counted and diluted 
with Hi:i;:"lk's Balanced Salt Hedium to give a cell 
pop1.l1at~_cn of 2 x 106 / 0.5 cm3 of the medium. 
This ~.;a..s subj ected to high speed centrifugation 
2. 
3 
exactly 8.8 described above 9 then 0.5 cm of the 
supern[;.t8,nt injected intraperitoneally into mice. 
6 Nor!l121 rr::i.r:.c received 2 x 10 TLX-5 lymphoma 
cell:::: according to the standard procedure, that 
is tht:~ cells were harvested from mice bearing the 
tumour, cour.rted and diluted without further prior 
treatment. 
3. TLX- 5 lJIilphoma cells were harvested as before, 
3 then rni)(ed with approximately 5 cm of Hank's 
BEd 8.D.r-,eJ Salt Hedium. After centrifugation at 
2,700 f, for 10 minutes, the supernatant was removed, 
and the cells resuspended in about 5 cm3 of the 
mecl:l.ulTI. After again centrifuging 1 the supernatant 
was L'elTloved, and the washing process repeated. 
The supernatant 'V'JaS again removed and discarded, 
then the cells were counted and diluted to give a 
cell population of 2 x 106 / 0.5 cm3 and this was 
injected i.p. into mice. 
In sUITmary therefore? five different groups of 
1.41 
animals 'i'Jere studied. These had received: 
1. High~~speed supernatants from TLX-5 lymphoma cells. 
2. Non-viable washed TLX-5 lymphoma cells. 
3. i,Jashed live TLX-5 lymphoma cells. 
4. High~speed supernatants of normal spleen cells. 
5. Untreated viable TLX-5 l~nphoma cells. 
Metabolites Studied 
The hepatic contents of a.c.etyl CoA, CoASH and 
citrate were determined on freeze-clamped livers as 
described previously. 
During the freeze-clamping '"'roceGnre 1-' , a small 
piece of liver was left in sit,2;!, and Elfte:t :-'he main 
portion had been clamped, this rer.mining portion was 
used for the determination of triglycerides. 
Other Determinations 
The liver~ spleen, and thymus ~\7eights we~n:' 
recorded. 
RESULTS 
Notes 
, 
Ell- so 
1. For purposes of clarity, the st~tistical 
significance of the data presented in. the cmr.rosite 
graphs could not be included. However, t~es~ are 
given in Tables adjacent to the Figures, 
2. The injection of normal mice 'i'lith th::: 1:-'~g:i-si=-2ed 
supernatant of normal CBA mice spleen cells had no 
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effect on any of the parametel's studied, with the 
exception that thymus weights increased significantly 
on the first and third day following the injection. 
These data are therefore not itJC'.luded. 
Mice that had received either the cell-free 
preparation of TLX-5 l-ymphoma cells, or the non-viable 
tumour cells showed no ill-effects of this treatment~ 
and no changes were found in the weight of liver of 
these animals. In both groups, observations were 
carried out for a period of 21 days following the 
injections in order to allow sufficient time for growth 
of the tUffi01D:" to occur due to posGi_ble contamination 
of the prc-o.p8ration with viable turnou;: c~lls. At the 
end of this t:L~Le, the animals we'Le l':.x3.mined carefully 
at auto}JEY for any evidence of tumour growth. 
The data presented in Figure :<2 shryw the daily 
changes iT, the:> j: .... epp.tic contents of triglycerides 
following the i.p. injec!:ion of eithey TLX-S lymphoma 
cells, or t.he c~U-free preparatioll ()f the tumour cells. 
In both groups, the triglyceride content in liver 
increas~d in par~ilel, reaching a peak on the second 
day following thE:; illje,..:.t.ions, then fell again in both 
models on the ti .. i:cu ,lay. There was a slight increase 
again. in thr)sO bect--rilJ.g the tumours aE-; well as in those 
that had received the cell-free p~eparation, on the 
third to fifth day_ The latter group however showed 
a further marb:d in~'..r€''lse ~ which reached a peak on the 
sixth day, and therRafter decreased (day 10). This 
was followed by a~ irc~eRse on the 15th day following 
the 
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FIGURE :32 Daily changes in the triglyceride content 
of liver of hli.cc following the i.p. injection of TLX-5 
lymphoIlta cells, or the cell~free preparation of the 
lym1)homa cells. 
. . . Results are expressed as means. 
Six animals were used for each time interval. 
Statistical evaluation of the results however 
showed that changes in the hepatic content of 
triglycerides only reached significance (p <.02) on 
the sixth day following the injection of the cell-free 
preparation. No significant changes occurred at any 
other time, nor in those bearing the tumour. 
fhanges i~~~~ \\Teights (L~re 33) 
The composite graph shown in Figure 33 presents 
the ehanges in the mean thymus 'iV'eights of the four 
models studied. In each of t.hese, thymus weights 
showed increases on the first day following the 
injection, thereafter progressive decrH2ses occurred 
which paralleled each other until t.ho f::'x:th or 
seventh day, at which period the experiments on mice 
bearing the tumour were terminated. 
After the fifth day following thc~ i:1j p.L.ti.cn of 
dead tumour cells, thymus weights in thESe anlr,wJs 
increased and by the 21st day had returr.ed to lLJLITIal 
values. Mice that had received trle cell-t'.::ee :':"umour 
cell preparation also showed B.n :LIJGre!::l.~;e ; r. thyrf'us 
weight from the sixth to the 10th day, 'Lut 
to those that had received the dead tllffiC:lY' 
thymus weights in this group therenfte"_' :.;1::~)wt:::d a further 
fall as determined on the 21st day< 
Chang~ in S£leen Weights (Fi~u~e ~~) 
Spleen weights in mice that had received either 
the dead tumour cells, 
of the tumour cells increased in parallel with those 
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Day 
1 
2 
3 
4 
5 
6 
7 
10 
21 
· \ 
I 
I TABLE 23 
STATISTICAL EVALUATION OF DATA PRESENTED IN FIGURE _ 33 
EFFECT ON THYMUS WEIGHTS 
Cell-free Dead Cells Washed Supernatant Live Cells 
P P P 
N.S. N.S. N.S. 
N.S. 
NoS. N.S. ~ 0.001 
<0.02 
<0.001 < 0.01 
~ 0805 
<: 0.01 N.S. <. 0.001 
N.S. 
<::'0.02 N.S. 
, 
NoS .. = Not significant when compared to control group. 
'Whole' 
Live Cells 
P 
N.S .. 
NoS. 
N .. S .. 
~ 0.05 
~0.01 
Spleen wI. \mgl 
150 
100 
50 
0'-----.--
control 
FIGlJRE 34 
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DC'ily chD.n~es in sp leer, Wf; Lght in the 
four models studied., T{csults arc ex~)::>::,essed as means. 
Six animal s :v(:re used fo:-c each tim~ irot.erval. 
Day 
1 
2 
3 
4 
5 
6 
7 
10 
21 
l'ABLE 24 
STATIS:'ICAL EVAVJAIION OF DATA PRESEX7ED IN FIGUP.E 34 
Cell-tree 
Su.pernatant 
P 
..(0.02 
L 0.01 
<. 0.02 
~ 0.001 
~ 0.001 
<. 0.001 
.t?. 0.001 
N.S. 
EFiECT ON SPLEK\f 'V7EIGH'IS 
Dead Cells 
P 
N.S. 
N.S" 
~ 0.01 
<:: 0.001 
<: 0.001 
Washed 
Live Cells 
p 
N.S .. 
N"S" 
.(. 0.001 
z 0.001 
NoS .. = Not significant when compared to control groupo 
'Whole' 
Live Cells 
P 
N.S. 
<: 0.02 
< 0.01 
< 0.001 
<:. 0.001 
from mice growing the tumour, Thereafter, spleen 
weights of those that had received either the dead 
tumour cells, or the cell-free preparation showed a 
progressive fall that had returned to normal values 
on the 21st day following the inoculations. Mice that. 
had received the 'whole' live tumour cells however 
showed a greater increase in spleen weight on the 
seventh day when the experiment was terminated, than 
in those that had received the washed tumour cells. 
Inj ~ctio"'. of the cell-free p'c~parat.ion into normal 
. . d 1 • • f" . t' h t' nnce J.n "\Jt..:;.eG. slgrJ.J_ -lcant lncreaSE~S :J...Q .ne epa -lC 
content of ~"U,.l.:3.t~ on the first anti, s,~c.ond day, these 
changes \\'e':,:> ?aralleled in miCe that had received the 
'whole! j.~LVC tl.~'TICUr C2U_S, with incr.?a::;p.s in the hepatic 
content of thi~ metabolite occurring on th~ first, 
d . t' . d ' sec.on. antJ llL':" Q2y. In these an i.mals, the ci.trate 
content t:l.en dc,:,,:~eased t') nOrm[l::. values on the fourth 
day ,but ;:'[k_l rr::,~e to highly significant values (p~ 0,001) 
ex-;;>erimE;'nt was terminatc;d. 
The cell-free prpr/a't:'.s,t·~_\JT'. of the CL.,mour cells however 
did not in-luce .o>.ny f 1.l:c:·her significant c.hanges in the 
hepatic contelx 'Ji c:L trrlte in the recipients. 
In C on'Crast, l!l mice t.hat. Lad Y(~c.ei ved the non-
viable tumour cells, the .::.itrate content of liver 
decreased si.£;EificRl'ltl)' en the first day, C' • .nd no 
significant: char.ges occ'~r!:'ed until the 21st day, when 
the hepatic ,:,-cmtl'n: I.hen increased significantly. 
\-Jashing of the live tumour cells prior to their 
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Dr.c!.ily changes in the hepatic content of 
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expressed as means. Six animals were used for each 
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TABLE 25 
STATISTICAL EVALUATION OF DATA PRESENTED IN FIGURE 35 
EFFECT ON THE HEPATIC CONTENT OF CITRATE 
Cell-free Dead Cells Washed Supernatant Live Cells 
p p p 
<: 0.01 < 0.05 N~So 
<" 0.02 
N.S~ t~ 6 S e < 0.02 
N.S8 
N • .3~ ~ .. , S~ 
='T. S • 
N. ·s. IJ • ~ $ <- 0.001 
l'f:'f S. 
N.S~ <. C.Os 
N. S .. = Not. sigr~ificant when compared to cont'J:-ol group. 
'Whole' 
Live Cells 
P 
< 0.01 
< 0.05 
< 0.02 
N.S. 
<. 0.001 
injection into normal mice, appeared to delay the 
initial changes in the citrate content of liver, which 
only showed a significant increase on the third day. 
HO'i\Tever, a highly significant increase had occurred 
on the seventh day, in parallel '!.lith those that had 
received the 'whole' live tumour cells. 
Changes in the Hepatic Content of !Total' CoA (Figure 36) _~ __ -_ e==m- ... ~ ____ "
Nice that had received the 'V7hole l live tumour 
cells showed significant decreases -l"t"!. the hepatic 
content of 'total' CoA over the wh,)le six days following 
,the inj eelion. These changes W2re paralleled closely 
with those th&t had received the ~ell-free preparation 
of the tlJIt,(Y,.1.r c:.~-;lls, with signLCic8,nt. d.ecreases also 
occurrinf from the first to the: sixl:h day. In these 
animals J dil::' l!.c~creased ~ontent of t t'JLl.l Y CoA was 
maintain·.ld '~p to the 10th clay ~ bnt hadr:~turned to 
normal on ti-;.e ~l::::t dav. 
As WEtS seE>:"~. in the-: delay U)r1.~ occurred before the 
onset of ch8L1ges in the b.epaLis. c(·lttent of citrate in 
mice th.c\t had. J~ec...~ived t.h2 Kashl:~rl. live tumour cells, 
the I total! Cell.. i.E 1. i V::"0:>;:'8 of these aniP-IcJls did not 
change sign] £j cant-Iy el, the first-. day following the 
inj ec tion ~ anu. hdC: not. D.l tered sigroificantly on the 
third day, but: on the seven:-.h day ~ ,,,1::.en the experiment 
'vas terminatE:d, highly sj.8;nificant reductions in the 
hepatic centent of 't<..'i:al' CoA had occur:red. The 
ini tial chG.lLges in aId.mals that had received the 
washed live l.UITl0111: r..·.pl~.s in fact paralleled those tha.t 
had received the non-viable tumour c.ells; with inc.reases 
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TABLE 26 
STATISTICAL EVALUATION OF DATA PRESENTED IN FIGURE 36 
EFFECT ON THE HEPATIC CONTENT OF 'TOTAL f GoA 
Cell-free Dead Cells vlashed Supernatant Live Cells 
p p p 
.( 0.02 < 0.001 NQS • 
.( 0.001 
< 0.001 N .. S~ N,Sc> 
<: 0.02 
.< 0 .. OOj_ ,~ 0.001 
I( O.o~ 
-< O. (()l ~~ ~ 0., <: 0.001 
<C. 0,001 
N r-~ , ;:'. I': ~ S • 
t;-. S. = Not si£n-Lficant wrhen cO:7lpareo. to con1::::-ol group. 
'Whole' 
Live Cells 
p 
< 0.001 
< 0.01 
< 0.02 
"" 0.05 
< 0.001 
< 0.001 
occurri.ng on the first days which in the case of the 
latter modpl this change was highly significant 
(p~o. 001). The 'total' CoA in liver of animals 
that had T2ceived the non~viable tumour cells then 
fell in parallel with those growing the tumours with 
a signific:::mt decrease being found on the fifth day. 
Changes in ~.J1e HeI2.atic_=Cont:~"l.ts of Acetvl CoA and 
foASH (!.~g~I2s 37 and 38) 
Mice chat had received the cell-free preparation 
of the tum01n~ cells, showed a significant fall in t.he 
hepatic (;'O.:1.tents of acetyl CoA on the second and third 
day fol10wh'b the inj ection (Figure 37). Thereafter, 
no sig1l.:i.f:l(:'G.:r.t changes were found, until the seventh 
and 10th day, ·ihen marked decreases occurred (P<: 0.001). 
On thE 21st Gay~ however, the hepatic contents of this 
ITLstaboli te hs,d roturned to normal values. In contras t, l.n 
anim:J.ls that had received the 'whole f live tumour cells s 
tben;"! ",-eYe s!.gnificant decreases in the hepatic content 
of acetyl C()A on the first day with no further changes 
until the fifth and sixth day when signific.ant decreas(~s 
again ocC';u~red (p "::'0. 05 and <: 0, 001 respectively). 
As S110VvTI in Figure 38, signi.ficant changes in the 
hepatic COYltent of CoASH occurred in normal mice on 
thE: fJ.r8t~ seeoEd and third day following the injection 
of t.he cell-free preparation of the tumour cells~ and 
1n this respect paralleled closely similar changes 
occurring at that period in mice growing the tumour. 
Bowever in the latter group the hepatic content of 
11+ 7 . 
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FIGURE 37 Daily changes in the he1!atic.:. content of 
acetyl CoA in mice following the inj~ction of TLX-S 
lymphoma cell s, or a cell-free pr.epD.r8t.iou of L.he cell s. 
Results are expressed as means. 
used for each time interval. 
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FIGURE 38 Daily changes in the hepatic content of 
CoASH in mice following the injection of TLX-5 lymphoma 
cells or a cell-free preparation of the cells. :Results 
are expressed as means. Six animals were use~ for 
each time interval. 
six days of tumour growth, whereas in those that had 
received the cell-free preparation the hepatic content 
of this metabolite again decreased significantly on 
the seventh and lOth day. 
In contrast, in mice that had received the non-
viable tumour cells (Figure 39), there was a significant 
increase in the hepatic content of acetyl CoA and 
CoASH on the first day following the injection. On 
the fifth day however, significar1t decreases occured 
in the level of both metabolites. 
When the TLX-S lymphoma cells were washed prior 
to their il'j~y;t:ioll into normal mic.C9 the hepatic 
content cf a-:.ctyl eoA decreased s-Lgnif~_cantly (p ~ 0.05) 
on the f1",(,8t, day' (data not shown) ~ '.'i.i.ttl no further 
signific('l,nt.: cD8nges until the fifth an.d seventh day, 
when decreases (F.1., C. 001 and.4 O. 01 re8~)E:ctively) 
occurred. The.32 chc:m~es w'erE; similar t,J those found 
at these periods in mice foll~wjng the injection of 
the '"I.'/hole! liv'2 tumour cells. 
HO'iveV2T in C0I! trast, i t \\~as found that the 
inj ection of l:he washed tumour ccl'Ls :~nto· mice did 
not induce sign:~ficant ,iee-reases in t-he b(~patic 
content of CoASB: (d.ata not shown) unt.il the fifth day 
following t~e injec~ion. ~his was ~n marked contrast 
to those animo,ls d~8cribed 3.bo'1'" that. hi3.d received 
the 'whole I ] i'T2 tl"!.~.,our cellt::. 
Normal mice that had received the cell-free 
preparation of TLX~':, lymphoma cells or non··viable 
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TABLE 27 
STATISTICAL EVALUATION OF DATA yR~SENT~~N _fIGURES 37, 38 AND 39 
Day 
, 
2 
3 
4 
5 
6 
7 
10 
21 
EFF'SC'J' ON Tn E REP ATI C CON'},SNT OF ACETYL eoA 
Ce '1.1- :C-ce e 
Su}?ernai.::.':3.Dt 
.? 
N.S. 
< 0.001 
~. 0.01 
N .. S. 
N"S. 
< 0.001 
< 0.001 
N.S. 
-,-_. ---",---_.--------
:Jead Cells 
p 
~ O. 001 
H.S., 
< ,-. (' 'i 
. V. v ... 
N.S. 
N.S. 
'v.,1hole' 
Live Cells 
p 
<. 0.02 
NoS. 
N.S .. 
rq 3 S-
~ 0.05 
<=0.001 
NoS 0 = Not significaIlt 't\7hen compared to control group.' 
TABLE 28 
STATISTICAL EVALUATION OF DATA PRESENTED IN FIGURES 37, 38 AND 39 
EFFECT ON THE HEPATIC CONTENT OF CoASH 
Day Cell-free Dead Cells 
'~fuole t 
Supernatant Live Cells 
p p P 
1 ~ 0.05 .( 0.05 L. 0.01 
2 ~ 0.01 .::;;, 0.01 
3 <. 0.02 NoSe <. 0.001 
4 NtiS" < 0.05 
5 c.: 0.001 ~ 0.001 
,- 1'1. S eo <- 0.001 iJ 
7 t' C _ (l.j N.S. 
10 <0.01 
21 r~. s .. N.So 
N.S .. = ~Jot significant when compared to control grou.p. 
tumour cells showed no changes in the catalase activity 
of liver (data not shmvn), although as shown in 
Figure 40 in mice growing the tumour, a significant 
decrease in activity of the enzyme occurred from the 
first day following inoculation with the tumour cells, 
until the seventh day, when the experiment was 
terminated. 
The laf.-k of response in the activity of catalase 
in liver of TIlice that have received either the cell~free 
preparat.icfl) or the non-viable tumours, therefore differ 
in this respect to mice growing the tumour. This may 
have been dUe to the low concentration of the material 
injected. It in no way however implies that toxohOJ:mone 
is presen.t. in these preparations, which as discussed 
previmlsly produces decreases in the activity of this 
enZ)ln:c~ in nOTII1al rat liver. This is however a non-
specific effE'..ct and is also found in normal starved 
rats (Hiller, 1948) and as shovffi in Figure 41 also in 
starvfdn:d.c.e ,. 
DISCDSSI0N 
Heasurer.ient of the daily changes in t:he hepatic 
contents of acetyl CoA, CoASH and citrate in mice 
injection of a cell-free preparation 
of TLX-S lymphoma cells showed that the changes 
produced followed to a large extent, those found in 
mice that had received viable TLX-S lymphoma cells. 
These findings suggested that a product or products 
of the tumour cells are involved in the aetiology of 
the3e changes. They also support the previous 
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S~LX animals were studied in each group. 
observation~ that similar changes in the hepatic 
contents of these metabolites in mice bearing a 
transplantable C3H mammary tumour can revert to 
normal values, following curative resection of the 
tumour. 
A notable feature was that these changes occurred 
24 hours after injection of the cell-free preparation, 
or the live tumour cells (cf. also Figure 8 Chapter 
2) • In fact, the original observation tIl.at viable 
tumour c.ells induced these early changes, was the 
first indication that products present in the ascitic 
fluid might be responsible. 
The cell~free preparation al '30 :i nduced a rapid 
iei!"'t..".f"'~ t?,- ;~~ response in irm:nunolo2;ic:::t:Lly associated 
tissue such as spleen. The onset: of thymic atrophy 
in these animals, also paralleled -t:hese changes in 
thymus of mice bearing the tumour ~ '!:;.ut ;.:~':~ dl.sn::ssed 
earlier thymic atrophy in tl1mour~be3.rin~ animals 
requires clarification. 
Although it was thought that washing of vi;::lble 
TLX-S lymphoma cells might indu.ce 8. dc::1_ay :tn t.h.e onset 
of char..ges in the hepatic content of thesr-:: m2t.at-::)lj tes. 
as well as in spleen and thymus wej ghts; dl~k to removal 
of factors responsible from the sur[ac~ o( the c~lls, 
the results were inconclusive. '!'he p03sH,i1itY8L:o 
exist.s that the washing process in fa,:t ki11c:1 s:)ITce 
of the cells. 
\-Jb.en the non-viable tumour cells were inj ec.ted 
into normal mice, the hepatic contents of acetyl CoA 
and CoASH increased on the day following the injection, 
with a concomitant fall in citrate at that time. As 
discussed previously, these changes in the direction 
of acetyl CoA and citrate were similar to those found 
in liver of starved normal rats (Start and Newsholme, 
1968; Herrera and Freinkel, 1968; HcGarry and Foster, 
1972). 
Later however, a significant decrease in acetyl 
CoA and CoASH occurred on the fifth day in liver of 
these mice, but without a change 1.n th"~ citrate 
content at that time. The heDat:.i c COIltenL of citrate ~ --
in these livers however showed a si[nif::":.:.ant. increase 
~n the 21st day. We have no adeql.18te explanation for 
the changes in the direction of the8t~ iJ~'~t8.bOlit.e'3 on 
the first day following the inj ec::.icr:.l. of L<'1e no·cl-vi2ble 
tumour cells. Observation of these ani'1l.:<ts showed 
however that they suffered no ill~cifecc of the 
injection and as far as could be jtvl;?ec1 fr)od ilit.ake 
rer:-lai ned normal. 
IT: a previous section of this thl';:si s (Cb.::p',-.'?r Ii-) 
it was postulated that a fall in theilep .... iLJ_2. 2.0:'1tent 
of acetyl CoA, and increase in citrate m:i.iSttt be due to 
some disturbance of lipid metabolism L:J these ,'lIlim;:11.s. 
It is of interest therefore in the pLt:.sent CGTIDf'_ction, 
that in studies on the rapid triphasic i.OS3 o~ body 
fat in mice bearing Krebs-2 carcinomct~ Costa i::md 
Holland (1962) have demonstrated that t.he lr..jt:lc+:.:L01.l of 
the frozen and thawed tumour cells into norma1 mice 
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also induced loss of body fat and increases in the 
'f' " f f f 1 14C Th specl lC actlvlty 0 at -rom acetate- -. ey 
concluded however that this effect may have been due 
to an associated virus in their preparation. 
It has also been postulated (Liebelt, Gehring, 
Delmonte, Sctwster and Liebelt, 1974) that the triad 
of fat loss~ suppression of appetite and hyperlipaemia 
in mice bem~ing a stomach tumour might involve the 
release of a humoral factor from the tumour cells. 
Such products have not however been characterised, 
although there is evidence that factors are present 
in the blend of tumour-bearing rats that are responsible 
not only £Dr: stimulation of liver protein synthesis 
and inh~.bid UP of serum protein synthesis (Toporek, 
1973), bl'.t also for the inhibition of NAD-synthesising 
enzymes in li.ver of rats (Waravdekar and Powers, 1.957). 
TLesE. l.2.tter Ylc)'(kers also showed that these effects 
(,·hn be ~ceve:r:sed following removal of the tumOUT. 
Al t;-louGh the studies presented here showed that 
produc.ts ot tumour cell origin may well be involved in 
changes in th2 hepatic contents of acetyl CoA, CoASH 
and ci trqte in liver of tumour~· bearing mice, much 
further work is necessary to define the nature of these 
veoduc t s . 
Hcn.vEver, since Parry and Ghadial1y (1970) have 
, 
shown that treatment of normal rats with 'toxohormone' 
\'Jill induce ultrastructural changes in the hepatocytes 
of these animals, we next examined whether such changes, 
particularly in mitochondria were present in liver of 
tumour~bearing mice, and whether these could be 
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mimicked in normal mice, following the injection of 
cell-free preparations of TLX-5 lymphoma. 
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CHAPTER 7 
A NOTE ON ULTRASTRUCTURAL CHANGES IN LIVER 
OF HICE FOLLOHING THE INJECTION OF A 
CELL-FREE PREPARATION OF TLX-5 LYMPHOl1A 
In recent years, several workers have described 
ultrastructural changes in livers of animals bearing 
different transplanted or induced tumo'.lrs (Ghadially 
and Pc-lrry, 1965; Parry and Ghadja~ .. ly, 1.966, 1967, 
1969; Bhmvan, Friedell and Jacobs, 1975; Khandekar, 
Dardachte, Garg, Tuchweber and Kovacs, 1972). 
Thest: ch&i1:~es include increD.=:,es in the number of 
lysosornes ~\7ith :3Kt?lling a.nd rupLu·.ce oT: Lhese organelles 
(Ghadial1y .!lnd Parry, 1965; Parry and Ghadially, 
1966), pleolllo1:~'hi sm and swelling of I1H~ochondria 
(GhadialJ.y fmd Pct.~~r:19 1965; Parri n.l1ct Gbadially, 
1966) \·;rith 1.'-)S8 ct cri.3tae (Bhmvan, Friedell and 
Jac 'Dc 10/S') . ~O L:), ~ " ! .... / 0 Inc:cease~~ in tDf'! rmInber of microbodies 
have also h:'en reported (Bhaltmn et. &1. 1975). 
has not been ob3er~cd l~ animals bearing different 
types of t1w0ur2~ Qnd it has been su~gested (Khandekar 
et a1. 1972), thdt differences :~n the strain of animal 
used, the type of tumour, and ~he condition of the 
animal at the time i:he ob",ervations are made, may well 
be responsible for these differences. 
It is not the 0hjec~t of this presentation to 
discuss thesE: ultJ:."<'t,srruct 11ral changes in detail, but 
rather to focuss attention on two areas in this field, 
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that were felt to be pertinent to the work in the 
present thesis. First, in view of our previous 
observations of alterations in the hepatic contents 
of several tricarboxylic acid cycle intennediates and 
adenine nucleotides in tumour-bearing mice, it was of 
interest tu examine whether there were ultrastructural 
changes in mitochondria in these livers. Second, 
since it was previously shown that the administration 
of a cell·-free preparation of TLX-5 lymphoma to normal 
mice, c(luJ.d also induce similar changes in the hepatic 
contents of some of these metabolites, we also examined 
whether this treatment would induce ultrastructural 
changes in livE~r. 
PROCEDURES 
Thre.e gT01.T~)S of animals were studied, (a) nOTIIml 
mice ~ (b) mi(~e bearing Sarcoma 180 and (c) mice that 
bad receiv~d 0.5 cm3 i.p. of the cell-free preparation 
of TLX·- 5 lymphoma, details of which have already been 
given (Chapter 6). The choice of mice bearing 
Sarcoma. 180 was dictated by the fact that TLX-5 
lymphoma. InT,Tades liver. 
Sc.rCOTED. 180 was implanted subcutaneously in the 
s1.1bscapulA:r position under light ether anaesthesia as 
previously described. After 12 days of tumour g:r:owth, 
at which period the animals showed no apparent ill-
effects of their tumours, and continued to eat normally, 
they were sacrificed by cervical dislocation. 
As described previously~ mice that had received 
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the cell·ofree preparation of TLX-S lymphoma showed no 
ill-effects of this treatment. These were sacrificed 
two days after injection. In order to check that 
the cell-free preparation was not contaminated with 
the tumour cells, another group of mice that had 
received the same preparation were observed over a 
period of three weeks. No evidence of tumour growth 
could be detected in these animals. 
Immediateiy after sacrifice, small pieces of liver 
were removed from the animals, as well as t.1 from 
normal mice of similar age and the tissue processed 
for electron microscopy by the method 81ready noted. 
RESULTS 
The electron micrographs of ]_iver of mic('; ~earing 
Sarcoma 180 showed swelling of mitochondria with 
prominent vacuolation (Figure 42), loss o£ cris~ae 
was also observed (Figure 43). Tj1E:Se r:.hanges 
contrast markedly with mitochondr:i ~J. ;_1' 
of TJ.ormal mice (Figures 44 and L: 5 >. Oth p~· cl'pn '"0·<:' , .. - - • L.4 b -~ 
h f . ] . . 1 • seen are t e presence 0 a paracrystal _lTI6 J.n~lUSlon, 
and eli latation of the smooth endopJa,<;tuic. rc:~ticLlluril. 
As shown in Figure 46 mitochonnr~a in lIver of 
mice that had received the cell-free. preparation of 
TLX-5 lymphoma, also show swelling wi1:.h pror:tincnt 
vacuolation, and in this respect mimicked thGs,:- tm.md 
in mice bearing Sarcoma 180. Other change'" ::;een in 
those that had received the cell-free pre~oT~t~0c are 
an increElse in the number of microbodies '·Jhich COT1tain 
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paracrystalline inclusions (Figure 4.6) and, as 8hO\\TD 
in Figure 47 a Kupffer cell containing much phagocytosed 
material. 
DISCUSSION 
Changes in the structure of mitochondria in liver 
of mice bearing Sarcoma 180 reported here have also 
been observed in rats bearing a subcutaneous saTcoma 
induced by m,1BA (Parry and Ghaclially, 1966), as well 
as in rats bearing a subcutaneous mammary tumour 
(Bhaw-an, Friedell and Jacobs, 1975). These latter 
worke~cs have also described inc.reases in the nUJllber of 
microbodies in liver of these animals, a::; \'vc.:s also 
found in the present study. 
The reason for ul trast:ructuro 1. C.h8.'.lges in liver 
mitoc.hondria of tumour~bearing animcls -ts uncle;;:tr, 
and have also been observed in states uf i"')lpoxia and 
hyperoxia (Schaffner, 1970) as tllel] as tn iroIl 
deficiencies (Dallman and Goodman, 197]). Acc;:n'ding 
to ot.her workers (Khandekar, Dm~d['chtf:? Tt).('hweb~r and 
Kovacs. 1972) alterations in the u1 tra.Jt::::-~~·.tun; of 
mitochondria in liver of tumour~be8::iTIg ra::s f.lSY 
reflect a direct toxic effect of the t.l.1~Ll0U::r:- on t:1S 
liver. In this connection it is or hlLerE.~t thai.:. 
ultrastructural changes in rat hepatocyte::: h3ve been 
reported by Parry and Ghadial1y (1970) foJ.l()w~.Ls the 
administration of toxohormone to these an:_r.:1al~, These 
changes were similar to those found il1 tUlTIC1!J"-b2aring 
animals 5 and included increases in the mlIl1be.r: or: 
hepatocellular lysosomes, and focal cytoplas:n:.c 
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degenerLttion. Umvever changes in the structure of 
mitochondria were not observed in these studies, and 
as previously reported (Parry and Ghadially, 1969) the 
administration of necrotic tl®our tissue to nOl~al rats 
failed 1:0 induce increases i.n the number of lysosomes, 
and other ultrastructural changes. 
In the studies cited above (Parry and Ghadially, 
1970), th.e animals were given about 100 mg of toxohormone 
daily for a period of 10 days, prior to examination, 
whereas in the present investigation, the material 
injected was derived from 2 x 106 tumour cells. These 
changes i.n mitochondria induced by thi.s treatment were 
observed two days following the injE:~CUN1:, and therefore 
occurred, as was previously shown at a r:-e-r'iod when 
changes in the hepatic contents of [I.cetyl GoA, CoASH 
and ci.trate were also found. 
The present studies thereforl': JU6~~e.S·t Lb:-'l.t t.he 
ultrastructural changes in liver of miu~ 'tJ26X::'ug S~lr.COTTl,:::l 
180 may well involve the re1e':1s2 fact-orE! fr~ln the 
tumour cells. It is of particular incercss thdt che 
cho:Qges observed in the mitochcTh'lria ()f" ~:' '':0 becring the 
sarcom.':-, can also be mimicked in mice foll.~)Y\~::!g the 
inj ection of a preparation from a dlffer\~~.:-. typ'" of tUIEOil'J-:'. 
To suggest however that i.njury to mitocfLondria 
in liver of tumour-bearing mice a:::oe respon;::;ib1c>. for 
the changes in the hepatic contents of: l.DEoth1:J'.Ilites 
studied here would at the present stEtSC:: ,,[ >nO'id.eC1.~;e 
be speculative. 
However, swelling of mitochondria is u3ually 
• l' t . fl' -1= • d' 1. " 1./- • lnalca J.ve 0 - an uncoup lIig 01- OX]. atl ve pncI s;:mory LEl.L.lon 
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(Packer and Utsumi, 1969), but according to Greene 
(1960), mitochondria from liver of -cats bearing Walker 
256 carcinoma did not show a decrease in oxidative 
phosphorylation. Later, other wo:r1.,e·'cs (Baldwin, 
George and Cunningham, 1975) studied respiratory control 
in mitochondria from liver of rats bearing Walker 256 
carcinoma, using more refined techniques. They showed 
that there was no significant difference in the rate 
of loss of respiratory control of Ii.ver mitochondria 
in these animals ~ when compar:ed i:o Donnal controls. 
These obsE;rvations were made on anirnals at a period 
when they presented no ill-effects of their tumours, 
although tumour growth was well advanced. However, 
when anima12 ·br.:;c3ring this tumour TvRre studied in the 
agonal p~ascs mitochondria from livezs could not 
catalvse P;P sY'llthesis 9 They conclude from these 
studi.es t-hl'it. the ultrast.ructural changes in mitochondria 
reported by Pan ... y and Ghadially (1966) in ,rats bearing 
subcutanem.: .. s S8.tcomas i'.:-ldllC8d by DMBA and which were 
observed durin;! the terminal St:~ig2 of life, were due 
to the degenero..tive process of dying, and not as a 
resul t of any di::cect e.f[ect of the tUrl.01Jr on liver. 
ClearJy the VC€:SCi ..... t studies shO\ving that swelling 
of liver rrd ... toc tioDG-r:'i8. occur in app.s.rently heal thy 
animals bearing Sa.!.'::'~-:·llla. 1...80, and Lhat tl-:ese changes 
also occur in tumouY-'-free animals that had received a 
ce11~free p-cep2.ratj.on Gt TLX-5 lymphoma, refute the 
above suggestion. 
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CHAPTER 8 
A NOTE ON THE RELATIONSHIP BET\'JEEN 
THYMIC ATROPHY AND LOSS OF BODY HEIGHT 
IN TUMOUR-BEARING MICE 
Although as discussed previously thymic atrophy 
is a frequent finding in tumour-bearing animals, there 
is still doubt as to the mechanisms i.nvolved. 
Some studies however have indicated that thymic 
atrophy in these animals may be associated with other 
systemic effects of a tumour. Thus S.iegler and 
Koprmvska (1962) noted that the beginl1:i Pg of th)l1nic 
atrophy in mice bearing an undiffE-'reGtj.::it~d C3H tumour 
in ascites fonn, correlated in tine with the 
commencement of hypertrophy of splS'0'n;'.md assuc:i..ated 
fatty changes in liver of these aLliwals 
More recently, Ertl (1973) in an extellsiv(; sC·'..ldy 
on rats bearing the Walker 256 carc;inomp, has shuI'm 
that the beginning of thymic atrcmhv in thEse 
~ ~ 
allirilals 
could be correlated with the co~'~n~em~nt of loss of 
body ·wEc.lght and progressive cachexia. 
These data suggested that in tumou:!:'~·bC;dJ_·i:-lg; 
animals~ there appeared to be a clo~e physioLogj(,al 
relationship between thymic atrophy ard SOH:'2 of Lhe 
systemic effects of a tumour on its hust. 
In view of the importance of tht>sE:: ob:;2rvatJ.oIls, 
we have confirmed these findings in mlOthe~ spec.ies 
of animal, and in one bearing a different tl2.ITtour by 
examining the relati.onship between thymic at~ophy 
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and loss of body weight in mice bearing Sarcoma 180. 
Materials and Methods 
Height-matched three to four month old male CBA 
mice were used throughout. Sarcoma 180 was implanted 
subcutaneously in the subscapular position as described 
in Chapter 1. 
Twenty-·four hours after tumour implant six animals 
were taken, weighed individually~ then sacrificed by 
cervical dislocation. Thymus glands were carefully 
removed and i.veighed rapidly. 
The:reafte-c) the same procedure "Vv'c.s carried out at 
daily for up to 15 days. When t:lI'10Ur growth in these 
mice beC8.flle apparent, the tumour \'1[1.S also carefully 
dissec.ted f~'ee .crom cO'J.nective tissue and weighed. 
Results 
As s(!Q,\\m il., Figure !~8, the ~Rt body weight (body 
weight - tUrIlot:r 'iveight) decreased an the second day 
follo~ving tUlTiO'.2r 1::l1plant, and tl"lis corresponded with 
an increase in thy:nllS v.'eight. 
The initj a1 c1eCre8.S2 in body ~·.Jeight: was most 
likely due ~o the trauma of tuniOUT irr,plant, which we 
have observed previously. 
The initial i7,:f: !:'28. se in thyrrnls weight on the 
second day fel I.e'·ling tl:anO'L,r implant is in agreement 
\'lith Ertl (1973)~ but. :tn his study, this occurred at 
the stage whe'11 the tU:flCU:" became palpable. 
The data pr2sented here (Figure 48), sho\>7 that 
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FIGURE 48. The relationship bet~veen ['h,:: ~\.:giI!:l1n6 'Jf 
thymic atrophy, loss of net weight (body weight minus 
tumour weight) and commencement of tUT.10ur g~ .. r)-.vt~l i.n 
mice bearing Sarcoma 180. 
a marked decrease in thymus weight occurred from the 
second to the fourth day following tumour implant, and 
this continued, although to a lesser degree until the 
15th day when the experiment was te·.cminated. 
It will also be seen that on the fourth day 
decreases in the mean thymus weight cc.>rresponded wit.h 
the stage when the tumour weight became measurable, 
and \'1hen the net body weight (body VJ8ight - tumour 
weight) began to decrease. 
Discussion 
ThE. d<J.ca presented here is in C.I o~-je agreement 
with the finciings of Ertl (1973) \Jho studied these 
changes in rats bearing the Walker 2.'JS carcinoma. 
Thp.yc::"f::>r' only 1:1 the fact that in his study, 
an ini tL:1.1 increat;e in r:hyrilus weight occurred at the 
stage ,-;Then the t:.l1TnOUr became palpable. This he 
attributed to Lhc immune :response: of the host, but in 
studies al.ready' made in mice b.::::ar:i_ng TLX-5 lymphoma 5 
it 'vas shovV'D that the weight of thymus progressively 
decreased foll o~'7iT'.g tUTour implant (Cha?ter 2) • 
Therefore the i:lit.ic.l increase in thy:nHs weights 
reported heee in fTlic:e oRaring Sarc.Oll~cl 180, may depend 
on the type 0': tum0U-L· us~d. 
On the tasis oE studying the stage of thymic 
atrophy in re13.tioll t.o cllanges in other non-involved 
organs in rc:tts hostir:.g r..:he Halker 256 carcinoma, Ert1 
(1973) proposed thaL t 11ese can be correlated with one 
another. He has suggested an arbitrary classification 
in terms of pre- and post··involution of thYTIluS in these 
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animal s. Thus histological studies of adrenals 
showed the beginning of hyperplasia and hyperfunction 
at the pre-involution stage, 'vhereas in the post-
involution stage, this progressed tco exhaustive 
insufficiency. It was also demonstrated (Ertl, 1973) 
that at the pre-involution stage, liver showed the 
beginning of hypertrophy, and in the post.-involution 
stage, increases in liver weight occtlrred. The exact 
significance of these relationships must however await 
further investigation. 
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CONCLUSIONS 
This thesis concludes with a short discussion on 
further approaches considered necessary to elucidate 
some of the metabolic changes described in liver of 
tumour-bearing mice. 
First f the cause of some of these changes. 
Good ev~dence was presented showing that some of 
the charlges io the hepatic content of metabolites 
such as acetyl CoA~ and citrate were mediated by 
products of tumour cell origin, and that such products 
are also involved in some of the ultrastructural 
changes fourLd in liver of tumour-bearing mice. Much 
work is no,,! n'22-eSsary to define the nature of these 
products~ and this is being actively pursued at the 
present thle. The immunological effects of these 
products ero c"lso 'being investigated by Nr John 
B9.nce\d.cz of the Department of Surgery J and by 
Pl"ofessor Kenneth C. Caiman I s group in the Department 
of Clinical Oncology. 
It ·w£..s noted at various stages in this presentation 
that any further biochemical approaches, aimed at 
defining thE- Ifi'O!chanisms involved in some of these 
m8taboli,::. abr:ormali.ties, will require much more 
in[onnf::~ti.on on the hepatic. contents of other metabolic 
intermc:d:Lates~ as well as on the activities of several 
enzymes. However, as was stressed previously, the 
problem of the distribution of these metabolites in the 
~ytoplasmic and mitochondrial compartments remains, 
and must await further assessment by other workers~ 
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of the methods currently available for rapid cell 
fractionation. '>Jhat may be a major problem in the 
application of such techniques to livers of tumour-
bearing animals are the structural abnormalities present 
in the mitochondria. 
However, until these problems of methodology are 
resolved, several experimental approaches suggest 
themselves, which were not possible to explore in the 
time available for the completion of this thesis. 
The mechanisms involved in the accumulation of 
citrate in livers of these mice, requires clarification, 
and here information is required on th,.o activity of 
isoci trate dehydrogenase, as well as the £'82.80n why 
tumour-growth induces marked deCl.'03.:3c::S El the activity 
ofjthe citrate cleavage enzyme. 
111e important fin.ding of Ncvy,sholme c.lld StE.i::...'t (197~) 
that insulin release induces marked .Lnr.~cea3es in the 
hepatic content of citrate in tU!TIc)1lr--free rat.s prompts 
an investigation of the level of circu~0.t:i_::lg i:l.s1l1in 
in these tumour-bearing mice. Ic keepin~ ~ith t~e 
above authors we proposed that the tUrJJur···;_nduced 
increase in the hepatic cont.ent of c.i:-.rf,l.2 vifJ 111u 
stimulate fatty acid synthesis s but. he:;:-e i'-fie [.r.oE181oilS 
situation arose when it was found ttlat starva!:icll 1." r d 
tumour-bearing mice induced a fureher inCYc9.se in 
citrate, and this lead to the suggestLor.. t:-.?t:. ~_n Lh~s<:; 
livers, the regulation of fatty acid synth23is dI'pcared 
to be out of control. Clearly a major stlld:.v ot fa'c 
metabolism in these animals is indic2.i.:.ecL 
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The finding that the decrease in the hepatic 
content of free coenzyme A could not be normalised by 
the administration of pantothenate to these animals 
suggested that there may be a block in the biosynthesis 
of the coenzyme. The deleterious effect that this 
treatment had on the tumour-bearing host defies a 
satisfactory explanation at this stage 9 but clearly 
this may be a very good model for the study of the 
problem of \veight los s induced by a tumour. 
Conc~YYling a possible mechanism for the fall in 
the hepatic contents of free coenzyme in livers of 
tumour-bearing mice, the question arises as to whether 
this reflects an increase in the rate of dissimulation. 
Firstly> il- is only recently that the degradation of 
coenzyme A in living systems has been examined (for 
revie\A' see A1iko, 1975). These studies have shown 
h h'" 1 'h d' , l' f 1 tl,}it t 1e ]_nlt~lEL step III t e lSSlmu atlon 0 tne 
coenzyrTI'? in normal rat liver involves it:.s conversion 
to dephc~cho3 eoA by lysosomal acid phosphatase 
(Bremer, Wnjtczak and Skrede, 1972). It is of interest 
therefcn .. e til::-~t marked increac,es in the number of 
lysosomes, with rupture of thesp organelles, has been 
r:eported to occur in liver of tumour-bearing rats~ as 
shown by eJ cC::'l~on microscopy (Ghadially and Parry, 
1. 96S ~ Pc}!.' ry bnd Ghadially, 19(6), and increases in 
the riumbc:r of lyse somes have also been reported in 
normal rats follmv i.ng the inj ection of toxohorrnone 
(PE',rry aEd Ghadially, 1970). Unfortunately in our 
. mvn studies on ultrastructural changes in livers of 
tumour-bearing mice, a detailed study of lysosomes 
W8.S not ca~cried out, and clearly this is called for. 
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However, in support of these observations, other 
workers have reported incres_sed activity of lysosomal 
enzymes in non~involved liver of patients with cancer 
(Schersten, Wahlqvist and Johannsen, 1969; Schersten, 
Walqvist and Barbaro-Jilderos, 1971), although in the 
former study, it was reported that the activity of 
lysosomal acid phosphatase only showed a tendency to 
increase. 
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ADDENDUM 
Here it is proposed to consider some of the 
s these metabolic changes in liver 
on the condition of the animal, and to consider the 
ssibility of extending some of these studies to 
cancer patients. 
It was noted early in this thesis. that changes 
s metabolites such as acetyl 
CoA could not be related to anorexia or in 
mice. this connection observations 
(1966) are of interest. He 
cachectic rats with untreated alloxan diabetes in 
which the fat stores were completely exhausted, the 
acetyl CoA content of liver remained at normal s. 
In fact a significant decrease in the hepatic content 
of this metabolite is an unusual finding, only 
been previously reported in fasted rats following the 
inhibition of lupolysis by adminis 
nicotinamide (Talke et ale 1973~ European Journal of 
Clinical Investigation 3. 407-474). Of too 
was the observation that fasting of mice 
failed to induce s 
liver, with subsequent sis. means 
that ketone body utilisation by 
as an ternative source s 
to be unavailable to anorexic 
mouse. 
Another important 8 is the decreased 
of both a 
~~~-- - ~-~-----~- ~----------
recent 
mice, 
in s of both 
metabolites. , as was 
information on the s 
in biosynthe s coenzyme in 
se livers, but it may recalled Rapp 
( a non- method as 
s some of these precursors, also found 
s organs of tumour-
however, 
is not complete answered, 
it temic tumour 
such as atrophy, hypertroptty spleen 
so 
rats and mice. 'lAle 
this a good working . s~s .. 
1y, the question as to the ication 
0 s cancer • Little 
is known of the coenzyme A content of blood (Abiko, 
75) , been reported to be in 
blood and urine of humans, and it would be of interest 
to 
metabol 
abnormalities in the of this 
or in its excretion ccm in 
• 
pantothenate s such patie:nts 
too 
s of liver could 'be obtained it would of 
considerable f:t to if 
the hepatic contents of metabolites as 
as ul s the hepatocyte could be 
also detected. 
